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ABSTRACT OF THE DISSERTATION
Characterization of Human Gut Microbiota Dynamics Using Model Communities in
Gnotobiotic Mice
by
Nathaniel Patrick McNulty
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Professor Jeffrey I. Gordon, Chair
The human gut is colonized by a diverse array of microbes, collectively referred to as the micro-
biota. The microbiota’s complexity poses significant challenges in characterizing the rules dictat-
ing its assembly, inferring the functional roles of its component species, and understanding how 
communities sense and respond to changes in their habitat. We developed defined, representative 
model communities comprised of sequenced human gut bacteria that could be characterized in a 
highly controlled manner in gnotobiotic mice, plus a suite of scalable molecular tools for assaying 
community properties. These tools were first used to evaluate how the microbiota is impacted by 
probiotic bacterial strains found in fermented milk products (FMP). Introduction of a consortium 
of five FMP strains resulted in only minimal changes in the structural configuration of a 15-mem-
ber model microbiota. However, RNA-Seq and follow-up mass spectrometry revealed numerous 
functional responses, many related to carbohydrate metabolism. Results from a study performed 
in monozygotic twin pairs confirmed many of our observations in the model microbiota, showing 
that lessons learned from preclinical models can inform the design and interpretation of human 
studies. In a second set of experiments, we evaluated the impact of food on both a model com-
munity and its constituent taxa by feeding gnotobiotic mice oscillating diets of disparate composi-
xiv
tion. In addition to prompt and reversible structural reconfigurations suggesting rules-based diet 
effects, we noted consistent, staggered changes in the representation of many functions within the 
metatranscriptome related to carbohydrate and amino acid metabolism. One prominent commu-
nity member, Bacteroides cellulosilyticus WH2, was identified as an adaptive forager that tailors 
its versatile carbohydrate utilization strategy to the dietary polysaccharides available. The specific 
carbohydrates that trigger expression of many of this organism’s 113 predicted polysaccharide 
utilization loci were identified by RNA-Seq analysis during in vitro growth on 31 distinct carbo-
hydrate substrates, aiding our interpretation of in vivo RNA-Seq and high resolution proteomics 
data. These results offer insight into how gut microbes adapt to dietary perturbations, both at a 
community level and from the perspective of a well-adapted symbiont with exceptional saccharo-
lytic capabilities, and illustrate the value of studying defined models of the human gut microbiota.
xv
“In the vernacular of the times, we must unite and confront these microbes with a non-negotiable 
demand to increase our time of usefulness to them. Mankind should no longer die of infectious 
diseases; hospitals can be made infection-free; we should live in peaceful coexistence with ‘our 
microbes,’ and they should contribute positively to our continued health and well-being.”
-T. D. Luckey (1972)
1Chapter 1
Introduction
2The human gut microbiota: a metabolic organ of substantial complexity
Host-microbial mutualism in the human gastrointestinal tract
While nearly every surface of the human body is colonized with microbes, the greatest density 
of microorganisms is found within the distal colon (1011-1012 CFUs/ml) [1]. Other, more proxi-
mal sites in the gut, including the stomach and duodenum, are also inhabited by microbes, but in 
smaller numbers (<103 to 104 CFUs/ml). The prevailing thought among ecologists today is that this 
population of microbes, collectively referred to as the human gut ‘microbiota’, represents one of 
the earth’s most dynamic and densely-populated ecosystems [2]. If one assumes that the human 
body consists of approximately 1013 cells (as postulated by Theodosius Dobzhansky in 1970, [3]) 
and that the human gut harbors some 1014 microbial cells (as calculated by T.D. Luckey in 1972, 
[1]), it becomes clear that the sum of microbial cells inhabiting each of us exceeds our ‘own’ num-
ber of H. sapiens cells by an order of magnitude. Going one step further, the number of distinct 
microbial genes within the collective genomes of these microbes (the human gut ‘microbiome’) is 
estimated to exceed our human genome’s gene content by perhaps as much as 100-fold. Thus, we 
are living amalgamations of both microbial and non-microbial cells, whose biological operations 
are inextricably linked with one another in a finely tuned mutualism.
Humans and microbes have co-evolved [4]. In exchange for the shelter we provide them, 
our gut microbes carry out important functions that the proteins encoded by our own human genes 
cannot perform. Recent comparative studies of humans, non-human primates, and other mammals 
have found that each species’ microbiota is tailored to include symbionts with traits well-suited 
to the host’s anatomy, diet, and other biological parameters [5,6]. And, the results of microbiota 
transplantation studies in mice and zebrafish suggest that there is selection within a host for those 
microbes well-suited to a particular habitat [7]. While the human genome is probably not chang-
ing very quickly over modern timescales, the conditions in which people live and operate, and 
the environmental factors shaping our gut communities, are changing at a rapid pace. Thus, if we 
are to understand the complexities of our biology and how we are evolving as a species, we must 
3understand who our microbial symbionts are and how our relationship with them is affected by the 
changing ways we live, eat and interact.
Phylogenetic diversity and interpersonal variation
Substantial advances in sequencing technology over the last ten years have allowed microbial 
ecologists to greatly expand the breadth and depth of culture-independent (metagenomic) surveys 
of the human gut [8]. As the per nucleotide cost of DNA sequencing has dropped precipitously, at 
rates even exceeding those predicted by Moore’s Law, researchers have seized on the opportunity 
to enumerate the microbial diversity in a number of human populations differentiated by many 
metrics (e.g., geography, health status, cultural tradition). Collectively, the results of these studies 
provide us with our most comprehensive understanding yet of the incredible diversity that exists in 
the gut, highlighting both similarities and differences that exist between individuals [9,10].
The intestine is home to species from all three domains of life, though it is dominated by the 
Bacteria. Representatives of at least 14 bacterial phyla have been identified in human fecal samples 
to date, including Bacteroidetes, Firmicutes, Proteobacteria, Actinobacteria, Verrucomicrobia, 
Fusobacteria, Tenericutes, Lentisphaerae, TM7, Cyanobacteria, Synergistetes, Spirochaetes, SR1, 
and Deinococcus-Thermus [11]. When more resolved levels of taxonomy are considered, the num-
ber of bacterial phylotypes that colonizes human beings increases dramatically. One helpful, previ-
ously proposed analogy for visualizing the phylogenetic structure of the gut microbiota suggests 
that a community can be represented as a grove of palm trees with long trunks (one tree per bacte-
rial phyla), each trunk topped with fans representative of divergent lineages of related bacteria, and 
each fan comprised of leaflets representative of individuals strains [4]. This illustration emphasizes 
that a great deal of bacterial diversity in the gut exists at the strain level. Although bacteria are 
without question the dominant constituents of the gut ecosystem, this microbial menagerie also 
includes representatives from two other domains (Archaea and Eukaryota), as well as viruses (bac-
teriophage). However, our understanding of non-bacterial diversity in the gut is in its infancy, and 
only a small number of studies addressing this area have been reported so far [12-14].
4Results from some of the deepest surveys suggest that a typical healthy human is colo-
nized by approximately 100-150 bacterial phylotypes [10]. Comparisons of these many bacterial 
phylotypes across individuals suggest that each of us is also colonized with a unique assemblage 
of species [15]. Efforts in recent years to identify a subset of species that reside in all human be-
ings that might constitute a ‘core microbiota’ at the phylogenetic level have not been successful, 
suggesting it is likely that many different configurations of gut phylotypes can achieve stable or 
quasi-stable equilibria, presumably because of functional redundancy between different strains/
subspecies. These observations suggest that the human gut microbiota’s ‘alpha diversity’ (i.e., the 
number of distinct microbial organisms observable within an individual) and ‘beta diversity’ (i.e., 
the degree of differentiation between individuals) are both quite high. The total species diversity 
within human guts, typically represented by ‘gamma diversity’ (the product of alpha and beta di-
versity measures), is therefore quite significant. This staggering complexity presents those study-
ing the gut microbiota in human subjects with significant challenges as they attempt to compile 
generalizable principles about the system and its constituents.
Despite the exceptional diversity described above, there are common themes in community 
structure and composition when comparing the microbiota of different individuals. For example, 
although at least 14 bacterial phyla have been observed in human fecal samples, the overwhelm-
ing majority of bacteria hail from just two: the Bacteroidetes and the Firmicutes (collectively, taxa 
from these two phyla constitute approximately 95% of adult gut communities based on recent 
surveys) [11]. Representatives of the Proteobacteria and Actinobacteria are also common, but are 
typically observed in low numbers (i.e., <3%) in healthy adults. Although microbes common to 
all human communities have proven elusive, some individual taxa and related groups of taxa are 
observed on a regular basis in a large proportion of individuals. One example is Clostridium clus-
ter XIVa of the Firmicutes, which has been suggested to account for as much as 60% of the total 
mucosa-associated microbiota [16]. This cluster includes a number of species (e.g., Ruminococcus 
torques, Ruminococcus obeum, Clostridium symbiosum) that have been detected consistently in 
different subjects from large-scale surveys of the human fecal microbiota [10]. The incidence of 
5some particular species from the genus Bacteroides is also quite high in gut surveys. Some of the 
most common representatives include Bacteroides ovatus, Bacteroides vulgatus, and Bacteroides 
caccae, though there are many others as well. Of those bacteria hailing from the phylum Actino-
bacteria, Collinsella aerofaciens appears to be most prevalent. A confounding factor in accurately 
deciphering the representation of different bacterial taxa among humans representing different 
ages, physiological states, and geographic regions/cultural traditions is the lack of methodological 
standards in microbiota research. Studies may rely on different methods for extracting microbial 
DNA from samples, different PCR primers and cycling conditions to amplify different regions of 
the 16S rRNA gene used as a phylogenetic marker, different sequencing platforms, and different 
bioinformatics tools to deal with artifacts (sequencing errors, chimeras) arising from amplicon 
sequencing. Nevertheless, consistent similarities (and differences) between healthy gut communi-
ties such as those described above are important for the researcher to consider when attempting to 
build experimental models of the healthy human gut microbiota.
Microbial contributions to human physiology and metabolism
The previously described diversity of our gut microbes (and their genes) affords them a central role 
in our physiology and metabolism [17]. These microbes encounter innumerable substrates (e.g., 
dietary compounds, drugs, host molecules, and microbial metabolites, to name a few), and these 
compounds enter the intestinal ecosystem in a number of ways (orally, as components of biliary 
and mucosal secretions, or through the circulatory system). This multiplicity of compounds and 
routes of introduction makes characterizing the biotransformation of different molecules by gut 
microbes especially challenging.
One way the gut microbiota benefits its human host is by salvaging energy from com-
pounds that we are incapable of efficiently processing with our own metabolic machinery [18]. 
Bacteroides spp., for example, are known for their substantial capacity to degrade and ferment a 
broad range of plant-derived polysaccharides and oligosaccharides found within our diets, as well 
as host-derived glycans (e.g., mucin). Gut microbes are thought to liberate energy from some-
6where between 20 and 70 g of carbohydrates per day, suggesting that their impact on the extraction 
of calories from food could be significant [19]. As gut microbes disassemble poly- and oligosac-
charides, they ferment their constituent subunits, generating a number of short-chain fatty acids 
(SCFA; e.g., acetate, propionate, and butyrate) and other end-products (e.g., lactate, succinate, and 
formate) [20]. In addition to serving as important sources of energy for a subset of host cells (e.g., 
colonocytes), these SCFA also stimulate epithelial renewal and facilitate the absorption of salt and 
water in the distal gut [17]. Unfortunately, little is currently known about which microbes within 
these complex communities are responsible for degrading particular dietary substrates.
In addition to strongly influencing macronutrient processing in the distal gut, the micro-
biota also impacts how we process a host of smaller molecules that are exogenously as well as en-
dogenously derived. Several examples of gut microbial biotransformation of orally administered 
drugs have been documented, including the inactivation of digoxin by Eggerthella lenta [21] and 
the deglucuronidation of the chemotherapeutic irinotecan by microbial beta-glucuronidases [22]. 
Gut microbes are also known to play an important role in the deconjugation of bile acids, ensur-
ing efficient reabsorption of free bile acids from the ileum and colon and the loss of only around 
5% of all bile acids in feces [23]. Finally, the microbiota plays an important role in the synthesis 
of some vitamins. Previous work has shown that while adults maintained on a diet low in vitamin 
K do not develop deficiencies even after several weeks, the administration of antibiotics that have 
activity against gut microbes significantly impacts the host’s ability to carry out processes requir-
ing vitamin K [24]. Experiments in conventionally-raised and germ-free rats have demonstrated 
that gut microbial synthesis of biotin is sufficient to meet the animals’ requirements [25]. As with 
macronutrient processing, a detailed understanding of how individual components of the micro-
biota cooperate and compete to process and synthesize micronutrients and other small molecules 
is currently lacking. New approaches to studying the microbiota that reduce the complexity of the 
system while preserving the way in which it operates should allow us to monitor the activities of 
individual members so that we can better understand the roles played by key taxa and the meta-
bolic guilds of which they are members.
7Though beyond the scope of this dissertation, it is important to note that gut microbes 
are also known to play a key role in shaping features of the innate and adaptive immune systems 
[26]. Some gut microbes prevent colonization of the intestine by pathogens or other allochthonous 
(transient) microbes by colonizing mucosal surfaces and/or secreting antimicrobial peptides. Oth-
ers have been shown to exert strong influences on specific subsets of immune cells. For example, 
researchers have reported that members of the genus Clostridium induce the regulatory lineage of 
CD4+ T cells (Tregs) in mice [27]. And still other work has implicated reduced diversity of the 
microbiota, especially during infancy, with increased rates of atopy [28]. Although there have been 
a small number of cases in which specific human gut microbial lineages have been tied to immune 
phenotypes, further dissection of these important and complex interactions is needed.
The need for representative models of the human gut microbiota
Although the importance of studying the gut microbiota in human subjects is undeniable and has 
resulted in many important insights, such studies are limited in several ways and present challeng-
es that can be overcome by studying animal models of the human microbiota. First, it is logisti-
cally difficult, expensive and time-consuming to study the microbiota in recruited human subjects. 
Animal studies (e.g., in mice) are by comparison relatively inexpensive, require shorter amounts 
of time, and are easier to plan and oversee. The expense and logistical challenges of human stud-
ies also typically restricts researchers from carrying out experiments in large cohorts, restricting 
the amount of biological replication that can be built into a study, as well as the number of times 
large-scale human studies can be replicated. Small, unrepeated human studies may not provide the 
statistical power required to work out complex relationships in a system whose biological signals 
may be faint and noisy. Studies in animal models, by comparison, are much more amenable to 
replication. In contrast with human subjects, animals can also be maintained in habitats where 
environmental variables such as diet can be tightly controlled, along with important host param-
eters such as genotype, age, and health status. Additionally, longitudinal studies of the human gut 
8microbiota have in nearly every case been limited to analyses of feces, whereas studies of model 
human microbiota in animals allow for sampling along the length of the gut at the time of sacrifice.
The complexity of the human microbiota makes it extremely difficult to define and charac-
terize relationships between different taxa and between taxa and ecosystem parameters. For exam-
ple, if we assume that in a microbiota comprised of 500 distinct taxonomic groups, all components 
interact with one another, there would be 124,750 distinct pairwise combinations of relationships 
to characterize. Experimental models of the microbiota, on the other hand, can intentionally reduce 
this complexity while preserving the key features of the microbiota. A calculation similar to the 
one above in which a model microbiota of 15 taxa are considered yields a more manageable 105 
distinct pairwise interactions between community members. Additionally, our ability to precisely 
manipulate the composition of the microbiota in humans to test particular hypotheses is extremely 
limited; such manipulations are usually restricted to the administration of antibiotics whose micro-
bial targets constitute a broad range of organisms. Taken together, the many advantages of animal 
studies argue strongly for the development of representative models of the human microbiota 
in mice whose characterization can complement and inform research in human subjects (e.g., 
by generating/testing hypotheses, by helping to define effect sizes, by identifying surrogate and 
mechanism-based biomarkers, etc.).
Creating a defined system: model communities of sequenced human gut microbes
Colonization of germ-free mice with complex, undefined communities[29]
Germ-free (GF) mice can be colonized with microbial communities of different origins and de-
grees of complexity at defined stages of host development. When such colonizations are per-
formed using one or more known microbial species, the resulting animals are often described as 
‘gnotobiotic’ (from the Greek roots gnostos for ‘known’ and bios for ‘life’), though technically 
the term applies to GF animals as well. The microbial communities used as inocula in gnotobiotic 
experiments can be harvested from any number of habitats, including various body sites of con-
9ventionally-raised mice with defined genotypes and physiological phenotypes of interest. These 
communities can be introduced into GF recipients (possessing a desired genotype) to determine 
how much of a donor’s phenotype is transferrable to the resulting ‘conventionalized’ mice via their 
microbiota. If partial or complete phenotypic transfer occurs, follow-up studies can be performed 
in order to define the composition of the donor community, the mechanisms by which the donor 
community impacts host physiology, and how the recipient affects the transplanted microbiota/
microbiome. These types of studies have typically been performed using gut contents [30], but in 
principle could be extended to communities harvested from any body habitat.
Procedures for transplanting human fecal microbial communities into GF mice to generate 
‘humanized’ mouse models have been developed by members of our laboratory [31]. A remarkable 
portion of human fecal microbial community diversity can be transferred in this fashion even when 
a donor specimen has been frozen at -80°C for several years. Past studies suggest that all bacterial 
phyla, up to 90% of class-level and genus-level taxa, and 60-90% of species-level phylotypes in a 
given human donor’s sample can be identified in recipient gnotobiotic mice when the 16S rRNA 
gene is sequenced from fecal DNA. While some human gut taxa may be refractory to transplanta-
tion, these results seem to suggest that a large number of the most prevalent human gut microbes 
may be capable of colonizing Mus musculus. Once engrafted, the transplanted human microbial 
communities are remarkably stable, can be reliably transmitted across generations of animals and 
exhibit well defined and reproducible biogeographical features along the length of the mouse gut 
[31]. Efficient intergenerational transfer of transplanted human fecal microbiota also allows the 
microbiota and the host’s innate/adaptive immune system to co-evolve beginning at birth in ‘sec-
ond generation’ mice.
‘Humanized’ gnotobiotic mice can be used for proof-of-mechanism studies that cannot 
be readily conducted in humans where potentially confounding variables, including variations in 
host genotype, diet, and antibiotic consumption are notoriously difficult to control. As such, they 
are a powerful model for conducting first-generation experiments whose goal is to determine if 
microbes influence a host phenotype or physiological parameter of interest.
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Like any experimental model, humanized gnotobiotic mice are subject to limitations. 
When studying a biological system, it is obviously important to have as complete an understand-
ing as possible of its components and parameters. Unfortunately, a researcher colonizing germ-free 
mice using a human fecal suspension is typically unable to discern the exact identities of all the 
microbes within the donor community, even using the most sophisticated metagenomic and 16S 
rRNA gene sequencing techniques available today. The level of taxonomic resolution that can 
be achieved when sequencing these donor communities is in fact the same as for the researcher 
studying the microbial composition of human feces, and the same is true for the sequencing of 
fecal communities from humanized mice. In some cases, 16S rRNA gene-based identification of 
taxa can achieve species-level resolution, but often only genus (or higher) levels of classification 
are possible when microbes hail from taxonomic clades where few representatives have been se-
quenced. This ‘fuzziness’ when assigning identities to microbes also negatively impacts our ability 
to accurately estimate the alpha, beta, and gamma diversity present in gnotobiotic recipients of 
human gut microbiota transplants. Additionally, genome information is often lacking for microbes 
transplanted from complete (uncultured) human communities. This lack of genomic data limits our 
ability to make predictions about the functional capacity of any given constituent of the system, as 
well as the ways in which it might interact with other microbes (and the host). While metagenomic 
sequencing of a donor community or the humanized mouse fecal community can provide some in-
formation about a community’s genetic potential, it is not yet a substitute for a completely defined 
metagenome whose genes can be attributed to specific taxa. Finally, the use of intact human com-
munities to colonize GF mice currently does not allow for targeted manipulation of the donor com-
munity’s composition. This inability to intentionally manipulate the membership of communities 
before or after their transplantation to GF mice can make testing hypotheses about the operations 
of the microbiota and its individual components either incredibly challenging or impossible. Thus, 
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while the humanized mouse model provides several important advantages, there is a substantial 
need for more defined systems that are more amenable to mechanistic dissection.
Assembling defined, representative model communities in vivo[29]
Thanks to previous and ongoing efforts by many to culture and sequence human gut microbes [32-
35], an opportunity exists to create representative model human gut communities in gnotobiotic 
mice in which the identities of all community members and the sequences of all of their genomes/
genes are completely defined. Members present in these model communities can be selected from 
both public and private culture collections based on various criteria relevant to the researcher’s 
experimental focus. Reasons for a microbe’s inclusion in a model community might include its 
consistent association with specific human physiological or pathophysiological states, its repre-
sentation in a fecal microbiota that confers a phenotype to recipient germ-free mice when trans-
ferred en masse, its representation in healthy individuals, its evolutionary ancestry, its functional 
potential as predicted by in silico inspection of its genome, or any number of other criteria. These 
defined communities can be used to address a number of basic questions in the field of microbiota 
research, among them: (i) to what extent do established species who presumably sequester limiting 
space and/or resources exclude potential colonizers and influence community composition; (ii) to 
what extent is the dynamic behavior of the microbiota determined by inter- and intra-specific inter-
actions [36]; (iii) what are the genetic predictors of niche overlap; (iv) how robust are assembled 
communities to various environmental perturbations; and (v) how do different gut microbes pri-
oritize available resources in a highly competitive environment. The defined nature of model gut 
communities comprised exclusively of sequenced microbes allows these questions and others to 
be addressed at levels of resolution that are simply not possible in undefined systems.
It is important to emphasize here that the introduction of defined assemblages of microbes 
into gnotobiotic mice is by no means a new experimental approach. In the 1960’s, Dr. Russell W. 
Schaedler (then at Rockefeller University) was the first to colonize GF mice with panels of bacte-
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ria isolated from healthy conventionally-raised mice [37]. Today, the 8-species ‘altered Schaedler 
flora’ (the result of several rounds of improvement to the original ‘Schaedler flora’ [38]) is inter-
nationally recognized as the standard microbiota for colonizing neonatal mice kept in the barrier 
rooms of all major animal suppliers. In this case, however, the model community’s main utility is 
as a means of standardization and ensuring that animals remain pathogen-free.
More recently, simple model communities comprised of 2-3 species have been studied 
in germ-free mice in order to explore some of the metabolic interactions that take place between 
different microbes (microbe-microbe interactions) and between particular microbes and the host 
(host-microbe interactions) [39-42]. The studies described in this thesis have utilized communities 
comprised of as many as 15 different sequenced human gut microbes in an effort to more faith-
fully reproduce many of the key taxonomic and functional features of the human gut microbiota. 
Though these communities are significantly more complex and representative of the human mi-
crobiota than past systems, further increases in the complexity of model microbiota introduced 
into mice and other gnotobiotic hosts are anticipated as we strive to improve our understanding of 
this dynamic ecosystem (discussed in Chapter 4). Methodologies for characterizing the structure 
and function of these defined models of the gut microbiota, many of which were developed or 
improved during the course of this thesis, are described below.
Compiling a molecular tool kit: methods for characterizing model community structure 
and function
Profiling community structure and the development of COPRO-Seq
While many parameters of a microbial community can be measured and characterized in order 
to better understand its properties, one of the most important is its ‘structure’. Species richness, 
species diversity and patterns of species abundance within a microbiota each constitute different 
elements of this structure. Measuring changes in gut microbial community structure over time 
provides a researcher with insights about how the different populations with the system are re-
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sponding to changes in their environment, how they are responding to one another, and how they 
are responding to other elements of the larger ecosystem (e.g., changes in host physiology). One of 
the earliest aims of this dissertation was to develop a robust, rapid, and cost-effective method for 
evaluating the structure of a defined model microbiota comprised of sequenced human gut-derived 
bacterial species.
In principle, the structure of a defined microbiota can be assessed in a number of different 
ways. Because the genome sequence of each species in a defined community is known, primers 
specific to a particular organism can be designed for quantitative PCR (qPCR)-based assays of spe-
cies abundance, yielding data for one member of the community at a time. However, this approach 
is not tractable if the goal is to longitudinally study many microbes in many animals subjected 
to multiple experimental treatments. An alternative approach is based on sequencing of the 16S 
rRNA gene. However, this type of approach is hampered by known PCR primer biases [43] and 
the need for fairly long DNA sequences (which might significantly inflate the cost of evaluating 
community structure across large numbers of samples).
At the time this dissertation work began, ‘massively-parallel’ or ‘next-generation’ sequenc-
ing was a relatively new technology, and the first commercially-available Illumina sequencers 
were entering the market. The first-generation Illumina platform was capable of generating many 
millions of short (35 nt) reads – a number that was many orders of magnitude greater than previous 
technologies. This significant increase ultimately paved the way for a new approach to defining 
the structure of model communities in gnotobiotic mice, a method I dubbed COmmunity PROfil-
ing by Sequencing (‘COPRO-Seq’). COPRO-Seq takes advantage of the fully-defined nature of 
the model microbiome to precisely measure the relative abundance of every community member 
in a given sample simultaneously. After generating large numbers of short reads from community 
DNA using the Illumina platform, each read is quantitatively mapped back to its genome of origin 
using a short read aligner. In some cases, because of genetic overlap between microbial species, 
reads cannot be assigned unambiguously to a single genome. These reads of unknown origin are 
excluded from the analysis. To compensate for their removal, the ‘informative genome size’ (IGS) 
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of each genome is calculated and used to normalize the sum of the read counts attributed to each 
species in the community. Each genome’s IGS value is calculated by multiplying two values: (i) 
the fraction of all k-mers (e.g., 35-mers) that can be derived from a genome’s sequence and oc-
cur only once when considering all k-mers within the defined community’s microbiome (i.e., the 
fraction of a genome that does not overlap with any other genome in the defined community), and 
(ii) the genome’s total length. Dividing the normalized read counts for each species present in the 
community by the total normalized read counts in a sample (e.g., feces) results in a comprehensive 
profile of community structure that provides the relative abundance of every species detected in 
that sample. All calculations are performed in an automated fashion by a workflow implemented 
in Perl to ensure reproducibility and to avoid human error. High-throughput sample processing is 
achieved by generating barcoded Illumina libraries for each sample and pooling multiple barcoded 
libraries on each lane of an Illumina flow cell. By taking advantage of the high yields of the Illumi-
na platform and the known genome sequences of a defined community microbiome, COPRO-Seq 
allows a researcher to quantitatively assess the structure of a defined microbiota in many hundreds 
or even thousands of samples with exceptional sensitivity (species comprising as little as 0.001% 
of a community are typically detectable) in rapid fashion.
Additionally, because COPRO-Seq can quantify the abundance of a taxon based on a rela-
tively small number of species-specific reads (compared to the total number of sequences gener-
ated from each sample characterized), it is well-equipped to characterize defined communities 
much larger than those studied in this dissertation. Provided all strains in the model community 
have a sequenced genome available, it should be possible in the future to enumerate the propor-
tional abundance of hundreds or even thousands of sequenced community members simultane-
ously. Further details regarding the COPRO-Seq methodology are provided in the study described 
in Chapter 2.
Profiling community function using improved methods[29]
Understanding how different gut communities modulate their activities in response to changes in 
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diet, host physiological status, or the introduction of new microbial species is a key step in under-
standing the operations of the gut microbiota. Microbial RNA-Seq can be used to quantify changes 
in community gene expression at high resolution and with substantial dynamic range [44]. In the 
case of model communities of sequenced gut microbes, where all species and genes are known, 
this high-resolution data can be used to verify gene structure/operons, generate in silico recon-
structions of expressed metabolic pathways for each member in the community, and make predic-
tions concerning the metabolic niches of taxa of interest. Functional predictions about community 
operations can also be informed by RNA-Seq analyses of individual members grown in monocul-
ture under highly defined conditions (e.g., minimal medium supplemented with systematically var-
ied carbon sources; see Chapter 3 for an example of this approach involving a prominent member 
of the gut Bacteroides). In addition, gnotobiotic mice harboring defined collections of sequenced 
organisms provide an opportunity to further develop and test methods for extracting and charac-
terizing, by high-performance liquid chromatography-mass spectrometry (LC-MS), the proteins 
expressed by their model microbiota. Given accurate gene predictions based on the sequenced ge-
nomes of each community member, theoretical peptidomes/proteomes can be calculated in silico, 
and peptides detected in community-extracted protein can be mapped back to their proteins of 
origin. In collaboration with researchers at Oak Ridge National Laboratories, we have picked up 
where early work in two-member model microbiota left off [40] and significantly improved our 
methods for characterizing the metaproteomes of model human gut communities comprised of 
up to 12 species (see Chapter 3). Finally, targeted and untargeted quantitative mass spectrometry 
(MS)-based measurement of metabolites in the gut (as well as other biocompartments) can provide 
an even more direct assessment of how community operations change as the result of experimental 
perturbations. These MS-based metabolomics methods allow the researcher to characterize the 
effects of systematically manipulating the species composition of a model microbiota or perturb-
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ing the activities of key community members [42]. Collectively, these improved systems-level 
approaches in metatranscriptomics, metaproteomics, and metabolomics allow for unprecedented 
time-series assessments of expressed functions in model communities.
Genetic manipulation of the community metagenome[29]
Community genetics represents another powerful means by which the researcher may dissect the 
operations of microbial communities. The addition or removal of particular species prior to ga-
vaging the model microbiota into GF mice constitutes the simplest genetic perturbation that can 
be imposed on the system to identify taxa that confer a benefit or detriment to other community 
members or the host. Another method for manipulating the gene content of the metagenome is 
insertion-sequencing (INSeq), which combines genome-wide transposon mutagenesis with mas-
sively parallel sequencing [45,46]. In this approach, complex populations of tens of thousands of 
transposon mutants of a given sequenced community member are generated and introduced into 
wild-type or genetically manipulated GF mice in the presence or absence of other (sequenced) 
microbes. The representation of each mutant in both the input community and each experimental 
sample (output community) is determined by targeted, quantitative sequencing of transposon-ad-
jacent chromosomal DNA. Any differences in mutant representation in input versus output com-
munities provide a quantitative measure of the degree to which loss of a gene’s function imposes a 
fitness cost on the species of interest within a given experimental framework (i.e., set of selective 
pressures). Additionally, the inclusion of a species-specific barcode within the transposon con-
struct used to mutagenize individual community members allows multiple mutagenized species to 
be studied simultaneously, permitting assessment of the importance of fitness determinants within 
and between multiple species. Thus, by including or excluding species of interest when construct-
ing model communities and by mutagenizing individual members of those communities using a 
randomly inserting transposon, a researcher studying model communities can directly determine 
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which genes and which species are most important for specific functional features of a microbiota. 
This approach proved particularly informative in two studies included here (see Chapter 3, Ap-
pendix A).
Studying the system: characterization of communities and specific taxa in contexts relevant 
to human health
If one accepts the premise that the microbiota plays an important role in human health, it is rea-
sonable to think that methods for preserving a ‘healthy’ microbiota configuration or driving the 
microbiota away from ‘pathological’ states could serve as the basis for new therapeutic modalities. 
Developing safe, efficacious microbiome-directed therapies requires a much better understanding 
of how human gut communities assemble, operate, and respond to environmental changes over 
time. As discussed, characterization of model communities of human gut microbes using molecu-
lar tools that leverage the completely defined nature of these systems represents an approach to 
achieving this goal of greater understanding. Over the course of this dissertation, I have used these 
systems and tools to study the microbiota in two contexts with significant relevance to human 
health.
The impact of probiotic interventions on the microbiota
Though the term ‘probiotic’ is one whose definition has evolved substantially over time [47], pro-
biotics are generally described as live microorganisms that when ingested confer a health benefit 
to their host. In 1907, Élie Metchnikoff (often referred to as the ‘father of probiotics’) proposed 
that ingesting lactic acid bacteria could replace or diminish ‘putrefactive’ bacteria in the human 
intestine, normalizing gut function and prolonging human life [48]. Since Metchnikoff’s time, the 
market for probiotic foods and supplements has become a booming business as more and more 
individuals turn to these products in hopes of improving intestinal health and general well being. 
Yet, while a small number of probiotic strains of bacteria have been carefully studied [49], in 
most cases we have a poor understanding of the mechanisms by which these bacteria influence 
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human health and how their introduction into the gut microbiota influences its operations. Chapter 
2 describes a staged ecological ‘invasion’ of a consortium of five strains reputed to have probiotic 
properties into the guts of monozygotic twin pairs as well as gnotobiotic mice colonized with a 
defined model human gut microbiota. This study of the model community in parallel with human 
subjects allowed us to characterize the ways these probiotic microbes influence gut communities 
at the level of individual genes and taxa, and resulted in the identification of numerous functional 
responses that are shared between humans and mice. Additionally, the results show that model gut 
communities can play an important role in identifying biomarkers and mediators of the direct and 
indirect effects of probiotics on gut microbiota and their hosts.
The impact of diet change over time
Many studies in recent years have suggested that the well-known idiom ‘you are what you eat’ is 
apt not only in terms of general human health, but also applies to the composition of the human mi-
crobiota [50-52]. While these studies have contributed significantly to our appreciation of diet as 
a paramount environmental factor in shaping the microbiota’s structure and function, further work 
is needed to determine how the many interactions between individual microbes and food lead to 
diet-induced effects at the community level, how microbes prioritize utilization of different com-
ponents of our diets, and how microbes carve out metabolic niches that allow them to persist over 
time in individuals eating diverse diets. In Chapter 3, we use the model community experimental 
framework to evaluate how diet change influences the structure of the microbiota over time, the 
dynamics of community’s functional responses to diet change, and metabolic strategies prominent 
taxa rely on in a changing nutrient landscape. We then go on to further characterize the carbohy-
drate utilization of a well-adapted xylanolytic Bacteroides species, the genetic factors that allow it 
to utilize diverse simple and complex saccharides, and which of those factors are most important 
for in vivo fitness in a host harboring a model human gut microbiota and consuming different diets.
Footnote
The text within some sections of this Introduction includes both direct and revised excerpts from 
19
a previously published review (see reference [29]). These sections are designated by a reference 
number (in superscript) at the end of their titles.
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Abstract
Understanding how the human gut microbiota and host are affected by probiotic bacterial strains 
requires carefully controlled studies in humans and in mouse models of the gut ecosystem where 
potentially confounding variables that are difficult to control in humans can be constrained. There-
fore, we characterized the fecal microbiomes and metatranscriptomes of adult female monozy-
gotic twin pairs through repeated sampling 4 weeks before, 7 weeks during, and 4 weeks after 
consumption of a commercially available fermented milk product (FMP) containing a consortium 
of Bifidobacterium animalis subsp. lactis, two strains of Lactobacillus delbrueckii subsp. bulgari-
cus, Lactococcus lactis subsp. cremoris, and Streptococcus thermophilus. In addition, gnotobiotic 
mice harboring a 15-species model human gut microbiota whose genomes contain 58,399 known 
or predicted protein-coding genes were studied before and after gavage with all five sequenced 
FMP strains. No significant changes in bacterial species composition or in the proportional rep-
resentation of genes encoding known enzymes were observed in the feces of humans consuming 
the FMP. Only minimal changes in microbiota configuration were noted in mice after single or 
repeated gavage with the FMP consortium. However, RNA-Seq analysis of fecal samples and 
follow-up mass spectrometry of urinary metabolites disclosed that introducing the FMP strains 
into mice results in significant changes in expression of microbiome-encoded enzymes involved in 
numerous metabolic pathways, most prominently those related to carbohydrate metabolism. B. an-
imalis subsp. lactis, the dominant persistent member of the FMP consortium in gnotobiotic mice, 
up-regulates a locus in vivo that is involved in the catabolism of xylooligosaccharides, a class of 
glycans widely distributed in fruits, vegetables, and other foods, underscoring the importance of 
these sugars to this bacterial species. The human fecal metatranscriptome exhibited significant 
changes, confined to the period of FMP consumption, that mirror changes in gnotobiotic mice, 
including those related to plant polysaccharide metabolism. These experiments illustrate a trans-
lational research pipeline for characterizing the effects of FMPs on the human gut microbiome.
28
Introduction
Our physiology and physiological differences are not only manifestations of our human genes and 
epigenomes but also a reflection of the genes and genetic variations that exist in our resident mi-
crobial communities (microbiomes). Our microbiomes contain at least 100 times more genes than 
our human genomes (1). Marked increases in DNA sequencing capacity have led to an explosive 
increase in the number and types of culture-independent metagenomic studies of intra- and inter-
personal variations in human microbial ecology—as a function of our human life cycle, cultural 
traditions, and health status (2–7). Long-term goals of this quest to understand the genomic and 
metabolic underpinnings of our mutually beneficial relationships with microbes include using our 
symbionts as a new class of biosensors and biomarkers of wellness, and devising safe and effec-
tive ways to deliberately manipulate the structure and functions of our microbiome to optimize our 
health, as well as to treat various diseases.
A necessary starting point for assessing how the structure and functions of the human 
microbiome are related to our biology is to characterize the normal variations that occur in these 
communities, their gene pools, and their gene expression profiles both within and between indi-
viduals. This requires carefully designed studies where potentially confounding variables such as 
host genotype, diet, and various environmental exposures can be controlled and systematically 
manipulated. Monozygotic (MZ) twins represent one way to constrain some of these variables, 
given that they have more similar genotypes and have experienced more similar dietary and other 
early environmental exposures than any other combination of individuals. A complementary ap-
proach is to use germ-free mice colonized at various points in their life with defined collections of 
microbes, with sequenced genomes, that represent major phylogenetic lineages encountered in the 
body habitats of human populations of interest. Gnotobiotic mice harboring “synthetic” model hu-
man microbiomes, where all component organisms and microbial genes are known, can be reared 
under conditions where a number of the variables that confound human studies are extremely well 
controlled. Insights gleaned from these gnotobiotic animals can be applied back to humans (8).
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Common intended or unintentional disturbances to our microbiomes include changes in 
our diets, consumption of antibiotics, and ingestion of live microbial strains posited to improve 
health. The latter include commercially available probiotics that are incorporated into fermented 
milk products (FMPs). With increasing regulatory pressure to validate the composition and health 
claims of probiotics and “functional” foods, it is particularly important to develop informative 
translational medicine pipelines so that proof-of-concept clinical trials can be performed with 
validated biomarkers for quantitative phenotyping of subjects and of their responses. The present 
study demonstrates one type of approach. It uses adult MZ twin pairs and metagenomic methods 
to first define temporal fluctuations in the organismal and gene content and gene expression pro-
files of their fecal microbial communities as a function of administration of a widely used com-
mercial FMP. It then takes the five sequenced strains present in the FMP and introduces them as a 
consortium, at a dose analogous to that experienced by humans, into gnotobiotic mice containing 
a model human microbiome composed of 15 sequenced human gut symbionts. Quantitative analy-
ses of temporal changes in the proportional representation of microbial species and genes, and of 
microbiome gene expression and metabolism before and after an ecological “invasion” with the 
five-member FMP microbial consortium, have provided insights into the ways that FMP strains 
and the indigenous model gut community respond to one another. The transcriptional responses 
were used as biomarkers to interrogate metatranscriptome data sets obtained from the MZ twins’ 
fecal specimens.
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Results
Human studies
Study design and assessment of intra- and interpersonal variations in the fecal microbiota of 
MZ twin pairs over a 4-month period. Details concerning the seven adult female MZ twin pairs 
recruited for this study are provided in table S1. All had been vaginally delivered; none consumed 
antibiotics in the 6 months before and during their participation in the present study; none had 
a history of gastrointestinal diseases (including irritable bowel syndrome) or any other acute or 
chronic medical conditions; none were consuming dietary supplements or probiotics at the time 
of enrollment; and none had a history of gluten sensitivity or other food allergies, nor were any 
vegans or lacto-vegetarians.
Fresh lots of an FMP were shipped every 2 weeks to the participants’ homes from the same 
pilot production facility; strain-specific quantitative polymerase chain reaction (qPCR)–based as-
says indicated that, at the time of shipment, each gram of the FMP contained on average 3.2 × 
107 genome equivalents (GEs) of Bifidobacterium animalis subsp. lactis (strain CNCM I-2494) 
and 6.3 × 107 GEs of Lactobacillus delbrueckii subsp. bulgaricus (CNCM I-1632, CNCM I-1519). 
These results were consistent with previous measurements of the number of colony-forming units 
(CFU) in a typical cup of the FMP [4.9 × 107 CFU/g (B. animalis subsp. lactis), 8.4 × 107 CFU/g 
(L. delbrueckii subsp. bulgaricus)].
Three fecal samples were obtained over the course of a 4-week period before initiation of 
FMP consumption (“pretreatment phase”; see Fig. 1A). Each co-twin then consumed two serv-
ings of the FMP per day for 7 weeks (breakfast and dinner). Four fecal samples were collected 
at defined intervals during this treatment period, whereas two additional samples were collected 
during the 4 weeks after cessation of FMP consumption (“posttreatment phase”; Fig. 1A). Par-
ticipants kept a daily log of their FMP consumption and stool parameters including frequency. 
Statistical analyses of this log indicated that, in this population, FMP consumption was associated 
with significantly softer stools but no significant changes in stool frequency (see the Supplemen-
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tary Material). However, based on existing regulatory criteria, our study of this small cohort was 
insufficiently powered to draw clinical conclusions about these stool parameters. Moreover, the 
MZ twin population recruited was composed entirely of healthy individuals, so these data cannot 
be used to make statements about the impact of FMP consumption on stool softness in unhealthy 
patient populations.
All fecal samples collected during the three phases of this study were frozen at −20°C 
within 30 min of their passage and maintained at this temperature during overnight shipment to a 
biospecimen repository where they were subsequently stored at −80°C before metagenomic analy-
ses. To assess intra- and interpersonal variations in microbial community structure, we performed 
multiplex 454 FLX pyrosequencing of amplicons generated from variable region 2 of bacterial 
16S rRNA (ribosomal RNA) genes present in fecal DNA. A total of 431,700 sequencing reads 
were obtained from 126 fecal samples (3426 ± 2665 sequences per sample; table S2A). Noise due 
to PCR and pyrosequencing artifacts was removed from this data set using software incorporated 
into the QIIME suite of 16S rRNA analysis tools (9). Denoised reads were binned into species-
level phylogenetic types (phylotypes), with a species defined as isolates that share ≥97% identity 
in their 16S rRNA gene sequence. To ensure even coverage across samples, we subsampled each 
of the 126 data sets to 1640 reads per fecal microbiota. A phylogenetic tree was built from one 
representative sequence from each phylotype using FastTree’s approximately maximum-likeli-
hood implementation (10) and communities were compared using unweighted UniFrac (11): The 
UniFrac metric measures community similarity based on the degree to which their members share 
branch length on a reference phylogenetic tree of Bacteria.
To quantify temporal variation in community composition within and between MZ twins, 
we generated a matrix of unweighted UniFrac distances for all pairwise comparisons of all 126 
fecal samples obtained from the twins in our study. This matrix allowed us to compare any two 
fecal communities separated by all possible time intervals between sampling for each individual 
in each of the seven twin pairs (Fig. 2A). The results indicated that no matter how far apart in time 
sample collection occurred (1 week to 4 months), the phylogenetic distance between communi-
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ties from the same individual was less than the distance between communities between co-twins 
or unrelated individuals. UniFrac distances between samples harvested from a given individual 
increased modestly as a function of time during the 4-month period, although the changes were not 
statistically significant (Fig. 2A).
Each sample contained 163 ± 3 (mean ± SEM) observed species-level phylotypes. Four of 
the total 1673 phylotypes identified in our data set were found in all 126 samples; all belonged to 
the family Lachnospiraceae (order Clostridiales; phylum Firmicutes) and represented 2.5 ± 0.04% 
of the 16S rRNA sequences in each sample. We determined that 26.4 ± 0.4% of species-level 
phylotypes observed in a given sample were consistently represented in all nine samples from 
that individual (Fig. 2B): The family-level taxa to which these species belong consist principally 
of Lachnospiraceae, Ruminococcaceae, and Veillonellaceae (phylum Firmicutes); the Bacteroida-
ceae and Rikenellaceae (phylum Bacteroidetes); and Coriobacteriaceae (phylum Actinobacteria). 
Moreover, 13.7 ± 0.2% of the observed phylotypes were represented in all samples from both co-
twins (Fig. 2B).
Impact of FMP consumption on fecal bacterial community composition. A qPCR as-
say disclosed that 1 week after initiation of FMP consumption, the level of representation of B. 
animalis subsp. lactis (CNCM I-2494) was 107 cell equivalents per gram of feces; this level was 
sustained in all 14 individuals throughout the ensuing 7 weeks of FMP consumption (that is, there 
were no statistically significant differences between the 1-, 2-, 4-, and 7-week time points as deter-
mined by Friedman test with post hoc correction). The Spearman correlation test revealed no sig-
nificant effect of human family membership on the levels of B. animalis subsp. lactis during FMP 
consumption. Levels fell to below the limits of detection of the assay in all but four participants 
within 2 weeks of cessation of FMP consumption (fig. S1); two of these individuals represented a 
twin pair, whereas the other two individuals were unrelated to each other.
Co-occurrence analysis (see the Supplementary Material) indicated that with the FMP dos-
ing schedule used, no species-level phylotypes present in the pretreatment microbiota exhibited a 
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statistically significant change in their proportional representation in feces in any individual, dur-
ing or after the period of FMP consumption. In addition, no species-level taxa that were undetected 
in the pretreatment period appeared and persisted during and/or after treatment in any individual 
[paired t test, analysis of variance (ANOVA)]. It is possible that with even deeper sampling, differ-
ences might be revealed in feces or may exist in more proximal regions of the gut. Further details 
of this co-occurrence analysis, including the results of tests at the genus and family level, plus 
deeper sequencing of a subset of twin pairs are provided in the Supplementary Material.
Effects of FMP consumption on the functional gene repertoire of the fecal microbi-
ome. To determine the effects of FMP consumption on the representation of gene functions in the 
microbiome, we performed shotgun sequencing on 48 of the fecal DNA preparations generated 
from four of the MZ twin pairs (n = 6 samples per individual; two fecal samples obtained before, 
two during, and two after cessation of FMP consumption; see Fig. 1A). Two of these twin pairs 
lived together, whereas two pairs lived 3 and 932 miles apart. A 634-Mb data set was generated 
(60,863 ± 28,775 sequences per sample; average length, 238 nucleotides; table S2B). A BLASTX 
search against version 54 of the Kyoto Encyclopedia of Genes and Genomes (KEGG) GENES da-
tabase (12–14) yielded a total of 2205 ± 26 (mean ± SEM) KEGG Orthology identifiers (KOs) per 
microbiome sample: 64% of the KOs in a given sample (1417 ± 46) were consistently represented 
in all 6 samples from that individual; 55% were consistently represented in all samples from both 
co-twins; 892 KOs (41% of the total KOs in a given sample) were identified in all 48 samples 
forming a core set of shared fecal microbiome-associated functions. Figure 2C provides a visual 
representation of this conserved set of 892 KOs: 38% of the 892 belong to six KEGG categories: 
“membrane transport,” “carbohydrate metabolism,” “DNA replication and repair,” “amino acid 
metabolism,” “translation,” and “metabolism of cofactors and vitamins.”
The proportional representation of KEGG pathways and their component KOs was sub-
sequently calculated for each of the 48 microbiomes. The microbiomes were then subjected to 
all possible pairwise comparisons on the basis of these two classification schemes. The results, 
quantified using the Hellinger distance metric, disclosed that over time, unlike the UniFrac-based 
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16S rRNA comparisons of community bacterial species composition, there was no significant dif-
ference in the degree of similarity of microbiome functional profiles for a given co-twin compared 
to the degree of similarity that existed between co-twins (that is, intrapersonal variation was not 
significantly different from interpersonal variation between co-twins). However, as with the Uni-
Frac results, individual and twin pair microbiomes were significantly more similar to one another 
than those from unrelated individuals (Fig. 2D). No KEGG pathways or KOs exhibited a statisti-
cally significant change in their relative abundance in response to FMP consumption in any of the 
subjects at any of the time points (Student’s paired t test and two-way ANOVA with Bonferroni 
post hoc testing).
At this point in our analysis, the human studies indicated that exposure of a healthy indi-
vidual’s resident gut microbiota to the FMP strains did not produce a detectable perturbation in 
fecal bacterial species composition, nor did it have a broad effect on the functional profile of fecal 
microbiome genes. To help guide further analysis of the human data sets, we turned to a simplified 
in vivo model of the human gut microbiota. We based our selection of model community members 
on several criteria. All members of this model community, or their close relatives, would be repre-
sented in the fecal microbiota of the MZ twins and other sampled human populations. They would 
encompass the three major bacterial phyla present in this host habitat (Firmicutes, Bacteroidetes, 
and Actinobacteria) and would have deep draft or finished genome sequences available. Gnotobi-
otic mice harboring such a model human microbiome would be used to characterize the impact of 
FMP strain introduction on the community’s species and microbial gene abundances, as well as 
the microbiome’s transcriptional profile, and to ascertain the impact of the model community on 
the abundance and gene expression profiles of the FMP strains whose genome sequences were also 
known. The knowledge gleaned would then be used to help guide further analysis of the human 
fecal microbiome data sets, including microbial RNA-Seq data sets generated from a subset of the 
human fecal samples.
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Studies in gnotobiotic mice
Study design. A community of 15 sequenced human gut-derived microbes containing a total of 
58,399 known or predicted protein-coding genes was constructed (Fig. 1B and table S3). Figure 
S2 uses assigned KOs to provide evidence of the functional similarity of this model human micro-
biome to a collection of 127 genomes generated from cultured members of the human gut micro-
biota, a deeply sampled set of fecal microbiomes obtained from 124 unrelated Europeans (1), and 
deeply sampled microbiomes from a pair of obese MZ co-twins (15).
Figure 1B presents the study protocol. Two groups of adult 6- to 8-week-old germ-free 
C57BL/6J male mice were colonized with a single gavage of the 15-member community (6 × 
106 CFU per member, total of 9 × 107 CFU). Each group (n = 5 animals) was maintained on a 
low-fat, plant polysaccharide–rich diet. Fourteen and 15 days after gavage with the 15-member 
community, both groups of mice were inoculated with a mixture of the five FMP strains. One 
group received a second pair of gavages of the five strains 7 and 8 days later, and a third pair 21 
and 22 days after the first inoculation of the FMP consortium (multiple-treatment group). Each 
gavage consisted of a community composed of 2 × 107 CFU: 25% (5 × 106 CFU) Streptococcus 
thermophilus, 25% B. animalis subsp. lactis, and 25% Lactococcus lactis subsp. cremoris, with 
the remaining 25% split between the two L. delbrueckii subsp. bulgaricus strains (12.5% each; 2.5 
× 106 CFU per strain). Dosing was based on the following considerations: (i) a daily dose of two 
cups of the FMP contains ~1010 CFU of B. animalis subsp. lactis; (ii) assuming ~1014 bacteria in 
the human gut, the ratio of the number of input B. animalis subsp. lactis CFU to the human gut 
symbiont population is about 10−4; (iii) to maintain this ratio of 10−4 in mice, and assuming 1011 to 
1012 organisms in the mouse gut, we administered a total of 107 B. animalis subsp. lactis CFU per ga-
vage period (one period equals two gavages within 24 hours); (iv) the difference in CFU between 
the least and the most abundant microbial species in the FMP product remains less than or equal 
to twofold during manufacture and storage; therefore, each species in the gavage was represented 
at equivalent levels.
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FMPs contain defined collections of microbes, a dairy matrix, and products of microbial 
metabolism of this matrix generated during manufacturing and storage. In principle, the dairy ma-
trix and microbial metabolic products could be responsible for some of the effects observed when 
humans consume an FMP. Nonetheless, we chose to administer the strain consortium to mice di-
rectly by gavage, rather than by giving them the corresponding commercial FMP. This allowed us 
to more precisely control dosing. It also allayed concerns about possible unintended colonization 
of the gnotobiotic mice with microbial species (other than strains deliberately introduced during 
manufacturing) that could be introduced during handling of an FMP before gavage.
The repertoire of carbohydrate-active enzymes in members of the FMP consortium 
and model human gut microbial community. The genomes of the five FMP strains in this study 
were sequenced, either completely (B. animalis subsp. lactis) or at a deep draft level (other four 
strains) for subsequent analyses of their representation in the model community after gavage of 
gnotobiotic mice, and so we could define their in vivo patterns of gene expression (table S3).
Analysis of the 48 carbohydrate-active enzyme (CAZyme) families (16) identified in the five 
FMP strains and the 126 CAZyme families identified in the 15-member model human microbiota 
disclosed that 23 of the 24 CAZyme glycoside hydrolase (GH) families, 11 of the 12 glycosyltrans-
ferase (GT) families, 4 of the 4 carbohydrate esterase (CE) families, and 4 of the 8 carbohydrate-
binding modules (CBMs) represented in the former were also represented in the latter. The FMP 
consortium contains only six CAZyme families that were not represented in the model human gut 
community. Three of these are associated with L. lactis subsp. cremoris: of these, two are predicted 
to play roles in the binding and metabolism of chitin (fig. S3 and table S4). The other three are 
from B. animalis subsp. lactis: BALAC2494_01193 encodes a GT39 family mannose transferase 
involved in O-glycosylation of proteins; BALAC2494_01288 specifies a predicted β-mannanase 
carrying a C-terminal CBM10 module predicted to bind cellulose; BALAC2494_01971 gives rise 
to a protein with a CBM23 module predicted to bind mannan.
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Minimal changes in the species representation of the 15-member model human gut 
microbiota after introduction of the FMP strain consortium. We used COmmunity PROfil-
ing by Sequencing (COPRO-Seq), a generally applicable method based on highly parallel DNA 
sequencing (17), to quantify the proportional representation of each component of the 15-mem-
ber microbiota and of the FMP consortium in our gnotobiotic mice. Sequencing reads generated 
from fecal DNA samples collected before, during, and after introduction of the FMP strains were 
analyzed as described in fig. S4A. Briefly, “informative” tags (that is, reads that can be mapped 
uniquely to a single genome) were first identified. Informative tags were then summed by spe-
cies to generate digital “counts” of abundance. In cases where a read could not be assigned with 
certainty during COPRO-Seq analysis, it was ignored. To account for this fact, we normalized 
species-specific counts using their “informative genome size” (defined as the percentage of all 
possible k-mers a genome can produce that are unique multiplied by the total genome length). 
Multiplex sequencing using the Illumina GA-IIx instrument yielded sufficient numbers of reads 
per sample so that an organism comprising ≥0.003% of the community could be detected: For a 
mouse colonized at 1011 to 1012 CFU/ml cecal contents or feces, this represents 106 CFU/ml.
COPRO-Seq produced several notable findings. First, community assembly before intro-
duction of the FMP strains occurred in a highly reproducible manner, both within and between the 
two groups of animals (fig. S5A and table S5A). This reproducibility ensured that animals in both 
treatment groups harbored communities with structures comparable to one another at the time of 
administration of the five-member FMP strain consortium. Second, within 1 week of introducing 
the FMP strains, either in a single treatment or in multiple treatments, B. animalis subsp. lac-
tis and L. lactis were detectable in the fecal microbiota (fig. S5B and table S5A). These two spe-
cies persisted in the gut throughout the study. Importantly, B. animalis subsp. lactis was the most 
prominently represented member of the FMP consortium in the model human gut microbiota, 
exhibiting a progressive increase in its representation during the 28 days after initial introduction, 
and reaching comparable levels in both the single- and the multiple-treatment groups (up to 1.1%; 
see fig. S5B). In contrast, S. thermophilus and the two strains of L. delbrueckii subsp. bulgari-
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cus were undetectable or intermittently just over the limit of detection in the single- or the multiple-
treatment groups. Third, as with the MZ twin pairs, introduction of the consortium led to minimal 
rearrangements in overall community structure, whether or not the consortium was administered 
twice in a 2-day period or on two subsequent occasions (see table S5B for the results of Mann-
Whitney tests of significance for each species at each time point surveyed relative to the time point 
just before initial introduction). Collinsella aerofaciens, the lone Actinobacteria in the 15-member 
community, showed a significant reduction in its abundance in both treatment groups immediately 
after FMP strain introduction (fig. S5C) that persisted through later time points, raising the pos-
sibility of a competitive relationship between this organism and B. animalis subsp. lactis, the only 
Actinobacteria in the FMP strain consortium.
The Bacteroides thetaiotaomicron component of the 15-member human gut microbiota 
was composed of a library of 34,544 randomly inserted transposon mutant strains covering 3435 of 
the organism’s 4779 genes (72%). As noted in the Supplementary Material and table S6, by com-
paring the representation of mutants in fecal samples before and after introducing the FMP strains, 
we were able to determine that their presence did not affect the profile of B. thetaiotaomicron’s 
genetic determinants of fitness in the distal gut.
Microbial RNA-Seq analysis of the response of B. animalis subsp. lactis to the gut en-
vironment and members of the 15-member community to the FMP strain consortium. Mov-
ing beyond COPRO-Seq–based structural analysis, we performed microbial RNA-Seq analysis to 
determine the functional impact of exposing the established model human community to the FMP 
strains and to ascertain which FMP consortium genes are most highly expressed in the intestines of 
these animals. B. animalis subsp. lactis attained sufficient abundance in gnotobiotic mice to allow 
profiling of its transcriptome at late time points (days 35, 36, and 42). When its in vivo patterns 
of gene expression were compared with those documented during mid-log and stationary phase 
in MRS medium and in the commercial FMP (see the Supplementary Material and table S7), we 
noted that theBALAC2494_00604-BALAC2494_00614 locus, encoding enzymes involved in the 
catabolism of xylooligosaccharides (18), was strongly up-regulated in vivo (average across the 
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locus; 27-fold at the day 42 time point compared to mid-log phase in MRS monoculture; 128-fold 
compared to the FMP; table S7). Xylose is the main building block of dietary hemicelluloses. 
Addition of this pentose sugar is also one of the first steps in O-glycosylation of host mucins. 
These results support previous observations suggesting that xylooligosaccharides may serve as 
potent “bifidogenic factors,” whose consumption increases the densities of Bifidobacteria in the 
gut (19, 20).
Ordination of samples and B. animalis subsp. lactis CAZyme gene expression patterns by 
correspondence analysis identified additional CAZymes that correlate strongly with the in vivo 
state (Fig. 3), including members of families expected to play roles in the degradation of dietary 
plant polysaccharides [GH43 (xylan β-xylosidases), GH77 (4-α-glucanotransferases)]. The analy-
sis revealed sets of B. animalis subsp. lactis CAZymes that corresponded well with each growth 
condition (that is, MRS medium, commercial dairy matrix, and mice). Within each growth condi-
tion, the expressed groups of CAZymes often had related functions (Fig. 3).
We next examined the impact of the FMP strain consortium on expression of genes in the 
15-member community. In a “top-down” analysis, genes were binned by function and the com-
munity’s metatranscriptome was evaluated in aggregate, ignoring the species from which each 
transcript arose. A complementary “bottom-up” analysis allowed us to determine how each species 
in the community responded to the introduction of the FMP consortium.
Top-down analysis of the impact of the FMP strains on the community metatranscriptome 
revealed significant increases in expression of genes falling within the KEGG categories carbo-
hydrate metabolism and “nucleotide metabolism,” whereas decreases were observed in amino 
acid metabolism and “lipid metabolism” (Fig. 4A and table S8). Peak responses in both treatment 
groups occurred 3 weeks after the first gavage of the FMP strains, corresponding to the time of 
highest representation of B. animalis subsp. lactis in the community.
The genes that exhibited the highest fold change in expression were heavily skewed toward 
the KEGG categories carbohydrate metabolism and membrane transport. The latter includes a 
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number of adenosine triphosphate–binding cassette (ABC)– and PTS (phosphotransferase sys-
tem)–type carbohydrate transporters (table S9). When these KEGG category–level responses were 
subsequently broken down into KEGG pathways (Fig. 4B), it was apparent that the most significant 
responses in the carbohydrate metabolism category involved increases in “starch and sucrose me-
tabolism,” “fructose and mannose metabolism,” and “pentose and glucuronate interconversions.”
Transcript data were subsequently binned by enzyme commission (EC) number. The levels 
of mRNAs encoding these ECs at each time point were compared using ShotgunFunctionalizeR, 
an R-based statistical and visualization tool originally designed to identify genes significantly en-
riched or depleted in environmental microbiomes (21, 22). Using this approach, we were able to 
determine that the starch and sucrose metabolism pathway response to the FMP strains was driven 
by significant up-regulation of genes encoding three enzymes involved in metabolism of dietary 
plant polysaccharides: (i) EC 3.2.1.65 (levanase; Fig. 4C), which cleaves 2,6-β-D-fructofuranosidic 
linkages in 2,6-β-D-fructans (levans); (ii) EC 3.1.1.11 (pectinesterase), which de-esterifies pectin 
to pectate and methanol; and (iii) EC 2.4.1.20 (cellobiose phosphorylase), which uses cellobiose 
formed from partial hydrolysis of cellulose as its substrate to generate α-D-glucose-1-phosphate 
and D-glucose. The genes encoding these ECs, which catalyze early steps in three entry points 
of the starch and sucrose metabolism KEGG pathway, underwent significant increases in their 
expression within 24 hours after introduction of the FMP consortium (Fig. 5A). The levels of ex-
pression of these genes either increased further (levanase) or were sustained (the other two ECs) 
in both the single- and the multiple-treatment groups through the remaining 4 weeks of the experi-
ment (Fig. 5A). The levanase response showed remarkable species specificity: This gene is repre-
sented in 8 members of the 15-member community, yet the community’s transcriptional response 
is driven almost exclusively by the levanase in Bacteroides vulgatus (BVU_1663; Fig. 4C). In 
contrast, the pectinesterase response was distributed across six members of the community (Bac-
teroides caccae, Bacteroides ovatus, B. thetaiotaomicron, B. vulgatus, Bacteroides WH2, C. aero-
faciens), with changes in transcription largely due to pectinesterase genes found in B. ovatus (BA-
COVA_03576, BACOVA_03581, BACOVA_04902), B. thetaiotaomicron (BT_4109, BT_4110), B. 
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vulgatus (BVU_1116), and B. WH2 (BACWH2_3569, BACWH2_3615). Increases in the propor-
tional abundance of cellobiose phosphorylase transcripts reflected the contributions of three com-
munity members: Bacteroides uniformis, Eubacterium rectale, and Ruminococcus obeum (table 
S8).
The KEGG starch and sucrose metabolism, pentose and glucuronate interconversions, 
and “pentose phosphate” pathways process products generated by these three enzymes. Figure 
5B shows that many of the other components of these pathways are up-regulated in the 15-member 
community when the FMP strain consortium is introduced. ShotgunFunctionalizeR also identified 
significant increases in the expression of genes encoding five ECs that participate in the generation 
of propionate and succinate: The induction occurred within 24 hours after the FMP strains were 
introduced and involved acetate kinase (EC 2.7.2.1; catalyzes a bidirectional reaction between 
propanoyl phosphate and propionate), phosphate acetyltransferase (EC 2.3.1.8), methylmalonyl-
CoA (coenzyme A) decarboxylase (EC 4.1.1.41), propionyl-CoA carboxylase (EC 6.4.1.3), and 
methylmalonyl-CoA mutase (EC 5.4.99.2, yields succinyl-CoA as its product) (fig. S6). Only a 
single treatment with the FMP consortium was required to produce a sustained response involving 
the enzymes that can yield propionate (fig. S6).
A breakdown of RNA-Seq reads by the community member genome to which they mapped 
revealed that the abundance of a species in the 15-member community did not necessarily corre-
late with its contribution to the community transcript pool. At the time point sampled immediately 
before invasion (day 14), two of the most extreme outliers were B. WH2 [comprised 39.6 ± 1.6% 
(mean ± SD) of the community but only contributed 15.4 ± 2% of the raw reads to the total RNA-
Seq read pool] and R. obeum (2.1 ± 0.4% of the community; 18.2 ± 4.4% of the transcript pool) 
(fig. S7). These observations indicate that community-level transcriptional responses can be driven 
by species representing small fractions of the microbiota.
Our bottom-up analysis is summarized in fig. S8 and table S10, and disclosed early- and 
later-responding species. Specifically, there were more significantly highly regulated R. obeum 
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transcripts within the community metatranscriptome 1 day after gavage than would be expected 
based on its community representation, and more highly regulated R. obeum genes in the com-
parison between day 14 (just before gavage) and day 15 metatranscriptomes than between day 14 
and day 42 metatranscriptomes. In contrast, B. WH2, Clostridium scindens, and B. uniformis were 
defined as late responders to the FMP consortium.
Identifying predictive features from the model community metatranscriptome data 
using a random forests classifier. Machine learning techniques using the random forests clas-
sifier can be applied to metagenomic data (23) to learn a function that maps a set of input values 
or predictors (in this case, relative abundance of KEGG categories, KEGG pathways, or ECs in 
a community) to a discrete output value (here, the presence/absence of the FMP strains). KEGG 
categories, KEGG pathways, and ECs were all able to predict pretreatment/posttreatment status 
with low estimated generalization error (KEGG categories, 6.7%; ECs, 13.3%; KEGG pathways, 
10.0%). In all cases, these generalization error rates were less than half of the baseline error rate 
of 33% (that is, that achieved by always predicting the largest category). There were 11 predictive 
and 5 highly predictive KEGG categories, 35 moderately predictive ECs, and 27 predictive and 4 
highly predictive KEGG pathways (table S11). The predictive ECs identified using our supervised 
classification approach include a number of carbohydrate metabolism–related functions that were 
also identified using ShotgunFunctionalizeR in our top-down analysis.
Metabolomic analyses. To evaluate the impact of invasion with the five-member FMP 
consortium on microbial-host co-metabolism, we performed untargeted gas chromatography–
mass spectrometry (GC-MS) on urine samples collected at multiple time points (days 0, 14, and 
42) from members of the single- and multiple-treatment groups (Fig. 1B). A metabolite profile was 
constructed for each urine sample (n = 19) using the spectral abundances of all identifiable me-
tabolites. A total of 198 metabolites met our reverse match score cutoff of 65% and were present in 
at least 50% of samples at one or more time points [for an explanation of the reverse match score, 
see (24) and table S12]. Comparing day 0 and 14 samples revealed 39 metabolites whose levels 
were significantly higher or lower after colonization with the defined 15-member community (see 
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table S12A). The changes included decreases in the levels of oligosaccharides we would expect 
to be consumed by members of the microbiota [melibiose (87% decline); raffinose/maltotriose 
(98%); note that oligosaccharides are by their nature difficult to identify with certainty with the 
present, nontargeted GC-MS technique, and our annotations of these metabolites as melibiose and 
raffinose/maltotriose are provisional]. The observed 3.4-fold increase in pyrogallol, a polyphenol, 
is consistent with the known ability of many gut microbes to cleave these molecules from polyphe-
nols present in dietary plant material. A 4.4-fold increase in taurine after the initial colonization of 
mice was also noted, probably a result of microbial deconjugation of taurine from bile compounds.
Table S12B lists urinary metabolites that change significantly after introducing the five 
FMP strains (compare day 14 versus day 42 in table S12B). Fructose and xylose were not signifi-
cantly affected by the introduction of the defined 15-member community but increased signifi-
cantly after the introduction of the FMP strain consortium (2.3- and 2.9-fold, respectively; Fig. 6, 
A and B). Increases in fructose may reflect an enhanced capacity of the community to liberate this 
monosaccharide from levan and other polyfructans via levanase-catalyzed reactions. Increases in 
xylose might be explained by the additional xylanase activity introduced by B. animalis subsp. 
lactis (Fig. 3) or, alternatively, by the induction of microbiome genes encoding xylan-degrading 
enzymes (for example, BACOVA_04387and BACOVA_04390, which were up-regulated 5.2- and 
11.0-fold, respectively, after introduction of the FMP strains; table S10). Changes in other metabo-
lites such as xanthosine (Fig. 6C), a purine metabolite, suggest that the metabolic consequences of 
FMP strain introduction extend beyond the processing of carbohydrates.
Collectively, our transcriptional and metabolite analyses indicated that introducing FMP 
strains that constitute a small fraction of a defined model human gut microbiota signals the micro-
biota to change its metabolic activities, including activities related to carbohydrate metabolism. 
With this information in hand, we returned to the human fecal samples to determine the extent to 
which observations made in our gnotobiotic mouse model were applicable to humans.
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Microbiome transcriptional responses to FMP strains that are shared by gnotobiotic 
mice and humans. Microbial RNA-Seq analysis was performed on human fecal samples obtained 
1 week before FMP consumption, 1 and 4 weeks into the consumption period, and 4 weeks after 
cessation (both co-twins from family 1; one co-twin from family 3; see table S1). Using an analysis 
pipeline comparable to the one used for the mouse data, we first aligned all RNA-Seq reads against 
a reference set of 131 human gut microbial genomes plus the FMP strain genomes, binned the 
aligned transcripts on the basis of their EC annotations, and used ShotgunFunctionalizeR to iden-
tify ECs whose abundances were significantly changed as a function of FMP exposure (Benjamini-
Hochberg adjusted P < 0.01).
Categorical analysis of the responses of the human fecal community to FMP consumption 
revealed that significantly up-regulated ECs were principally distributed among the KEGG catego-
ries carbohydrate metabolism, amino acid metabolism, and metabolism of cofactors and vitamins 
(see table S13 for a complete list of ECs identified from the various pairwise comparisons of time 
points).
Figure 7 highlights the 86 ECs that were significantly changed (P < 0.01) in the same 
direction in all humans and in all sampled mice as a function of exposure to the FMP strain con-
sortium. Similar to our findings in mice, the most prominently represented KEGG category among 
up-regulated gene functions in all comparisons of human metatranscriptomes was carbohydrate 
metabolism (Fig. 7). The three ECs involved in entry points in the KEGG starch and sucrose 
metabolism pathway [levanase (EC 3.2.1.65), pectinesterase (EC 3.1.1.11), and cellobiose phos-
phorylase (EC 2.4.1.20)] were significantly up-regulated within 1 week after FMP consumption 
was initiated in the humans surveyed. This transcriptional response was sustained in the case of 
levanase and pectinesterase and ceased (fell to below the limits of detection) within 4 weeks after 
FMP administration was stopped (Fig. 5A).
ECs involved in succinate and propionate metabolism (EC 2.7.2.1 and EC 6.4.1.3) were 
also up-regulated in the human fecal metatranscriptome within 1 week of the initiation of FMP 
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consumption (FMP1 versus Pre1, Fig. 7). As with levanase, pectinesterase, and cellobiose phos-
phorylase, this response was sustained during and subsided after the period of FMP consumption 
(see “FMP4 versus Pre1” and “FMP1 versus Pre1” in Fig. 7 and table S13).
Human fecal transcripts were detected that mapped to the B. animalis subsp. lactis genome 
(see the Supplementary Material). The presence of these transcripts was limited to the period of 
FMP consumption, supporting the notion that they emanated from the FMP strain rather than from 
a related species present within the microbiota (fig. S9). This clear linkage to FMP consumption 
was not evident in the case of other members of the consortium, so we could not confidently ana-
lyze their patterns of gene expression in vivo. The highest number of mapped reads to the B. ani-
malis subsp. lactis genome was obtained 1 week after FMP administration began: Among the 4000 
reads, we were able to detect transcripts from all but 1 of the 10 genes in the BALAC2494_00604-
BALAC2494_00614 locus that encodes enzymes involved in the catabolism of xylooligosaccha-
rides, leading us to conclude that this locus is highly expressed in the distal human gut, just as it is 
in our mouse model.
Discussion
Repeated sampling of seven healthy MZ adult twin pairs over a 4-month period emphasized that 
intrapersonal variation in bacterial community structure was less than interpersonal variation, with 
co-twins having significantly more similar phylogenetic and taxonomic structure in their fecal 
microbiota compared to those from unrelated individuals (9, 25, 26). The results also showed that 
(i) consumption of an FMP containing five bacterial strains was not associated with a statistically 
significant change in the proportional representation of resident community members within and 
between individuals; (ii) the appearance and disappearance of strains comprising the FMP con-
sortium did not exhibit familial patterns in the fecal microbiota; and (iii) B. animalis subsp. lac-
tis CNCM I-2494 was the most prominent assayed member of the consortium represented in the 
microbiota during the 7-week period of FMP consumption. Analyses of the fecal gene repertoire 
over the course of the 16 weeks of the experiment indicated that (i) variations in the functional fea-
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tures of the (fecal) microbiome were less than the variations in bacterial species composition; (ii) 
there was no significant difference in the degree of similarity in representation of KEGG orthology 
group functions for a given co-twin at each time point compared to the degree of similarity that 
existed between co-twins, whereas individual and twin pair microbiomes were significantly more 
similar to one another than those from unrelated individuals; and (iii) there were no statistically 
significant changes in the representation of these functions when the FMP strain consortium was 
being consumed. With these findings in mind, and with each individual as well as each genetically 
identical co-twin serving as a control, we concluded that at least at the depth and frequency of 
sampling used for this small healthy cohort, the bacterial species and gene content of their fecal 
microbiota/microbiome were not an informative biomarker for understanding whether or how this 
commercial FMP affected microbial community properties.
Gnotobiotic mice harboring a model 15-member gut microbial community that represented 
the three principal bacterial phyla present in the human gut microbiota, and whose 58,399 known 
or predicted protein-coding genes encompassed many of the prominent functions present in the 
normal adult human fecal microbiome, provided a means for characterizing the impact of the five-
member FMP strain consortium on expressed gut microbial community functions and then apply-
ing the results to the human fecal specimens collected for this study. As with the MZ twins, intro-
duction of the five-member strain consortium did not significantly affect the representation of the 
15 species that make up the model human microbiota. As with the MZ twins, B. animalis subsp. 
lactis exhibited the greatest fitness of the five FMP strains in the gut, as judged by its prominence 
and persistence. Unlike the human arm of the study, where all subjects consumed the FMP twice 
daily, the design of the mouse study, with its single- versus multiple-treatment regimens, allowed 
us to directly compare the persistence of FMP consortium members. Only B. animalis subsp. lac-
tis and L. lactis subsp. cremoris were able to maintain a foothold in the gut ecosystem at detectable 
levels for the entire 4-week monitoring period after a single dose. In addition, colonization levels 
were not affected by the number of times the FMP strains were administered to mice.
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An advantage of constructing the model human gut microbiome was that its entire pre-
dicted gene repertoire was known. This allowed us to define the impact of introducing the FMP 
strain consortium on the functions expressed by the overall community as well as by its individual 
components. A major theme emanating from our analysis was the effect of introducing the FMP 
consortium on carbohydrate metabolism by the community, as well as the effect of the commu-
nity on a feature of carbohydrate metabolism by B. animalis subsp. lactis. The model 15-member 
community responded to the FMP consortium by inducing genes encoding enzymes involved in 
catalyzing reactions that represent the three entry points into the KEGG “starch and sucrose meta-
bolic pathway,” as well as enzymes that catalyze fermentation of carbohydrates to propionate. The 
mechanism by which the FMP strains elicit this response is unclear at present, but the effect is 
rapid (occurring within the first 24 hours after invasion) and was persistent whether the consortium 
was introduced in a single set of gavages during a 1-day period or with subsequent repeated gavage 
over a several-week period. The persistence of both the carbohydrate pathway response and of B. 
animalis subsp. lactis suggests but does not prove that the latter may be instrumental in instigating 
and maintaining the former.
Intriguingly, the carbohydrate response showed features of “differentiation.” As noted in 
the Results section, the levanase response was driven almost entirely by changes in transcription 
in just a single species (B. vulgatus), the pectinesterase response by six community members (B. 
caccae, B. ovatus, B. thetaiotaomicron, B. vulgatus, B. WH2, and C. aerofaciens), and the cel-
lobiose phosphorylase response by three components of the defined model human gut microbiota 
(B. uniformis, E. rectale, and R. obeum). Of the 50 genes with predicted xylan-degrading capac-
ity in the model microbiome (that is, those encoding enzymes in ECs 3.2.1.37 and 3.2.1.8), only 
BACOVA_04387 and BACOVA_04390 (both from B. ovatus) were significantly up-regulated after 
FMP strain introduction (this is ignoring xylanase genes encoded by FMP strains like B. animalis 
subsp. lactis). This up-regulation in a limited subset of the model community coincides with an 
increase in urinary xylose.
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The ability to attribute EC-level changes to individual genes in specific bacterial species 
was not possible with our RNA-Seq analysis of the human fecal samples. The differentiation of 
carbohydrate responses among bacterial species documented in gnotobiotic mice emphasizes a 
challenge and opportunity that can be addressed in these models, namely, to further delineate the 
niches, interactions, and adaptive resource switching behaviors of community members by inten-
tional addition, removal or substitution of taxa, and/or their modification through genetic manipu-
lation. Although requiring significantly more animals and loss of the ability to use an animal as its 
own control, future studies could be expanded to include sampling of community gene expression 
in different segments of the small intestine.
The increased expression of genes encoding enzymes involved in the interconversion of 
propionate and succinate is intriguing given the fact that this short-chain fatty acid has been linked 
in some reports to effects on gastrointestinal transit time. However, work in this area has yielded 
varying results and conclusions, perhaps because of the diversity of models and methodological 
approaches used (27–30). Propionate may also link the gut microbiota and human physiology 
through its effects on hepatic and adipose tissue metabolism (31). Notably, another group has re-
ported that in the T-bet−/−Rag2−/− mouse model of colitis, consumption of an FMP containing a dairy 
matrix plus the same strains used in this study led to increased cecal propionate levels and a reduc-
tion in intestinal inflammation (32).
The extent of translatability of data from gnotobiotic mouse models harboring collections 
of sequenced representatives of the human gut microbiota to humans themselves needs to be tested 
further, not only at the transcriptional level but also at the level of community-host co-metabolism. 
Although current models can and should be evolved to embrace more of the diversity present in 
our gut communities, even with current limitations, they can serve as part of a preclinical discovery 
pipeline designed to identify candidate biomarkers and mediators of the effects of existing or new 
probiotic strains on the properties of microbial communities and their hosts. They also represent 
an analytical tool for characterizing the effects of specified dietary components on the indigenous 
gut community and on probiotic species that are deliberately consumed. The results could yield 
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new candidate prebiotics that may affect the representation and metabolic properties of probiotic 
species or entrenched members of our gut microbiota and provide the proof-of-mechanism and 
proof-of-principle observations needed to justify, direct, and interpret human studies.
Materials and methods
Human studies
Subject recruitment. Seven MZ female twin pairs aged 21 to 32 years with body mass indices 
ranging from 20 to 25 kg/m2 were recruited for this study. These twins were long-standing partici-
pants in the Missouri Adolescent Female Twin Study (MOAFTS) (26, 33). Procedures for obtain-
ing consent, for providing fecal samples, and for maintaining diaries of FMP consumption, and 
stool frequency and consistency were approved by the Washington University Human Studies 
Committee.
Other procedures. Methods used for the production and distribution of the FMP to study 
participants, analysis of the effects of FMP consumption on stool parameters, qPCR analysis of 
fecal levels of FMP strains (table S14), multiplex pyrosequencing of 16S rRNA genes in fecal sam-
ples and the FMP, co-occurrence analysis, and shotgun sequencing of human fecal microbiomes 
are described in the Materials and Methods section of the Supplementary Material. Sequenced hu-
man gut–associated microbial genomes used to analyze the human fecal RNA-Seq data are listed 
in table S15.
Studies in gnotobiotic mice
Colonization of germ-free mice. The justification for using mice and the protocols used for treating 
them were approved by the Washington University Animal Studies Committee. Animals belonging 
to the C57BL/6J inbred strain were maintained in plastic flexible film gnotobiotic isolators and fed 
a standard autoclaved chow diet (B&K rat and mouse autoclavable chow #7378000, Zeigler Bros 
Inc.) ad libitum. Two groups of 6- to 8-week-old germ-free male animals (n = 5 per group) were 
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colonized with a single gavage of 500 μl of supplemented TYG medium (TYG
s
) (34) containing 
15 sequenced human gut-derived bacterial symbionts (6 × 106 CFU per strain; total of 9 × 107 CFU 
for the community). The B. thetaiotaomicron component of this community was composed of a 
library of 34,544 transposon mutants prepared as described (34). Fourteen and 15 days later, both 
groups of mice were gavaged with a mixture of the five FMP strains (each species at 5 × 106 CFU) 
in 300 μl of TYG
s
. One group of mice received a second pair of gavages 7 and 8 days later, and a 
third pair of gavages 21 and 22 days after the initial FMP strain introduction.
Other procedures. Methods used for sampling animals, COPRO-Seq, INSeq, microbial 
RNA-Seq, and nontargeted metabolomics via GC-MS, are described in the Methods section of 
the Supplementary Material, as are methods for sequencing and annotating FMP strain genomes.
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Footnotes
Accession numbers: The complete genome sequence of Bifidobacterium animalis subsp. lactis 
(CNCM I-2494) has been deposited at GenBank under accession number CP002915. The Whole 
Genome Shotgun projects for Lactobacillus delbrueckii subsp. bulgaricus (CNCM I-1632, CNCM 
I-1519), Streptococcus thermophilus CNCM I-1630, and Lactococcus lactis subsp. cremoris CNCM 
I-1631 have been deposited at DDBJ/EMBL/GenBank under accession numbers AGFO00000000, 
AGHW00000000, AGFN00000000, and AGHX00000000, respectively. The version of each 
of these genomes described in this paper is the first version (CP002915.1, AGFO01000000, 
AGHW01000000, AGFN01000000, and AGHX01000000, respectively). COPRO-Seq and RNA-
Seq data are deposited in GEO (accession numbers GSE31943 and GSE31670, respectively), 
while 16S rRNA pyrosequencing reads and shotgun pyrosequencing reads of human fecal com-
munity DNA are deposited in MG-RAST (accession numbers qiime:803 and 4473933-4473980, 
respectively).
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Figure legends
Figure 1. Experimental design for human and mouse studies. (A) Human study. Seven healthy 
lean MZ female twin pairs were sampled before, during, and after FMP consumption. (B) Gnoto-
biotic mouse study. Two groups of five germ-free mice were colonized by oral gavage at 6-8 weeks 
of age with a 15-member microbial consortium constituting a model human gut microbiota (day 
of gavage denoted by black arrows). Two weeks later, the five species FMP strain consortium was 
administered by oral gavage to each group of mice twice over two days (denoted by green arrows). 
Mice in the single treatment group underwent no further manipulations, whereas animals in the 
multiple treatment group received additional two-day gavages one and three weeks following the 
first gavage. Samples were collected at the indicated time points for profiling bacterial community 
membership (shotgun and 16S rRNA gene sequencing for human fecal samples, COPRO-Seq for 
mouse fecal and cecal samples), gene expression profiling (microbial RNA-Seq) and metabolite 
analysis (urines, GC/MS). The species comprising the model 15-member human community and 
the 5-member FMP consortium are listed in the gray and green boxes, respectively.
Figure 2. Metagenomic studies of human fecal microbiomes sampled over time. (A) 16S 
rRNA-based time course study of intra- and interpersonal variations in fecal bacterial community 
structure during the course of the 4-month study. Unweighted UniFrac measurements of commu-
nity distances, from pairwise comparisons of all samples obtained from a given individual, from 
co-twins, and from unrelated individuals are plotted as mean values ±SEM. (B) Colored boxes 
represent the proportion of bacterial phylotypes that were consistently present within an individual 
over time (gray), between co-twins over time (orange), and in all 126 fecal samples (red). The 
white box represents the average number of species-level phylotypes found in a given sample. 
All measures of spread provided in parentheses represent ±SEM. (C) KEGG Orthology groups 
(KOs) consistently present within the fecal microbiome of an individual over time (gray), between 
co-twins over time (orange), and in all 48 microbiomes analyzed from the 4 sets of MZ twins dur-
ing the 4 month study (red). The white box indicates the average number of unique KOs (±SEM) 
identified in a particular sample. All measures of spread provided in parentheses represent ±SEM. 
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(D) Hellinger distance measurements of fecal microbiomes based on their KO content. Tests of 
statistical significance are based on 1000 permutations of a Hellinger distance matrix. Mean val-
ues (±SEM) are shown for the three types of comparisons (self-self; co-twin-co-twin; unrelated-
unrelated individual).
Figure 3. Correspondence analysis of B. animalis subsp. lactis CAZyme gene expression. 
RNA-Seq data for all B. animalis subsp. lactis genes encoding known or predicted CAZymes were 
subjected to unconstrained correspondence analysis using the ‘vegan’ package in R. Correspon-
dence analysis (CA) allows for the generation of biplots in which samples and genes can be plotted 
in the same ordinate space to reveal associations/anti-associations between the two. Circles repre-
sent individual CAZymes (genes). The genes ordinating furthest from the origin in the direction 
of one of the sample clusters (treatment groups) are labeled according to their locus number and 
are colored based on CAZyme family assignment (see Table to the right of the Figure for details; 
the abbreviation NA refers to no designation). Red triangles represent samples and are labeled ac-
cording to the following nomenclature: LX, logarithmic phase cells in MRS with X being the tech-
nical replicate number (e.g. L1 refers to the first technical replicate harvested in log phase); SX, 
stationary phase cells in MRS with accompanying replicate number; MX, feces from designated 
gnotobiotic animals obtained 4 weeks after the initial invasion with the FMP strain consortium; 
PX, samples obtained after fermentation in the FMP dairy matrix. Each cluster of samples from a 
particular treatment is associated with a functionally related set of expressed CAZymes.
Figure 4. ‘Top-down’ analysis of the effects of the FMP strain consortium on the model 
15-member community’s metatranscriptome. RNA-Seq reads were mapped to the sequenced 
genomes of the 15 community members. Transcript counts were normalized [reads per kb of gene 
length per million reads (RPKM), see Supplementary Material] and binned using the hierarchical 
levels of functional annotation employed by KEGG. For each KEGG category (A) or pathway (B) 
shown, boxplots depict the proportion of normalized read counts assignable to that annotation out 
of all reads which could be assigned annotations for that hierarchical level. Data shown correspond 
to the ‘multiple’ treatment group of mice (the group for which the most time points were collected), 
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however, data for all mice are provided in Table S8. (C) Illustration of how a model community’s 
functional response (e.g., the increased expression of levanase-encoding genes) can be dissected to 
identify the subset of genes/species driving the response. Boxes denote top quartile, median, and 
bottom quartile. Whisker length represents 1.5x inter-quartile range (IQR), except where there are 
no outliers; in these situations, whiskers span the range from minimum to maximum values. Box 
color denotes the day fecal samples were obtained (day 14 is the pre-treatment timepoint imme-
diately preceding gavage of the FMP strain consortium). When an asterisk is centered over a box, 
it indicates that there was a statistically significant change following administration of the FMP 
consortium relative to the pre-treatment timepoint (p<0.05 by paired, two-tailed Student’s t test). 
The positioning of asterisks above versus below a box emphasizes the direction of change (above, 
upregulation; below, downregulation).
Figure 5. Mouse and human communities share transcriptional responses to the FMP strain 
consortium involving ECs related to carbohydrate metabolism. (A) Box plots of the proportion 
of all RPKM-normalized reads in mouse and human fecal metatranscriptomes represented by three 
ECs involved in plant biomass degradation. Individual samples are shown as black dots (n=2-10). 
Boxes are also colored by fold-change, as determined by comparing mean values at a given time 
point to the value at the pre-treatment time point [for gnotobiotic mice pre-treatment refers to day 
14; in the case of humans, pre-treatment refers to the fecal sample collected 1 week prior to ini-
tiation of FMP consumption (sample ‘Pre1’ in Fig. 1A)]. Statistical significance was determined 
using the ShotgunFunctionalizeR package in R and an adjusted p-value cutoff of <0.01. Pre-treat-
ment time points, and subsequent time points where expression levels were not significantly differ-
ent from the pre-treatment mean are colored white. (B) Components of KEGG ‘starch and sucrose 
metabolism’, ‘pentose and glucuronate interconversions’ and ‘pentose phosphate’ pathways whose 
expression in the 15-member model community changed compared to pre-treatment values when 
the 5-member FMP strain consortium was introduced. Gray indicates that the fold-change was sta-
tistically significant (adjusted p-value <0.01). Ovals highlight the three enzymes shown in panel A. 
Dashed arrows indicate that multiple enzymatic reactions lead from these ECs and their indicated 
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substrates to the products shown. These intermediate reactions have been omitted for clarity or 
because the omitted ECs did not manifest significant changes in their expression.
Figure 6. Select urinary metabolites whose levels are altered after the introduction of the 
FMP strain consortium into mice harboring a defined model human gut microbiota. The 
statistical significance in pairwise comparisons shown in panels A-C was evaluated using a two-
tailed Student’s t test on the log-transformed spectral abundance of the metabolite in each sample. 
Values for the statistical significance of differences between time points as evaluated by one-way 
ANOVA, followed by FDR-correction and a post-hoc Tukey HSD test are also provided in Table 
S12. Horizontal bars represent group means, vertical bars represent ± SEM. n/s; not significant.
Figure 7. Shared transcriptional responses to FMP strain exposure in mice and humans. The 
heatmap shows ECs that exhibit a statistically significant change in their expression (Shotgun-
FunctionalizeR, adjusted p < 0.01) and manifest a consistent direction of change in their expres-
sion in all four comparisons shown. Comparisons include those where the pre-treatment timepoint 
was compared with a timepoint shortly after FMP strains were introduced (mouse: ‘d15 vs d14’, 
human: ‘FMP1 vs Pre1’) and those where the pre-treatment period was compared to a timepoint 
several weeks after strain introduction (mouse: ‘d42multi vs d14’, human: ‘FMP4 vs Pre1’). 
‘d42multi’ indicates the multiple-treatment group at day 42 of the mouse experiment. The colored 
boxes correspond to the KEGG categories that contain the ECs shown to the right of the heatmap. 
The scale refers to fold-difference in the mean of relative abundance of each EC between treatment 
and pre-treatment groups based on the mean number of normalized reads (RPKM) of transcripts 
assigned to a given EC. The 18 ECs shown at the bottom of the Figure are not associated with the 
five prominent KEGG categories listed. Their assigned categories are provided in Table S13.
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 EC 1.2.1.11  Aspartate-semialdehyde dehydrogenase 
 EC 1.4.1.16  Diaminopimelate dehydrogenase
 EC 3.5.4.19  Phosphoribosyl-AMP cyclohydrolase
 EC 3.6.1.31  Phosphoribosyl-ATP diphosphatase 
 EC 4.2.1.20  Tryptophan synthase 
 EC 4.2.1.52  Dihydrodipicolinate synthase 
 EC 4.1.3.-  Oxo-acid-lyase
 EC 2.6.1.9  Histidinol-phosphate transaminase 
 EC 2.6.1.1  Aspartate transaminase
 EC 2.4.2.-  Pentosyltransferase
 EC 2.7.1.31  Glycerate kinase
 EC 6.3.1.1  Aspartate--ammonia ligase 
 EC 6.3.5.5  Carbamoyl-phosphate synthase (glutamine-hydrolyzing) 
 EC 1.1.1.86  Ketol-acid reductoisomerase 
 EC 4.2.3.1  Threonine synthase
 EC 6.3.4.4  Adenylosuccinate synthase 
 EC 6.1.1.9  Valine--tRNA ligase 
 EC 1.1.1.69  Gluconate 5-dehydrogenase] 
 EC 5.3.1.-  Intramolecular oxidoreductase
 EC 2.2.1.1  Transketolase 
 EC 2.5.1.10  Geranyltranstransferase 
 EC 1.1.1.18  Inositol 2-dehydrogenase] 
 EC 2.7.10.1  Receptor protein-tyrosine kinase] 
 EC 1.1.1.58  Tagaturonate reductase
 EC 2.7.1.16  Ribulokinase 
 EC 2.7.1.6  Galactokinase
 EC 3.1.1.11  Pectinesterase
 EC 3.2.1.65  Levanase 
 EC 3.2.1.8  Endo-1,4-beta-xylanase
 EC 3.5.99.6  Glucosamine-6-phosphate deaminase
 EC 4.2.1.44  Myo-inosose-2 dehydratase 
 EC 4.2.1.47  GDP-mannose 4,6-dehydratase
 EC 4.2.2.2  Pectate lyase 
 EC 4.2.3.3  Methylglyoxal synthase 
 EC 5.3.1.14 L-rhamnose isomerase
 EC 5.3.1.17  4-deoxy-L-threo-5-hexosulose-uronate ketol-isomerase 
 EC 5.3.1.4  L-arabinose isomerase 
 EC 5.3.1.5  Xylose isomerase
 EC 5.3.1.8  Mannose-6-phosphate isomerase
 EC 6.4.1.1  Pyruvate carboxylase
 EC 1.2.7.3  2-oxoglutarate synthase
 EC 2.7.2.3  Phosphoglycerate kinase 
 EC 2.7.9.1  Pyruvate, phosphate dikinase
 EC 4.1.1.49  Phosphoenolpyruvate carboxykinase (ATP)
 EC 4.1.2.13  Fructose-bisphosphate aldolase
 EC 5.3.1.1  Triose-phosphate isomerase
 EC 5.3.1.6  Ribose-5-phosphate isomerase
 EC 1.1.1.158  UDP-N-acetylmuramate dehydrogenase
 EC 5.1.3.14  UDP-N-acetylglucosamine 2-epimerase
 EC 3.2.1.-  Glycosidase
 EC 3.5.1.10  Formyltetrahydrofolate deformylase
 EC 2.7.2.1  Acetate kinase
 EC 1.2.1.12  Glyceraldehyde-3-phosphate dehydrogenase (phosphorylating)
 EC 2.7.6.1  Ribose-phosphate diphosphokinase
 EC 3.2.1.20  Alpha-glucosidase
 EC 1.17.4.1  Ribonucleoside-diphosphate reductase
 EC 3.4.24.- Metalloendopeptidase
 EC 1.2.7.-  Oxidoreductase
 EC 1.6.5.-  Oxidoreductase
 EC 3.6.3.17  Monosaccharide-transporting ATPase 
 EC 3.6.5.3  Protein-synthesizing GTPase 
 EC 3.4.11.18  Methionyl aminopeptidase 
 EC 3.4.21.92  Endopeptidase Clp 
 EC 6.3.5.2  GMP synthase (glutamine-hydrolyzing)
 EC 5.2.1.8  Peptidylprolyl isomerase
 EC 2.7.7.7  DNA-directed DNA polymerase 
 EC 2.5.1.55  3-deoxy-8-phosphooctulonate synthase
 EC 2.3.1.179  Beta-ketoacyl-acyl-carrier-protein synthase II 
 EC 2.7.3.9  Phosphoenolpyruvate--protein phosphotransferase 
 EC 2.4.2.19  Nicotinate-nucleotide diphosphorylase (carboxylating)
 EC 2.4.2.1  Purine-nucleoside phosphorylase
 EC 2.7.4.3  Adenylate kinase
 EC 6.3.2.6  Phosphoribosylaminoimidazolesuccinocarboxamide synthase
 EC 2.3.1.79  Maltose O-acetyltransferase
 EC 3.2.1.101  Mannan endo-1,6-alpha-mannosidase
 EC 4.2.99.18  DNA-(apurinic or apyrimidinic site) lyase 
 EC 3.1.26.-  Endoribonuclease 
 EC 6.1.1.3  Threonine--tRNA ligase 
Carbohydrate MetabolismAmino Acid Metabolism
Biosynthesis of Secondary Metabolites
Nucleotide Metabolism
Metabolism of Cofactors and Vitamins
 EC 6.3.4.5  Argininosuccinate synthase 
 EC 4.1.2.14  2-dehydro-3-deoxy-phosphogluconate aldolase
 EC 4.1.3.16  4-hydroxy-2-oxoglutarate aldolase
 EC 6.4.1.3  Propionyl-CoA carboxylase
 EC 6.3.5.4  Asparagine synthase (glutamine-hydrolyzing) 
 EC 3.5.4.16  GTP cyclohydrolase I
 EC 4.2.1.75  Uroporphyrinogen-III synthase
 EC 2.1.2.3  Phosphoribosylaminoimidazolecarboxamide formyltransferase
Scale
3  2  1 -1 -2 -3
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Supplementary material
Supplementary materials and methods
Microbial genome sequencing. The following bacterial strains are incorporated into the commer-
cially available FMP: Bifidobacterium animalis subsp. lactis (strain CNCM I-2494), Lactobacillus 
delbrueckii subsp. bulgaricus (strains CNCM I-1632, CNCM I-1519), Lactococcus lactis subsp. 
cremoris (strain CNCM I-1631), and Streptococcus thermophilus (strain CNCM I-1630). We per-
formed shotgun 454 FLX pyrosequencing of both L. delbrueckii subsp. bulgaricus strains (CNCM 
I-1632, CNCM I-1519), plus the L. lactis subsp. cremoris strain (33-, 32- and 51-fold cover-
age, respectively). Using the Newbler assembler (v1.1, 454 Life Sciences) and already sequenced 
strains of these species, we obtained draft genome assemblies with N50 contig sizes of 69,466 and 
55,626 and 55,851 bp, respectively. The total sizes of the assembled L. delbrueckii genomes were 
1,767,897 bp (CNCM I-1632) and 1,795,730 bp (CNCM I-1519), while the L. lactis assembly had 
an aggregate genome size of 2,511,332 bp. A finished genome sequence of the B. animalis subsp. 
lactis genome and a deep draft assembly of the S. thermophilis genome were previously generated 
by Integrated Genomics (see Table S3 for a summary of genome metrics).
Annotation and comparative genomic analysis. The predicted proteins of all the sequenced 
bacterial species used in this study were annotated using BLASTP searches (E-value <10-5) against 
version 54 (v54) of the Kyoto Encyclopedia of Genes and Genomes (KEGG) database (S1-3) and 
the Carbohydrate Active Enzyme (CAZy) database (S4). BLAST results were parsed into a lookup 
table for each genome, and each fecal microbiome, using a Perl script (lookup_KEGG_for_genes_
BLAST.pl) that assigned to each gene the KEGG Orthology (KO) identifier associated with its top 
BLAST hit (E-value <10-5). In cases where the query protein’s top match to the reference database 
was ambiguous (i.e., when there were multiple top matches with equally good scores), the gene 
was annotated with the KOs of all the top-matching database entries.
These lookup tables were then used to calculate the ‘coverage ratio’ of each KEGG meta-
bolic pathway for each bacterial genome in this study using the Perl script kegg_key.pl. For each 
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edge (enzymatic reaction) of each KEGG metabolic pathway, this script checks for the presence 
of a gene whose assigned KO corresponds with that reaction in (i) a given microbial genome, (ii) 
defined collections of microbial genomes, or (iii) larger, incompletely sequenced microbiomes. 
KEGG pathway coverage ratios for several combinations of genomes, as well as several published 
gut microbiomes, were calculated and used to perform average linkage hierarchical clustering in 
Cluster 3.0 (S5) using an un-centered correlation similarity metric. A heatmap visualization of this 
clustered data was generated using the Java Treeview application (jtreeview.sourceforge.net).
Culturing of B. animalis subsp. lactis. A frozen stock of B. animalis subsp. lactis (strain 
CNCM I-2494) was streaked out on MRS-agar plates (BD/Difco) and transferred to a Coy cham-
ber for overnight growth at 37oC under an atmosphere of 5% H
2
, 20% CO
2
 and 75% N
2
. Single 
colonies were picked and inoculated into 10 ml of pre-reduced MRS broth (BD/Difco) that had 
been stored for 24 h in an anaerobic chamber. The medium was not supplemented with cysteine. 
Each culture was passaged four times to stationary phase, and growth curves were recorded to dis-
cern growth kinetics under these conditions. 100 ml of an overnight culture was used to inoculate 
10 ml of fresh anaerobic MRS in 27 ml Balch tubes with rubber stoppers and aluminum crimp 
tops. The initial headspace of the tubes was composed of 5% H
2
, 20% CO
2
, and 75% N
2
 at ambient 
pressure. Tubes were incubated at 37oC, and 4 ml aliquots were collected at mid-log phase (9 h 
post-inoculation, OD
600
=0.2) and during late stationary phase (27 h post-inoculation, OD
600
=2.6). 
Each aliquot from each culture (n=2) was immediately combined with 8 ml of RNAprotect Bac-
teria Reagent (Qiagen), incubated for 5 min at room temperature, then centrifuged (3,220 x g; 15 
min at 25oC). The pellets were snap-frozen in liquid nitrogen and stored at -80oC, and total cellular 
RNA was subsequently isolated as described previously (S6).
Human studies
Production and distribution of the FMP to study participants. The FMP used for this study was 
produced in Danone’s pilot plant located in Fort Worth, TX. Batches were shipped directly to 
subjects by an independent delivery service so that the names of study participants would remain 
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unknown to all but those in the MOAFTS study group. Each subject received 4 shipments of FMP, 
spaced at 2-week intervals. Each shipment was composed of sufficient numbers of cups (pots) so 
that study participants could consume one 4 oz serving twice a day (each serving consisted of a 
single pot). Each co-twin chose her flavors (strawberry, vanilla, and/or peach). The same flavor 
selection was shipped each time. Each subject was allowed to vary the sequence of selected flavors 
according to her wishes.
Analysis of the effects of FMP consumption on stool parameters. Stool consistency, dif-
ficulty of passage, and frequency were assessed using a daily stool diary in which participants 
recorded the time of day for each bowel movement. Participants rated the stool consistency using 
the seven point Bristol Stool Form Scale (S7) and the difficulty of passage using a five-point scale 
(no difficulty to extreme difficulty).
Quantitative PCR (qPCR) analysis of fecal levels of FMP strains. qPCR was used to de-
fine the levels of selected FMP strains in fecal samples obtained from MZ co-twins and gnotobiotic 
mice (S8-12). The PCR primer sets targeting each strain’s 16S rRNA gene or CRISPR locus are 
described in Table S14, as are the amplification conditions. Samples were analyzed on an Applied 
Biosystems 7900HT instrument using SYBR Green chemistry. Standard curves were constructed 
using genomic DNA prepared from a known number of bacterial cells harvested from monocul-
tures grown to stationary phase (cells were DAPI stained and counted by microscopy); C
t
 values 
for each reaction could, therefore, be expressed in terms of cell equivalents (CE).
To calculate the concentration of a given bacterial strain in each fecal sample, three serial 
dilutions of extracted fecal DNA (10 ng, 1 ng, 0.1 ng) were assayed in at least two independent 
qPCR reactions. C
t
 values falling within the linear range of the assay were referenced to the stan-
dard curves, while those outside the linear range were excluded from the analysis. For human 
samples, data were log-transformed and normalized to fecal mass (log
10
 CE/g feces). For mouse 
samples, data were log-transformed and normalized to mass of template DNA (log
10
 CE/mg DNA).
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Multiplex pyrosequencing of 16S rRNA genes in fecal samples and the FMP. A total of 
126 fecal samples (9 samples per individual) were collected over the course of 4 months according 
to the schedule shown in Fig. 1. All fecal samples were frozen at -20oC within 30 min after they 
were produced. The samples were maintained at this temperature for the period of time required 
to ship them to a biospecimen repository (less than 24 h). As soon as samples were received, they 
were de-identified and stored at -80°C. DNA was extracted from frozen, pulverized fecal samples 
by bead beating followed by phenol-chloroform extraction, as described previously (S13). Meth-
ods for generating and performing multiplex pyrosequencing of amplicons from variable region 2 
(V2) of bacterial 16S rRNA genes are described in (S13). Bacterial V2 16S rRNA gene sequencing 
data were pre-processed to remove sequences with low quality scores, sequences with ambiguous 
characters, and sequences outside the length bounds (200-300 nt). All subsequent data processing 
and analyses were done using QIIME software (S14). Pyrosequencing ‘noise’ was removed with 
an algorithm implemented in QIIME. 16S rRNA reads were binned according to their sample-
specific, error-correcting barcode incorporated into the reverse primer. Similar sequences were 
binned into phylotypes using CD-HIT with minimum pairwise identity of 97% (S15).
Aliquots of freshly produced as well as 30 day-old FMP from 6 batches of each flavor were 
sent directly from the pilot production plant to one of our labs using the same shipping protocol 
that was used to deliver the FMP to study participants. DNA was extracted and amplicons from 
the V2 region of bacterial 16S rRNA were generated and sequenced using the protocols described 
above. 49,959 high quality reads were obtained from a total of 33 FMP samples (1,332±187 reads/
sample (mean ± S.D)): 43,729 reads of these were classified using the GreenGenes database (http://
greengenes.lbl.gov/cgi-bin/nph-index.cgi) and belonged to the genera Streptococccus, Lactococ-
cus, Lactobacillus or Bifidobacterium. 
Co-occurrence analysis. To determine whether there were statistically significant 
associations between the presence of B. animalis subsp. lactis and the occurrence of resident gut 
bacterial species-level phylotypes in human fecal samples, a co-occurrence analysis was performed 
using software tools present in QIIME under the script otu_category_significance.py. We used this 
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script to employ an ANOVA test to search our fecal 16S rRNA datasets for phylotypes whose 
relative abundances were higher in samples in which B. animalis subsp. lactis was present versus 
samples in which this strain was absent, as determined using qPCR. To avoid biases that might 
be introduced by differences in sample sequencing depth, we randomly selected an even number 
of sequences/sample (1,644 sequences) prior to performing the analysis. The raw p-values were 
corrected for multiple tests using the false discovery rate (fdr) correction (S16). We also performed 
the analysis at the genus and family levels by binning all operational taxonomic units (OTUs) 
that mapped to the same family or genus based on classification with the RDP classifier, using the 
summarize_taxa.py script in QIIME.
Shotgun sequencing of fecal microbiomes. Forty-eight fecal samples from four twin pairs 
were selected for multiplex shotgun pyrosequencing of total community DNA (454 FLX chemis-
try). For each individual, two fecal samples were analyzed before initiation of FMP consumption, 
two samples during the period when FMP was being consumed, and two samples after consump-
tion had ceased. 
Each fecal community DNA sample was randomly fragmented to an average length of 500 
bp by nebulization, and then labeled with a distinct multiplex identifier (MID; Roche) using the 
manufacturer’s protocol. Equivalent amounts of 12 MID-labeled samples from each family were 
pooled prior to each pyrosequencing run. Shotgun reads were subsequently filtered using publicly 
available software (S17) to remove (i) all reads less than 60 nt, (ii) LR70 reads with at least one 
degenerate base (N) or reads with two continuous and/or three total degenerate bases, (iii) all du-
plicates, defined as sequences whose initial 20 nt were identical and shared an overall identity of 
>97% throughout the length of the shortest read, and (iv) all sequences with significant similarity 
to human reference genomes (i.e., having a BLASTN match with E-value <10-5, bitscore >50, and 
percent identity >75%) to ensure continued de-identification of samples.
Reads obtained from shotgun sequencing of the twins’ fecal microbiomes were used to 
query v54 of the KEGG GENES database using BLASTX (E-value <10-5, bitscore >50, and 
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%identity >50). A comparable annotation was performed for published fecal microbiomes that 
had been generated from 124 deeply sampled unrelated adult Europeans (S18), and from a pair of 
obese adult MOAFTS twins (S19).
Microbial RNA-Seq analysis of human fecal metatranscriptomes. Methods used to pre-
pare fecal RNA, generate RNA-Seq data, and perform computational analyses of these datasets 
are described in detail below and in one of our previously published studies (S6, Fig. S4B). The 
only difference in the analysis pipeline used for human versus mouse RNA-Seq datasets was the 
choice of reference genomes. To map RNA-Seq reads from human fecal samples to genes, we used 
a collection of 131 bacterial genomes encompassing much of the diversity documented in human 
gut communities, plus the genomes of the five FMP strains; these genomes are listed in Table S15.
Studies in gnotobiotic mice
Using INSeq to assay the determinants of fitness in a saccharolytic member of the 15-species 
model human microbiota. INsertion Sequencing (INSeq) is a method based on a mutagenic trans-
poson modified so that discrete fragments of adjacent chromosomal DNA can be captured when 
the transposon is excised from bacterial genomes by the restriction enzyme MmeI (S20). Sequenc-
ing fragments excised from a mixed population of tens of thousands of transposon mutants pro-
vides information about the location of each transposon in the genome. The number of occurrences 
of the transposon insertion site sequence mirrors the relative abundance of that mutant in the mixed 
population. By identifying mutants that significantly decrease in relative abundance after passage 
through a selective condition, INSeq allows a genome-wide map of in vivo fitness determinants to 
be created. 
To determine whether introduction of the FMP strain consortium results in differences in 
the in vivo fitness requirements of a human gut symbiont present in the 15-member community, 
B. thetaiotaomicron strain VPI-5482 was mutagenized with the INSeq transposon (S20). A library 
of 34,544 randomly inserted transposon mutant strains covering 3,435 of the organism’s 4,779 
genes was introduced, by gavage, together with the other 14 non-mutagenized members of the 
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community into germ-free mice. Fecal samples were subsequently collected from each mouse (n 
= 10) before (d7, d14), immediately after (d16), and 7 d after (d21) initial introduction of the FMP 
strains. INSeq libraries were prepared as described (S20) and sequenced using an Illumina GA IIx 
instrument (~1,000,000 36 nt reads/sample; Table S6). Resulting sequences were mapped to the 
B. thetaiotaomicron reference genome and quantified as described (S20). We found that insertions 
in 626 genes showed a significantly decreased relative abundance in the day 14 fecal microbiota 
(multiple hypothesis testing-corrected q<0.001), reflecting a fitness requirement for these genes in 
the colonization process (Table S6). Analysis of fecal samples collected just prior to, one day after, 
and 7 days after introduction of the FMP consortium established that exposure to the FMP strains 
did not impose significant new fitness pressures on specific genes present in this saccharolytic 
bacterial species.
Animal sampling. Fecal samples were obtained from each animal at the time points indi-
cated in Fig. 1. Each fecal sample was collected directly as it emerged from the anus into a 1.7 ml 
screw cap Eppendorf tube, which was immediately deposited in a stainless steel dewer containing 
liquid N
2
 (the dewer was introduced into the gnotobiotic isolator on the day of collection after it 
had been sterilized in the isolator’s entry port with chlorine dioxide spray (Clidox-S; PRL Pharma-
cal)). Various subsets of samples were subjected to COPRO-Seq, INSeq and microbial RNA-Seq 
analyses. Blood samples were collected into lithium heparin tubes (Becton Dickinson), placed im-
mediately on ice, and then centrifuged (2,700 x g; 3 min at 4°C). The resulting plasma supernatant 
was stored at -80oC until assay. Urine was collected directly into Eppendorf tubes and immediately 
frozen in liquid N
2
. Upon sacrifice, ceca were dissected and cecal contents were frozen immedi-
ately at -80oC.
Isolation of DNA from cecal contents and feces. Microbial community DNA was pre-
pared in a two-step process consisting of a crude extraction step followed by additional purifica-
tion and RNAse treatment. 
75
Crude extraction. The sample (typically 25-100 mg of frozen feces or 50-125 mg of frozen 
cecal contents) was combined with 250 ml of 0.1 mm zirconium beads (BioSpec Products), 500 ml 
Buffer A (200 mM NaCl, 200 mM Tris, 20 mM EDTA), 210 ml SDS (20% v/v, filter-sterilized), and 
500 ml phenol:chloroform:isoamyl alcohol (25:24:1, pH 7.9; Ambion), and the mixture was briefly 
chilled on ice. Samples were then disrupted using a Mini-BeadBeater-8 (BioSpec) set to 'homog-
enize' (bead-beating for 2 min at room temperature, followed by placement on ice for 1-2 min, fol-
lowed by bead-beating for an additional 2 min). The aqueous phase (~600 ml) was collected after 
centrifugation (6,800 x g; 3 min at 4oC) and combined with an equal volume of phenol:chloroform 
in 2 ml ‘light’ phase-lock gel tubes (5Prime) per the manufacturer’s protocol. After spinning, the 
aqueous phase was combined with 1 volume of chilled 100% isopropanol (-20oC) and 1/10 volume 
sodium acetate (3 M, pH 5.5). Following incubation at -20oC for 1 h, the precipitate was pelleted 
(20,800 x g; 20 min at 4oC), washed in 100% EtOH, dried, and resuspended in 5 ml TE (pH 7.0) 
per milligram of original sample material.
RNAse treatment and further purification. Aliquots of crude DNA were transferred to a 
96-well plate. Buffer PM (Qiagen) was mixed with RNase A (Qiagen) to a final concentration of 
1.3 mg/ml. Three volumes of this mixture were added to each well and the reactions were allowed 
to incubate at room temperature for 2 min. Following RNase digestion, samples were applied to a 
QIAquick 96 PCR purification plate (Qiagen) and processed according to the manufacturer’s in-
structions using a QIAvac 96 vacuum manifold. DNA was eluted in 100 ml of Buffer EB (Qiagen). 
DNA quality and purity were verified using a NanoDrop spectrophotometer (model ND-1000).
Preparing DNA libraries for Illumina sequencing and COPRO-Seq analysis in a 96-well 
format. DNA libraries were prepared for sequencing using a modified version of Illumina’s sample 
preparation protocol for generating libraries from genomic DNA. The six steps of this modified 
preparation are as follows:
(i) Fragmentation. Two micrograms of each purified DNA sample was suspended in 100 ml 
Buffer EB and fragmented by sonication in 1.7 ml Eppendorfs using the BioruptorXL multi-sam-
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ple sonicator (Diagenode) set on ‘high’. Samples were sonicated over the course of 20 min using 
successive cycles of 30 sec ‘on’ followed by 30 sec ‘off ‘. Sonicated samples were subsequently 
cleaned up using the MinElute 96 UF PCR Purification Kit (Qiagen) per the manufacturer's in-
structions. Each sonicated DNA sample in each well of the 96-well plate was eluted with 22 ml 
Buffer EB.
(ii) ‘Add-only’ enzymatic modification. Ten microliters of each eluate from step (i) was 
transferred to a 96-well plate where it was subjected to enzymatic blunting. Each 20 ml reaction 
contained: 10 ml DNA, 2 ml T4 DNA ligase buffer [10X; New England Biolabs (NEB), catalogue 
number B0202S], 1 ml dNTPs (1 mM; NEB, N1201AA), 0.5 ml Klenow DNA polymerase (5 U/
ml; NEB, M0210S), T4 PNK (10 U/ml; NEB, M0201S), and 6 ml molecular grade water. Blunting 
reactions were incubated (25oC, 30 min) then heat-inactivated (75oC, 20 min). Residual dNTPs 
were dephosphorylated by adding 1 ml of shrimp alkaline phosphatase (1 U/ml; Promega, M820A) 
to each reaction. Reactions were incubated (37oC, 30 min) and heat-inactivated (75oC, 30 min). 
Adenine tailing reactions were set up in 30 ml reaction volumes that contained 21 ml of the inac-
tivated phosphatase reaction, 6.4 ml T4 DNA ligase buffer (diluted to 1X; NEB, B0202S), 0.6 ml 
dATP (5 mM), and 2 ml Klenow 3'->5' exo- (5 U/ml; NEB, M0212L). Reactions were incubated (37 
oC, 30 min) and heat-inactivated (75oC, 20 min).
(iii) Ligation. Customized Illumina adapters containing maximally distant 4 bp barcodes 
described elsewhere (S6) were ligated to the polyA-tailed DNA in 50 ml reactions as follows. 
Thirty microliters of the inactivated A-tailing reaction described in the preceding paragraph was 
added to 5 ml T4 DNA ligase buffer (10X), 5 ml adapter mix (1 mM final concentration per adapter), 
and 9 ml water at 4oC. One microliter of T4 DNA ligase (2,000,000 U/ml; NEB M0202M) was sub-
sequently added and reactions were incubated (16oC, 1 h), followed by heat-inactivation (65oC, 10 
min). Ligation reactions were cleaned up using the MinElute 96 UF PCR Purification Kit (Qiagen) 
according to the manufacturer’s recommended protocol. DNA was eluted in 22 ml Buffer EB. 
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(iv) Gel purification. 10 ml of each elution was separated by gel electrophoresis on 2% 
agarose. DNA migrating at 200 bp was excised and gel slices were purified using a QIAquick 96 
PCR Purification Kit (Qiagen). 
(v) PCR amplification. Each library was PCR amplified for 19 cycles using Illumina’s 
standard amplification primers with modifications to impart barcode-specificity (S6) and Illumi-
na’s recommended amplification conditions/reagents. Products were purified using a QIAquick 96 
PCR Purification Kit (Qiagen). An aliquot of this purification was also subjected to 2% agarose gel 
electrophoresis to confirm the absence of any significant adapter-dimer contamination.
(vi) Library pooling and sequencing. The concentration of each purified library was quan-
tified using the Qubit dsDNA HS Assay Kit (Invitrogen). Barcoded libraries were subsequently 
pooled (typically in groups of 16) at equivalent final concentrations. Sequencing was performed 
using the standard Illumina GA IIx sequencing protocol, with libraries loaded on the flow cell at 
a concentration of 2.0-2.5 pM).
A custom software pipeline was written in Perl for performing COPRO-Seq data process-
ing in a computer cluster environment running Sun Grid Engine. These data processing steps are 
schematized in Fig. S4A. Briefly, raw Illumina GA IIx reads from a sequencing pool were first de-
plexed by barcode and trimmed to 34 bp (30 bp genome sequence + 4 bp barcode). Trimmed reads 
were aligned to the genomes of the 20 microbial strains used in this study using Illumina’s ELAND 
aligner. Perfect, unique alignments to the reference genomes were retained, while those mapping 
less than perfectly or having multiple possible alignments to the reference genomes were filtered 
out, ensuring that only high-quality, unambiguous reads were used. Hits to each genome were 
then tallied, after which the summed counts for each genome were normalized by that genome’s 
‘informative genome size’ (term defined in Results) to adjust for both genome size and uniqueness 
relative to all other genomes in the experiment. The Perl scripts supporting the COPRO-Seq ana-
lytic pipeline can be downloaded from: http://gordonlab.wustl.edu/projects/2011-McNulty_etal. 
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Characterizing gene expression with microbial RNA-Seq. Following extraction of total 
nucleic acid with phenol-chloroform, and precipitation with isopropanol, fecal samples were sub-
jected to DNAse digestion (S6). Total RNA was then: (i) passed through a MEGAClear column 
(Ambion) to deplete RNAs <200 nt (removing most 5S rRNA and tRNA species; (S6)); (ii) sub-
jected to another round of DNAse digestion; (iii) passed through another MEGAClear column; 
and (iv) subjected to a hybridization-based pulldown of 16S and 23S rRNA using custom-designed 
biotinylated oligonucleotides that contain short rDNA sequences conserved across a set of 37 
human gut-derived sequenced microbial genomes (S6). The depletion protocol, which has been 
adapted to 96-well format, is described elsewhere (S6). PCR (30 cycles) targeting a short (<100 
bp) region from the genome of an abundant community member (typically Bacteroides WH2) was 
used to verify the absence of detectable gDNA in each RNA preparation. 
Doubled stranded cDNA (dscDNA) was synthesized using random hexanucleotide prim-
ers. At the conclusion of the reaction, Illumina adapters containing sample-specific 4 nt barcodes 
were ligated to the dscDNA. Multiplex sequencing was performed using the Illumina GA IIx 
instrument. We typically sequenced two barcoded in vitro samples/lane of the 8-lane flow cell; in 
vivo samples were not multiplexed (i.e. 1 sample was analyzed per sequencing lane). This allowed 
us to identify mRNA present at levels representing ≥0.001% of all reads.
The pipeline for processing microbial RNA-Seq data is presented in Fig. S4B. The 8-20 
million 36 nt cDNA reads from each sequencing lane were separated by barcode, and mapped 
against the relevant set of genome sequences using the SSAHA2 algorithm (S21) to determine the 
raw unique-match ‘counts’ (reads) for each gene present in the relevant microbial genome or mi-
crobiome. Reads that mapped non-uniquely were added to each gene in proportion to each gene’s 
fraction of unique-match counts (e.g., a non-unique read that maps equally well to gene A with 
18 unique reads and gene B with 2 unique reads would be scored as 0.9 of a count to gene A, and 
0.1 of a count to gene B; the influence of ties is negligible for RNA-Seq given the small numbers 
of distinct genomes, but would become more important with more complex communities). Raw 
counts were then normalized to reads/kb gene length/million mapped reads (RPKM) using one or 
more gene position file(s) in conjunction with custom Perl scripts. 
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Data normalization was carried out at two different levels in this study. For our ‘top-down’ 
analysis, data were normalized at the level of the entire community metatranscriptome (i.e., raw 
counts from all species were normalized simultaneously using a single gene position file that in-
cluded the positions of all genes in the model community metatranscriptome). Data normalized 
in top-down fashion allowed us to determine, after binning gene expression values by function, 
how the collective operations of the model community were changing as the result of experimental 
perturbations. In our ‘bottom-up’ analysis, data were normalized at the level of individual species 
(i.e., raw counts from each individual species were normalized separately from one another, in 
each case using a species-specific gene position file describing the positions of only that species’ 
genes). Data normalized in bottom-up fashion allowed us to interrogate what statistically signifi-
cant gene expression changes were occurring within a given species of interest.
Bottom-up normalized transcript data were analyzed by Cyber-T (S22) to identify mRNAs 
that exhibited significant differences in their levels of expression between samples. For each com-
parison, transcripts were then binned into a list where the magnitude of the difference in their 
expression was greater than or equal to 4-fold. Binned transcripts were subsequently annotated 
using the kegg_counting.pl Perl script described above. Each resulting annotated dataset was used 
to determine the representation of KEGG pathways and categories within these lists. 
Further functional comparisons were carried out using ShotgunFunctionalizeR, an R pack-
age designed to analyze differences between metagenomic datasets using a Poisson statistical 
model (S23). The RPKM-normalized counts for each gene in the model microbiome were then 
binned by EC number using each gene’s previously assigned annotation. Summed reads in each 
EC bin were rounded to the nearest integer, and the data were imported into ShotgunFunctional-
izeR, which was used to identify ECs that were differentially expressed.
Identification of predictive KEGG categories, pathways and ECs using a Random For-
ests classifier. To identify KEGG categories, ECs, or pathways that were significantly differentiat-
ed across treatment states, we used the Random Forests classifier (S24) described in (S25). Mouse 
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samples were divided into 10 pre-treatment samples (experimental day 14) and 20 post-treatment 
samples (experimental days 15 and 42). To estimate the generalization error of the classifier we 
used leave-one-out cross-validation, in which each sample’s group was predicted by a classifier 
trained on the other 29 samples. Training was done using default settings for the randomForest 
package in R (S24). Each feature’s predictiveness was estimated by calculating the mean increase 
in estimated generalization error when the values of that feature were permuted at random. Fea-
tures whose removal caused an average error increase of at least 0.1% were labeled as ‘predictive’; 
those with an increase of at least 1% were labeled as ‘highly predictive’.
Non-targeted metabolomics via gas chromatography/mass spectrometry (GC/MS). 
Urines were first assayed for creatinine content as measured by a modified Jaffe method using the 
three microliter “random-urine” routine and CR-S 3000 reagent on the UniCel DxC 600 Synchron 
Clinical System (Beckman Instruments, Brea, CA). A urine volume equivalent to 0.2 micromoles 
of creatinine was then aliquoted and spiked with perdeuterated myristic acid (D
27
-C14:0) as an 
internal standard for retention-time locking (RTL IS). Following treatment with 7.5 volumes of 
methanol, the mixture was centrifuged and the supernatant was decanted and dried.
Derivatization of all dried supernatants for GC/MS followed a method adapted with modi-
fications from that of (S26). Reagents were from Sigma-Aldrich (St. Louis, MO), unless otherwise 
noted. Briefly, certain reactive carbonyls were first methoximated at 50ºC with a saturated solution 
of methoxyamine hydrochloride in dry pyridine, followed by replacement of exchangeable protons 
with trimethylsilyl (TMS) groups using N-methyl-N-(trimethylsilyl) trifluoroacetamide with a 1% 
v/v catalytic admixture of trimethylchlorosilane (Thermo-Fisher Scientific, Rockford, IL) at 50ºC.
GC/MS methods generally followed those of Fiehn (S27) and Kind (S28), and used a 6890N 
GC connected to a 5975 Inert single-quadrupole MS (Agilent, Santa Clara, CA). A large-volume, 
ProSep inlet enabled programmed-temperature vaporization and diversion of heavy contaminants 
away from the GC and MS, as described below, greatly reducing maintenance time (Apex Tech-
nologies, Inc., Independence, KY). The two wall-coated, open-tubular GC columns connected in 
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series were both from J&W/Agilent (part 122-5512), DB5-MS, 15 m in length, 0.25 mm in diame-
ter, with a 0.25 µm luminal film. Prior to each run, initial inlet pressures were empirically adjusted 
such that the resulting retention time (RT) of the TMS-D27-C14:0 standard was set at ~16.727 
min. Under these conditions, derivatized metabolites eluted from the column and reached the elec-
tron-ionization (EI) source in the MS at known times (e.g., bis-TMS-lactic acid at ~6.85 min, and 
TMS-cholesterol at ~27.38 min). A mid-column, microfluidic splitter (Agilent) provided a means 
for hot back-flushing of the upstream GC column at the end of each run while the oven was held at 
325ºC for a terminal “bake-out” (another antifouling and anti-carryover measure analogous to that 
described in (S29)). During this terminal “bake-out,” the inlet was also held at 325ºC, and it was 
purged with a large flow of the carrier gas, helium. Positive ions generated with conventional EI at 
70 eV were scanned broadly from 600 to 50 m/z in the detector throughout the run.
Raw data from Agilent’s ChemStation software environment were imported into the free-
ware, Automatic Mass Spectral Deconvolution and Identification Software (AMDIS) (developed 
by Drs. Steve Stein, W. Gary Mallard, and their coworkers at National Institute of Standards and 
Technology (S30-32); http://chemdata.nist.gov/mass-spc/amdis/). Deconvoluted spectra were 
identified, to the extent possible, using several commercial and public spectral libraries. Our pri-
mary source was the Fiehn GC/MS Metabolomics RTL Library (a gift from Agilent Technologies, 
Santa Clara, CA, part number G1676-90000). Additional spectra for comparison were gleaned 
from the Golm Metabolome Library (courtesy of Dr. Joachim Kopka and coworkers at the Max 
Planck Institute of Molecular Plant Physiology, Golm, Germany (S33); http://csbdb.mpimp-golm.
mpg.de/csbdb/gmd/gmd.html), the commercial NIST/EPA/NIH Mass Spectral Library and our 
own purpose-built spectral library. Where indicated, peak alignment was performed with Spect-
Connect freeware (courtesy of Dr. Gregory Stephanopoulos, Massachusetts Institute of Technol-
ogy (S34); http://www.spectconnect.mit.edu). Chemometrics were performed with Mass Profiler 
Professional (a recent descendant of GeneSpring MS, purchased from Agilent), along with our 
own custom macros, written in Visual Basic for use in the Excel software environment.
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The statistical significance of differences in the log
2
 spectral abundances of each metabolite 
in samples obtained at different time points was tested using two approaches. A first-pass, highly-
permissive set of pairwise comparisons was calculated between each combination of samples (d0 
versus d14, d0 versus d42, d14 versus d42) using a simple two-tailed Student’s t-test. The result-
ing p-values, which were not corrected for multiple hypothesis testing, are listed in Table S12. 
Given the high ratio of hypotheses tested to samples per group (198 metabolites; 5-8 samples per 
group), we also guarded against false discovery by performing a more stringent set of calculations 
that produced a shorter list of metabolites with significant differences in abundance. This latter 
procedure consisted of first taking metabolite data from all three time points and subjecting them 
to a one-way ANOVA. The resulting p-values were then adjusted using Benjamini-Hochberg cor-
rection, generating q-values. The log
2
 spectral abundances of all metabolites whose q-values were 
below 0.05 were then subjected to Tukey’s HDS (Honestly Significantly Different) post-hoc test 
to determine which time points were significantly different from one another. All Tukey’s HDS 
p-values that were calculated are provided in Table S12.
Supplementary results
Human studies
Analysis of the effects of FMP consumption on stool consistency, difficulty of passage, 
and frequency. To determine whether there were differences in stool consistency and difficulty 
of passage of stools between pre-treatment, treatment, and post-treatment study periods, we first 
constructed a dataset in which the unit of analysis was ‘bowel movement’. Using ordinal logistic 
regression, we analyzed separate models predicting stool consistency and difficulty of stool pas-
sage using ‘treatment period’ as the reference group. We adjusted for clustering of observations 
using a Huber-White robust variance estimator (STATA 2004). When data from the entire study 
period were included in the analyses, no significant differences were observed between study 
periods for either stool consistency or difficulty passing stool. Next, we conducted an alternate 
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analysis in which data from the first two weeks of the treatment and of the post-treatment phases 
were omitted. We found that women had lower stool consistency scores during the last two weeks 
of the post-treatment phase compared to the last two weeks of the treatment phase: i.e., stools were 
softer during the treatment period (OR=0.69; p=0.04). The difference in stool consistency between 
the pre-treatment phase and the last two weeks of the treatment phase was not significant; how-
ever, there was a significant difference between the pre-treatment versus treatment compared to the 
post-treatment versus treatment odds ratios (p=0.005).
Analyses for stool frequency were conducted similarly to those above with the exception 
that the unit of analysis was the ‘person-day’ (i.e., one observation per person per day) and the 
dependent variable was number of bowel movements per day. We did not find stool frequency to 
be associated with study period regardless of which study days were included in the analysis.
One participant had a diarrheal illness on three of the FMP treatment days, with a dramatic 
increase in stool frequency and decrease in stool firmness on these days. She reported taking four 
2 mg tablets of loperamide [4-(p-chlorophenyl)-4-hydroxy-N, N-dimethyl- a, a-diphenyl-1-piper-
idinebutyramide monohydrochloride] to relieve her symptoms during this period. Therefore, data 
from these bowel movements were excluded from the analyses.
Co-occurrence analysis. As noted above, to identify species-level phylotypes that 
consistently increase or decrease in abundance when B. animalis subsp. lactis is present in human 
fecal samples, we performed a co-occurrence analysis using QIIME (see Supp. Methods). This 
analysis indicated that no OTUs present in the pre-treatment microbiota exhibited a statistically 
significant change in their proportional representation in feces during the period of FMP consumption 
or during the post-treatment period in any individual after correction for multiple tests. The OTU 
that most nearly achieved significance was closely related to Lactococcus lactis (raw p=0.00067; 
ANOVA: p>0.05 after FDR correction). A follow-up co-occurrence analysis for all genera also 
identified the genus Lactococcus as being significantly more abundant when B. animalis subsp. 
lactis was present (the latter determined by qPCR). It is reasonable that L. lactis would co-occur 
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with B. animalis subsp. lactis given the presence of both strains in the FMP. A co-occurrence 
analysis performed at the family level of taxonomy failed to identify any significant differences.
Our ability to identify L. lactis in our co-occurrence analysis was encouraging, but raised 
the question of why an OTU representing B. animalis subsp. lactis did not achieve significance, 
given that nearly every sample collected during the period of FMP consumption was positive for 
this strain by qPCR. Of the 58 samples deemed positive for B. animalis subsp. lactis by qPCR, 
only 7 yielded an OTU in our 16S rRNA dataset with a 100% identity match to B. animalis subsp. 
lactis. This OTU was not detected in any of the samples deemed negative by qPCR. Therefore, we 
concluded that the discrepancy between B. animalis subsp. lactis being called ‘present’ by qPCR 
and by 16S rRNA sequencing was due to inadequate depth of sequencing. Extrapolating, there 
could be other rare species whose changes in abundance were not detected. To explore this latter 
possibility, the fecal microbiota of two healthy MZ twin pairs, similar in age and body mass index, 
but with marked differences in their degree of geographical proximity (Table S1), were subjected to 
deeper sequencing (n=36 samples, yielding an additional 411,177 16S rRNA sequences, resulting 
in 14,241±2,144 (mean±SD) reads/sample from these individuals). No significant changes at any 
level of bacterial taxonomy were observed in this small sample dataset.
Studies in gnotobiotic mice
Measurement of adiposity. The body weights and epididymal fat pad weights of mice from both 
treatment groups were measured at the time of sacrifice. We observed no significant differences 
between the single and multiple treatment groups in either measurement (p=0.6865, p=0.3516, 
respectively; two-tailed Student’s t-test). Furthermore, all measurements of adiposity and weight 
were in line with those of mice from other studies that had involved animals from the same inbred 
strain, who were similarly aged, the same gender, on the same diet, and who harbored comparable 
defined model human gut microbiota (without FMP strains).
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In vitro studies 
RNA-Seq profiling of B. animalis subsp. lactis during growth in vitro. Sequencing of transcripts 
expressed by B. animalis subsp. lactis during mid-log phase growth in MRS medium (1.5-2.9 mil-
lion reads per technical replicate; n=2 independent cultures) detected products from 1,618 of the 
organism’s 1,660 predicted genes, while profiling during late stationary phase indicated that 1,609 
of its genes were expressed. The transition from logarithmic to stationary phase was accompanied 
by significant up- or down-regulation of 98 and 194 genes, respectively, including those involved 
in various aspects of carbohydrate, amino acid and nucleotide metabolism (see Table S7A).
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Supplementary figure legends
Figure S1. Levels of B. animalis subsp. lactis (CNCM I-2494) in human fecal samples col-
lected prior to, during, and after consumption of a FMP. (A) qPCR assays; each dot represents 
a sample from a given individual. The green bar denotes the period of FMP consumption. (B) 
Comparison of qPCR results to the number of shotgun reads mapped to the genomes of three B. 
animalis subsp. lactis strains. qPCR results are plotted on the X-axis, while the proportional repre-
sentation of reads that mapped to the B. animalis subsp. lactis genomes is presented on the Y-axis.
Figure S2. KEGG pathway coverage ratios suggest that the model human gut microbiome 
encodes many of the functions present in more complex human fecal communities. Genes in 
(i) the genomes of the five-member FMP strain consortium, (ii) the 15-member model human gut 
microbiota, (iii) a highly simplified two-member human gut microbiota composed of B. thetaio-
taomicron and a prominent gut Firmicute (Eubacterium rectale) (S35), (iv) a reference set of 127 
sequenced human gut microbial isolates, (v) the deeply sampled fecal microbiomes of 124 unre-
lated adult Europeans from a recent METAHIT study (S18), (vi) the fecal microbiomes of the 7 
twin pairs characterized in the present study, and (vii) the deeply sequenced fecal microbiomes of 
an obese adult MZ twin pair (S19) were annotated using v54 of the KEGG GENES database. The 
presence/absence of each KO in each KEGG pathway was determined for every set of genes and 
the pathway coverage ratio (i.e., % of a pathway’s components called ‘present’; BLASTP E-value 
<10-5) was calculated and depicted as the heatmap shown using Cluster 3.0/Treeview.
Figure S3. CAZyme profiles of the 20 bacterial strains introduced into gnotobiotic mice. The 
indicated genomes were annotated for all glycoside hydrolases (GH), glycosyltransferases (GT), 
carbohydrate binding modules (CBM), and polysaccharide lyases (PL) using the CAZy classifi-
cation scheme. The Bacteroides possess a larger and more diverse arsenal of CAZymes relative 
to the Firmicutes/Actinobacteria, though most CAZyme families encoded in the genomes of the 
FMP strains were also present in defined community members. The small number of FMP strain-
specific CAZyme families (CBM5, CBM10, CBM23, CBM33, GH85, and GT39) are highlighted 
in red. The scale refers to the number of genes in a given CAZy family in a given genome.
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Figure S4. Summary of analysis pipelines utilized in this study. (A) COPRO-Seq. (B) RNA-
Seq.
Figure S5. COPRO-Seq-based time series analysis of the abundance of members of the mod-
el human microbiota and of the FMP strain consortium in the feces of gnotobiotic mice. Rela-
tive abundance, expressed as the log
10
 of percent representation of all detected community mem-
bers was calculated over time (d0, time of colonization with the model 15-member community; 
d14, time of first gavage with the FMP consortium for the single and multiple treatment groups; 
d21 and d35, times of subsequent gavage with the FMP consortium for the multiple treatment 
group). For each treatment, animals were gavaged twice over a 24 h period. Mean values ± SEM 
are plotted (n=5 animals/treatment group; 1 fecal sample/animal/time point; limit of detection = 
0.003%). (A) COPRO-Seq data for 13 members of the 15 member community (F. prausnitzii and 
C. spiroforme were at levels below the limit of detection throughout the study and are not shown). 
(B) Data obtained from the two members of the FMP consortium that persisted at levels above the 
limit of detection following their introduction into mice. (C) Data from panel A representing the 
response of C aerofaciens to introduction of the FMP strain consortium (see text for details).
Figure S6. Top-down analysis of the model community’s transcriptional response to the FMP 
strain consortium reveals upregulation of genes involved in interconversion of propionate 
and succinate. RPKM-normalized RNA-Seq data were binned at the level of EC, and compari-
sons were made between early responses (d14 versus d15, representing time points just before 
and 1 day after gavage with the strain consortium) and late responses (d14 versus d42). Boxes and 
lines are colored according to the key shown above the pathway map and in the legend to panel B 
of Fig. 5.
Figure S7. A species’ contribution to the metatranscriptome is not necessarily proportional to 
its abundance in the 15-member community. Microbial RNA-Seq data from d14 of the mouse 
study were parsed by species to determine the total number of reads that each community member 
contributed to the total sequenced transcript pool (‘metatranscriptome’) (both raw and normalized 
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reads as defined in Fig. S4B). Data were further broken down into reads that could be mapped to 
genes with known functions (as defined by KEGG) and those with unknown functions (lacking 
any KO in v54 of the KEGG GENES database). Mean values ± SD are plotted for each of the four 
types of data presented. Note, for example, the large number of raw reads attributed to R. obeum 
despite its low proportional abundance in the community. Conversely, Bacteroides WH2 contrib-
utes a far smaller proportion of total raw RNA-Seq reads to the pool than its relative abundance in 
the community might have suggested.
Figure S8. Bottom-up analysis of genes whose expression changes significantly following in-
troduction of the FMP strain consortium. (A) Volcano plots of the >48,000 expressed genes 
detected in at least one fecal RNA sample. Colored points represent genes whose difference in 
expression following introduction of the FMP strain consortium was (i) ≥4-fold (increase or de-
crease) relative to the d14 pre-treatment time point and (ii) statistically significant (p<0.05; two-
tailed Student’s t-test). Dots are colored according to each gene’s species of origin (color key 
shown to the right of the panel). Black dots represent genes whose change in expression is less than 
4-fold at the time points indicated and/or not statistically significant. See Table S10 for a complete 
list of all the genes shown as colored dots. (B) Breakdown by species of differentially expressed 
genes. (C) Breakdown by KEGG category of differentially expressed genes, showing that late re-
sponses are more numerous than immediate ones, and that there is a noticeable bias towards genes 
involved in carbohydrate and glycan metabolism, particularly in the late response to introduction 
of the FMP strain consortium.
Figure S9. The number of RNA-Seq reads obtained from human fecal samples that map to 
genomes in the FMP strain consortium peaks shortly after FMP consumption begins. RNA-
Seq reads derived from selected human samples were mapped back to the five genomes in the 
FMP consortium to determine which species’ transcripts could be detected over time. B. animalis 
transcripts were detected only during periods of FMP consumption. Reads attributed to L. lactis, 
S. thermophilus, and L. delbrueckii at time points before consumption began may reflect ‘spuri-
ous’ mapping to related endogenous strains in the gut community. Facet labels located at the top 
94
of each bar chart correspond to the sample labels shown in Fig. 1A of the main text. Numbers are 
presented below each bar chart correspond to the code number assigned to each de-identified co-
twin (see Table S1). 
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Supplementary table legends
Table S1. Characteristics of adult female monozygotic (MZ) twins enrolled in study.
Table S2. Summary of human fecal metagenomic datasets. (A) Multiplex pyrosequencing of 
fecal bacterial 16S rRNA V2 amplicons. (B) Multiplex shotgun pyrosequencing of total fecal com-
munity DNA.
Table S3. Features of the microbial genomes in the 5-member FMP strain consortium and 
the 15-member model human gut microbiota.
Table S4. Carbohydrate active enzyme (CAZy) annotation data. (A) CAZy summaries by ge-
nome. (B) CAZy annotations for the 20 bacterial species in this study.
Table S5. COPRO-Seq analysis of bacterial species abundance in mouse fecal samples. (A) 
Proportional representation of the 20 bacterial species in this study in mouse fecal samples as 
measured by COPRO-Seq. (B) Statistical significance and fold-change of differences in pairwise 
comparisons of abundance calculated from data in panel A. The group mean for each day/treat-
ment/species combination at time points after the introduction of the FMP strain consortium was 
compared to the mean for the same treatment/species at d14 (the last time point collected prior to 
introduction of the FMP strains) using Welch’s t-test. Values have not been corrected for multiple 
hypothesis testing. p-values <0.05 are highlighted in pink. Fold-changes greater than 2 or less than 
-2 are highlighted in pink and green, respectively.
Table S6. INSeq analysis. (A) INSeq analysis sequencing statistics. Scale factor corresponds 
to counts per million normalization; underrepresented samples were re-sequenced and combined 
with original data so that all samples were represented by ~1 million reads. (B) Genes required by 
B. thetaiotaomicron for survival in the intestines of mice harboring the 15-member model human 
gut microbiota. The table describes the relative abundance of transposon insertions in each gene 
(rows) in the input community (average of two independent technical replicates) and in the output 
communities (fecal samples collected from 10 mice two weeks after introduction of the synthetic 
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model community, immediately prior to introduction of the FMP strain consortium). A z-test was 
used to identify genes whose log-transformed output to input ratios were significantly different 
from the overall distribution (a uniform value of 1 was added to all counts, and genes with no 
insertions were removed to allow ratios to be calculated). Resultant p-values were corrected for 
multiple hypothesis testing by q-test (S36). Genes assigned a q-value <0.001 are highlighted in red. 
Data filtering, normalization, mapping, and statistical analysis were conducted in Perl and Matlab.
Table S7. Differentially expressed B. animalis subsp. lactis (CNCM I-2494) genes. (A) Log 
versus stationary growth in MRS medium. (B) In vivo (mouse) versus in vitro (logarithmic phase 
in MRS) growth.
Table S8. Top-down function-level analysis of the impact of the FMP strain consortium on 
the model human gut microbiota’s metatranscriptome. (A) Proportional representation of as-
signable normalized RNA-Seq counts binned by KEGG category in fecal samples collected over 
time from singly- and multiply-treated animals. (B) Proportional representation of assignable nor-
malized RNA-Seq counts binned by KEGG pathway in fecal samples collected over time from 
singly- and multiply-treated animals.
Table S9. Model human gut microbiota membrane transport genes demonstrating ≥4-fold 
increases or decreases in their expression following introduction of the FMP strain consor-
tium.
Table S10. Bottom-up (gene-level) analysis of the impact of the FMP strain consortium on the 
model community’s metatranscriptome. (A) Breakdown by microbial species of significantly 
up/down-regulated genes. (B) Breakdown by KEGG category of significantly up/down-regulated 
genes. (C) Model community microbiome genes demonstrating significant increases/decreases in 
their expression following introduction of the FMP strain consortium.
Table S11. Results of Random Forests supervised classification analysis.
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Table S12. Urine metabolites whose levels change significantly in transitions between coloni-
zation states. The ‘Reverse match score’ column contains the AMDIS, dot-product, reverse-match 
scores (S32) which in this case evaluate not only mass-spectral concordance, but also the goodness 
of fit of chromatographic retention-time index made by comparison to (i) commercial and public 
target-compound libraries of small metabolites (S28, 33), and (ii) our own in-house reference li-
brary. Metabolites with match scores less than an arbitrary threshold of 65% were excluded from 
these results. (A) Day 0 (germ-free) versus day 14 (colonized with 15-member model commu-
nity). (B) Day 14 (colonized with 15-member model community) versus day 42 (colonized with 
15-member model community plus five-member FMP consortium).
Table S13. ShotgunFunctionalizeR analysis of EC-level changes in the metatranscriptome as 
a function of FMP strain introduction into mice and humans. The table shows fold-change in 
mean proportional representation of each EC between groups for each comparison. Values for non-
significant EC changes in a comparison (adjusted p≥0.01, ShotgunFunctionalizeR) are reported as 
“NS”. Note that ECs can have multiple KEGG pathway and category assignments.
Table S14. Primers and amplification conditions used for quantitative PCR assays of FMP 
consortium strains in fecal DNA. (A) Primers used to assay human fecal samples. (B) Primers 
used to assay mouse fecal samples. (C) Amplification conditions.
Table S15. List of 136 microbial genomes used to analyze human fecal RNA-Seq data.
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Abstract
The human gut microbiota is an important metabolic organ. However, little is known about how its 
individual species interact, establish dominant positions, and respond to changes in environmental 
factors such as diet. In the current study, gnotobiotic mice colonized with a simplified model micro-
biota composed of 12 sequenced human gut bacterial species were fed oscillating diets of disparate 
composition. Rapid, reproducible and reversible changes in community structure were observed. 
Time series microbial RNA-Seq analyses revealed staggered functional responses to diet shifts 
throughout the community that were heavily focused on carbohydrate and amino acid metabolism. 
High-resolution shotgun metaproteomics analysis confirmed many of these responses at a protein 
level. One member, Bacteroides cellulosilyticus WH2, proved exceptionally fit regardless of diet. 
Its genome has the largest collection of carbohydrate active enzymes of any Bacteroides species 
reported to date. Whole genome transcriptional profiling indicated that B. cellulosilyticus WH2 is 
an adaptive forager that tailors its versatile carbohydrate utilization strategy to the dietary poly-
saccharides available, with a strong emphasis on highly branched plant cell wall xylans that are 
abundant in dietary staples like cereal grains. Two highly expressed, diet-specific polysaccharide 
utilization loci (PULs) in B. cellulosilyticus WH2 were identified, one with characteristics similar 
to xylan utilization systems. Introduction of a B. cellulosilyticus WH2 library of 26,750 isogenic 
transposon mutants into gnotobiotic mice along with other model community members confirmed 
that these loci represent some of its most critical diet-specific fitness determinants. The specific 
carbohydrates that trigger overexpression of these two loci and many of the organism’s 111 other 
predicted PULs were identified by RNA-Seq analysis during in vitro growth on 31 distinct carbo-
hydrate substrates, allowing us to better interpret the in vivo RNA-Seq and proteomics data. These 
results offer insight into how gut microbes adapt to dietary perturbations, both at a community 
level and from the perspective of a well-adapted symbiont with exceptional saccharolytic capabili-
ties, and illustrate the value of studying defined models of the human gut microbiota.
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Introduction
A growing body of evidence indicates that the tens of trillions of microbial cells that inhabit 
our gastrointestinal tracts (microbiota) extend our biological capabilities in important ways [1,2]. 
Microbial enzymes process many compounds that would otherwise pass through our intestines 
unaltered [3], and cases of particular nutrient substrates favoring the growth of particular taxa are 
being reported [4,5]. Changes in diet are therefore expected to lead to changes in the composition 
and function of the microbiota [6]. However, our understanding of diet-microbiota interactions at 
a mechanistic level is still in its infancy.
The absence of a complete catalog of the microbial strains and associated genome sequenc-
es that comprise a given microbiota complicates efforts to describe how particular dietary sub-
strates influence individual taxa, how taxa cooperate/compete to utilize nutrients, and how these 
many interactions in aggregate lead to emergent host phenotypes. Gnotobiotic mice colonized with 
defined consortia of sequenced human gut microbes, on the other hand, provide an in vivo model of 
the microbiota in which the identity of all taxa and genes comprising the system are known [7]. In 
these systems, expressed mRNAs and proteins can be attributed to their genome, gene and species 
of origin, and findings of interest can be pursued in follow-up in vitro or in vivo experiments. These 
models afford an opportunity to tightly control experimental variables to a degree not possible in 
human studies and have proven useful in studying microbial invasion [8], inter-phylum microbe-
microbe interactions [9], and the metabolic roles of key ecological guilds [10]. Studies aiming to 
better understand community-level assembly, resilience, and adaptation are also likely to benefit 
from a focus on such fully defined systems.
Culture-independent surveys of the healthy adult gut microbiota consistently conclude that 
it is composed primarily of Bacteroidetes and Firmicutes species [11-13]. The dominance of these 
two bacterial phyla suggests that their representatives in the human gut are exquisitely adapted to 
its dynamic conditions, which include a constantly evolving nutrient environment. Members of the 
genus Bacteroides are known to be adept at utilizing both plant- and host-derived polysaccharides 
111
[14-16]. Comparisons of available Bacteroides genomes with those from other gut species indi-
cate that the former are enriched in genes involved in the acquisition and metabolism of various 
glycans, including glycoside hydrolases and polysaccharide lyases, as well as linked environmen-
tal sensors that control their expression (e.g., hybrid two-component systems, extracytoplasmic 
function (ECF) sigma factors and anti-sigma factors). Many of these genes are organized into 
polysaccharide utilization loci (PULs) that are distributed throughout the genome [17]. Recent 
studies have focused on better understanding the evolution, specificity and regulation of PULs in 
the genomes of species like Bacteroides thetaiotaomicron and Bacteroides ovatus [18,19]. Little 
is known, however, about the metabolic strategies adopted by multiple competing species in more 
complex communities, how dietary changes lead to shifts in the Bacteroides fraction of communi-
ties [20] through changes in individual species, or how dietary context influences the repertoires 
of genes the most dominant species rely on to remain competitive with other microbes, including 
those genes that are components of PULs.
Here, we adopt a multi-faceted approach to the study of model communities in gnotobiotic 
mice fed changing diets in order to better understand: (i) the process by which communities recon-
figure themselves structurally in response to changes in host diet; (ii) how aggregate community 
function, as judged by the metatranscriptome and the metaproteome, is impacted when host diet is 
altered; (iii) how the metabolic strategies of individual microbes change, if at all, when the nutri-
ent milieu is dramatically altered, with an emphasis on one prominent but understudied member of 
the human gut Bacteroides; and (iv) whether a microbe’s metabolic versatility/flexibility correlates 
with competitive advantage in a microbiota comprising numerous related and unrelated species.
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Results and discussion
Sequencing the Bacteroides cellulosilyticus WH2 genome
Though at least 8 complete and 68 draft genomes of Bacteroides spp. are currently available [21], 
there are numerous examples of distinct clades within this genus where little genomic information 
exists. To further explore the genome space of one such clade, we obtained a human fecal isolate 
whose four 16S rRNA gene sequences indicate a close relationship to Bacteroides cellulosilyti-
cus (Figs. S1A, B). The genome of this isolate, which we have designated B. cellulosilyticus 
WH2, was sequenced deeply, yielding a high quality draft assembly (23 contigs with an N50 value 
of 798,728 bp; total length of all contigs in the assembly, 7.1 Mb; Table S1). Annotation of its 
5,244 predicted protein-coding genes using the carbohydrate active enzyme (CAZy) database [22] 
revealed an extraordinary complement of 503 CAZymes comprising 373 glycoside hydrolases 
(GHs), 23 polysaccharide lyases (PLs), 28 carbohydrate esterases (CEs), and 84 glycosyltransfer-
ases (GTs) (see Table S2 for all annotated genes in the B. cellulosilyticus WH2 genome predicted 
to have relevance to carbohydrate metabolism). One distinguishing feature of gut Bacteroides 
genomes is the substantial number of CAZymes they encode relative to those of other intestinal 
bacteria [23]. The B. cellulosilyticus WH2 CAZome is enriched in a number of GH families even 
when compared with prominent representatives of the gut Bacteroidetes (Fig. S2A). When we 
expanded this comparison to include all 86 Bacteroidetes in the CAZy database, we found that the 
B. cellulosilyticus WH2 genome had the greatest number of genes for 19 different GH families, as 
well as genes from two GH families that had not previously been observed within a Bacteroidetes 
genome (Fig. S2B). Altogether, B. cellulosilyticus WH2 has more GH genes at its disposal than 
any other Bacteroidetes species analyzed to date.
In Bacteroides spp., CAZymes are often located within PULs [24]. At a minimum, a typical 
PUL harbors a pair of genes with significant homology to the susC and susD genes of the starch 
utilization system (Sus) in B. thetaiotaomicron [24]. Other genes encoding enzymes capable of 
liberating oligo- and monosaccharides from a larger polysaccharide are also frequently present. 
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The susC- and susD-like genes of these loci encode the proteins that comprise the main outer 
membrane binding and transport apparatus and thus represent key elements of these systems. A 
search of the B. cellulosilyticus WH2 genome for genes with strong homology to the susC- and 
susD-like genes in B. thetaiotaomicron VPI-5482 (see Methods) revealed an unprecedented num-
ber of susC/D pairs (a total of 118). Studies of other prominent Bacteroides spp. have found that 
the evolutionary expansion of these genes has played an important role in endowing the Bacteroi-
des with the ability to degrade a wide range of host- and plant-derived polysaccharides [18,25]. 
Deep sampling of the gut microbiota of adult humans indicates that B. cellulosilyticus strains are 
common in humans, colonizing approximately 77% of 124 adult Europeans characterized in one 
study [11] and 62% of 139 individuals living in the USA examined in another survey [12]. We 
hypothesized that the apparent success of B. cellulosilyticus in the gut is derived in part from its 
substantial arsenal of genes involved in carbohydrate utilization.
Measuring changes in the structural configuration of a 12-member model microbiota in 
response to a dietary perturbation
To test the fitness of B. cellulosilyticus WH2 in relation to other prominent gut symbionts, and the 
importance of diet on its fitness, we carried out an experiment in gnotobiotic mice (experiment 1, 
“E
1
”, Fig. S3). Two groups of 10-12 week-old male germ-free C57BL/6J animals were moved to 
individual cages within gnotobiotic isolators (n=7 animals/group). At day zero, each animal was 
colonized by oral gavage with a synthetic community comprising 12 prominent, sequenced hu-
man gut bacterial species (Fig. 1A) whose taxonomic and functional attributes (as judged by their 
annotated gene content) are representative of a more complex human microbiota (Tables S3, S4). 
For two weeks, each treatment group was fed a standard low-fat, high-plant polysaccharide (LF/
HPP) mouse chow, or a ‘Western’-like diet where calories are largely derived from fat, starch, and 
simple sugars [high-fat/high-sugar (HF/HS)] [9]. Over the course of six weeks, diets were changed 
twice at two-week intervals, such that each group began and ended on the same diet, with an inter-
vening two-week period during which the other diet was administered (Fig. S3).
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Using fecal DNA as a proxy for microbial biomass, the plant polysaccharide-rich LF/HPP 
diet supported 2- to 3-fold more total bacterial growth (primary productivity) despite its lower 
caloric density (3.7 kcal/g versus 4.5 kcal/g for the HF/HS diet; Fig. S4A). The HF/HS diet con-
tains carbohydrates that are easily metabolized and absorbed in the proximal intestine (sucrose, 
corn starch and maltodextrin), with cellulose being the one exception (4% of the diet by weight 
versus 46.3% for the other carbohydrate sources). Thus, in mice fed the HF/HS diet, diet-derived 
simple sugars are likely to be rare in the distal gut where the vast majority of gut microbes reside. 
This may provide an advantage to those bacteria capable of utilizing other carbon sources (e.g., 
proteins/oligopeptides, host glycans). In mice fed the LF/HPP diet, on the other hand, plant poly-
saccharides that are indigestible by the host should provide a plentiful source of carbon for sac-
charolytic members of the community.
To evaluate the impact of each starting diet and the diet switch on the structural configu-
ration of the model human microbiota, we subjected DNA isolated from fecal samples collected 
throughout the course of the experiment and from cecal DNA at sacrifice to shotgun sequencing 
(COmmunity PROfiling by Sequencing; COPRO-Seq) [8]. The resulting relative abundances of 
each species in each sample (defined by the number of sequencing reads that could be unambigu-
ously assigned to community members after adjusting for genome uniqueness) were subjected to 
ordination by principal coordinates analysis (PCoA) (Fig. S5A). As expected, diet was found to be 
the predominant explanatory variable for observed variance (see separation along principal coordi-
nate 1, ‘PC1’, which accounts for 52% of variance). Overall community structure achieved quasi-
equilibrium before the midpoint of the first diet phase, as evidenced by the lack of any significant 
movement along PC1 after day five. Reconfiguration of overall community structure following a 
transition to the second diet phase also took place over the course of ~5 days. Notably, communi-
ties showed a near-perfect inversion in their positions along PC1 after the first diet switch, with 
animals transitioning from LF/HPP to HF/HS diets adopting a structure like that of the communi-
ties that were initially assembled while animals were consuming a starting HF/HS diet, and vice 
versa. The second diet switch from phase two to three resulted in a similar movement along PC1 
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in the opposite direction, indicating a reversion of each community to its originally assembled 
configuration. These results, in addition to demonstrating the significant impact of these two diets 
on the structure of this 12-member model human gut microbiota, also suggest that communities of 
this size are capable of demonstrating resilience in the face of substantial diet perturbations.
The assembly process and observed diet-induced reconfigurations also proved to be highly 
reproducible as evidenced by COPRO-Seq results from a replication of E
1
 (experiment 2, “E
2
”). 
In this follow-up experiment, fecal samples were collected more frequently than in E
1
, providing a 
dataset with improved temporal resolution. Ordination of E
2
 COPRO-Seq data by PCoA (Fig. 1B) 
showed that the model microbiota in each E
2
 treatment group assemble in a manner similar to their 
counterparts in E
1
, that structural reconfigurations in response to diet occur with the same timing 
as in E
1
, and that the quasi-equilibrium community configurations achieved during each diet phase 
are highly similar between experiments for each treatment group. As in E
1
, cecal data for each E
2
 
treatment group overlap with their corresponding fecal samples, and DNA yields from E
2
 fecal 
samples vary substantially as a function of host diet (Fig. S4B).
COPRO-Seq provides precise measurements of the proportional abundance of each spe-
cies present in a defined microbiota. Data collected in both E
1
 and E
2
 (Table S5) revealed signifi-
cant differences between microbiota members in terms of the maximum abundance levels they 
achieved, the rates at which their abundance levels were impacted by diet shifts, and the degree 
to which each species demonstrated a preference for one diet over another (Fig. S4C). Changes 
in each species’ abundance over time replicated well across animals in each treatment group, sug-
gesting the assembly process and diet-induced reconfigurations occur in an orderly and rules-based 
fashion, with minimal stochasticity. A species’ relative abundance immediately after colonization 
(i.e., 24 hours after gavage / day 1) was, in general, a poor predictor of its abundance at the end 
of the first diet phase (i.e. day 13) (E
1
 R2=0.23; E
2
 R2=0.27), suggesting early dominance of the 
founder population was not strongly tied to relative success in the assembly process.
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In communities that assembled in mice initially fed a HF/HS diet, four Bacteroides spp. 
(B. caccae, B. cellulosyliticus WH2, B. thetaiotaomicron, and B. vulgatus) each achieved relative 
abundances of ≥10% by the end of the first diet phase (day 13 post-gavage), with B. caccae attain-
ing the highest levels (37.1±4.9% and 34.2±5.5%; group mean ± SD in E
1
 and E
2
, respectively). 
In animals fed the plant polysaccharide-rich LF/HPP chow during the first diet phase, B. cellulosi-
lyticus WH2 was dominant, achieving levels of 37.1±2.0% (E
1
) and 41.6±3.9% (E
2
) by day 13. B. 
thetaiotaomicron and B. vulgatus also attained relative abundances of >10%.
Changes in diet often resulted in rapid, dramatic changes in a species’ proportional rep-
resentation. Because the dynamic range of abundance values observed when comparing multiple 
species was substantial [lowest, D. longicatena (<0.003%); highest B. caccae (55.0%)], compar-
ing diet responses on a common scale using raw abundance values was challenging. To represent 
these changes in a way that scaled absolute increases/decreases in community proportion to the 
abundance range of each strain, we also normalized community representation at each time-point 
to the maximum level each microbe achieved across all time-points within each mouse. Plotting 
the resulting measure of abundance (percentage of maximum achieved, ‘PoMA’) over time dem-
onstrates which microbes are strongly responsive to diet (experience significant swings in PoMA 
value following a diet switch) and which are relatively diet-insensitive (experience only modest or 
no significant change in PoMA value following a diet switch). Heatmap visualization of E
1
 PoMA 
values (Fig. S5B) indicated that those microbes with a preference for a particular diet in one ani-
mal treatment group also tended to demonstrate the same diet preference in the other. Likewise, 
diet insensitivity was also consistent across treatment groups; diet-insensitive microbes were in-
sensitive regardless of the order in which diets were introduced.
Of the diet-sensitive components of the model microbiota, those showing the most striking 
responses were B. caccae and B. ovatus, which strongly preferred the ‘Western’-like HF/HS diet 
and the polysaccharide-rich LF/HPP diet, respectively (Figs. 1C, S4C). Of the diet-insensitive 
components of the microbiota, B. thetaiotaomicron showed the most stability in its representation 
(Figs. 1C, S4C), consistent with its reputation as a versatile forager. Paradoxically, B. cellulosi-
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lyticus WH2 was found to be both diet-sensitive and highly fit on its less-preferred diet. Although 
this strain clearly achieved higher levels of community representation in animals fed the LF/HPP 
diet, it maintained strong levels of representation in animals fed HF/HS as well (Figs. 1C, S4C).
When taking into account the abundance data for all 12 community members, proportional 
representation at the end of the first diet phase (i.e., day 13) was a good predictor of representation 
at the end of the third diet phase (i.e., day 42) (E
1
 R2=0.77; E
2
 R2=0.84), suggesting that the inter-
vening dietary perturbation had little effect on the ultimate outcomes for most species within the 
community. However, one very low-abundance strain (Dorea longicatena) achieved significantly 
different maximum percentages across the two treatment groups in each experiment, suggesting 
that steady-state levels of this strain may have been impacted by diet history. In communities that 
assembled in mice fed LF/HPP chow, D. longicatena was found to persist throughout the experi-
ment at low levels on both diet regimens. In communities that assembled in mice fed the HF/HS 
diet, D. longicatena dropped below the limit of detection before the end of the first diet phase, was 
undetectable by the end of the second diet phase, and remained undetectable throughout the rest of 
the time course. This interesting example raises the possibility that for some species, irreversible 
hysteresis effects may play a significant role in determining the likelihood that they will remain 
members of a microbiota over long periods of time. For most strains, however, these data suggest 
that diet-driven increases or decreases in a species’ abundance are likely to be reversible over short 
time spans.
The cecal community metatranscriptome sampled at the time of sacrifice
These diet-induced reconfigurations in community structure led us to examine the degree to which 
members of the community were modifying their metabolic strategies. To establish an initial base-
line static view of expression data for each microbe on each diet, we developed a custom GeneChip 
whose probe sets were designed to target 46,851 of the 48,023 known or predicted protein-coding 
genes within our model human gut microbiome (see Methods). Total RNA was collected from the 
cecal contents of each animal in E
1
 at the time of sacrifice and hybridized to this GeneChip. The to-
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tal number of genes whose expression was detectable on each diet was remarkably similar (14,929 
and 14,594 detected in the LF/HPPèHF/HSèLF/HPP and HF/HSèLF/HPPèHF/HS treatment 
groups, respectively). A total of 11,373 genes were expressed on both diets (Fig. S6A) while 2,003 
(4.3%) were differentially expressed to a statistically significant degree, including 161 (6%) of 
the 2,640 genes in the model human gut microbiome encoding proteins with CAZy-recognized 
domains. Fig. S6B illustrates the fraction of the community CAZome and several species-level 
CAZomes expressed on each diet (see Table S6 for a comprehensive list of all genes, organized 
by species and fold-change in expression, whose cecal expression was detectable on each diet and 
all genes whose expression was significantly different when comparing data from each treatment 
group).
Of the community members demonstrating obvious diet preferences (as judged by rela-
tive abundance data), Bacteroides caccae and Bacteroides cellulosilyticus WH2 served as a par-
ticularly interesting pair of organisms whose CAZy-level responses to diet change are different 
in several respects. Our ability to evaluate shifts in B. caccae’s metabolic strategy in the gut was 
limited by the very low abundance of this species in animals fed LF/HPP chow (i.e., at these low 
levels of abundance, our mRNA and subsequent protein assays were often not sensitive enough to 
exhaustively sample B. caccae’s metatranscriptome and metaproteome). Our observations regard-
ing this species’ carbohydrate utilization capabilities and preferences are summarized in Supple-
mentary Results. In contrast, the abundance of Bacteroides cellulosilyticus WH2, which favored 
the LF/HPP diet, remained high enough on both diets to allow for a comprehensive analysis of its 
expressed genes and proteins. This advantage, along with the exceptional carbohydrate utilization 
machinery encoded within the genome of this organism, encouraged us to focus on further dissect-
ing the responses of B. cellulosilyticus WH2 to diet changes.
Detailed inspection of the expressed B. cellulosilyticus WH2 CAZome (503 CAZymes in 
total) provided an initial view of this microbe’s sophisticated carbohydrate utilization strategy. A 
comparison of the top decile of expressed CAZymes on each diet disclosed many shared elements 
between the two lists, spanning many different CAZy families, with just over half of the 50 most 
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expressed enzymes on the plant polysaccharide-rich LF/HPP chow also occurring in the list of 
most highly expressed enzymes on the sucrose-, corn starch- and maltodextrin-rich HF/HS diet 
(Fig. 2A). 25 of the 50 most expressed CAZymes on the LF/HPP diet were significantly upregu-
lated compared to the HF/HS diet; of these, seven were members of the GH43 family (Fig. 2B). 
The GH43 family consists of enzymes with activities required for the breakdown of plant-derived 
polysaccharides such as hemicellulose and pectin. Inspection of the enzyme commission (EC) an-
notations for the most upregulated GH43 genes shows that they encode xylan 1-4-b-xylosidases 
(EC 3.2.1.37), arabinan endo-1,5-a-L-arabinosidase (EC 3.2.1.99), and a-L-arabinofuranosidases 
(EC 3.2.1.55). The GH10 family, which is currently comprised exclusively of endo-xylanases (EC 
3.2.1.8, EC 3.2.1.32), was also well represented among this set of 25 genes, with four of the seven 
putative GH10 genes in the B. cellulosilyticus WH2 genome making the list. Strikingly, of the 45 
predicted genes with putative GH43 domains in the B. cellulosilyticus WH2 genome, none were 
upregulated on the ‘Western’-style HF/HS chow.
The most highly expressed B. cellulosilyticus WH2 CAZyme on the plant polysaccharide-
rich chow (which was also highly-expressed on the HF/HS chow) was BWH2_1228, a putative 
a-galactosidase from the GH36 family. These enzymes, which are not expressed by humans in the 
stomach or intestine, cleave terminal galactose residues from the non-reducing ends of raffinose 
family oligosaccharides (RFOs, including raffinose, stachyose, and verbascose), galacto(gluco)
mannans, galactolipids, and glycoproteins. RFOs, which are well represented in cereal grains con-
sumed by humans, are expected to be abundant in the LF/HPP diet given its ingredients (e.g., 
soybean meal), but potential substrates in the HF/HS diet are less obvious, possibly implicating 
a host glycolipid or glycoprotein target. Surface glycans in the intestinal epithelium of rodents 
are decorated with terminal fucose residues [26] as well as terminal sialic acid residues and sul-
fate [27]. Hydrolysis of the α-2 linkage connecting terminal fucose residues to the galactose-rich 
extended core is thought to be catalyzed in large part by GH95 and GH29 enzymes [28]. The B. 
cellulosilyticus WH2 genome is replete with putative GH95 and GH29 genes (total of 12 and 9, 
respectively), but only a few (BWH2_1350/2142/3154/3818) were expressed in vivo on at least 
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one diet, and their expression was low relative to many other CAZymes (see Table S6). Cleavage 
of terminal sialic acids present in host mucins by bacteria is usually carried out by members of 
the GH33 family. B. cellulosilyticus WH2 has two GH33 genes that are expressed on either one 
diet (BWH2_3822, HF/HS) or both diets (BWH2_4650), but neither is highly expressed relative 
to other B. cellulosilyticus WH2 CAZymes. Therefore, utilization of host glycans by B. cellulosi-
lyticus WH2, if it occurs, likely requires partnerships with other members of the community that 
express GH29/95/33 enzymes (see Table S6 for a list of members that express these enzymes in a 
diet-independent and/or diet-specific fashion).
Among the 50 most highly expressed B. cellulosilyticus WH2 CAZymes, 12 were signifi-
cantly upregulated on the HF/HS diet compared to the LF/HPP diet, with members of family GH13 
being most prevalent. While the enzymatic activities and substrate specificities of GH13 family 
members are varied, most relate to the hydrolysis of substrates comprising chains of glucose sub-
units, including amylose (one of the two components of starch) and maltodextrin, both prominent 
ingredients in the HF/HS diet.
GeneChip-based profiling of the E
1
 cecal communities provided a snapshot of the meta-
transcriptome on the final day of the final diet phase in each treatment group. The analysis of B. 
cellulosilyticus WH2 CAZyme expression suggested that this strain achieves a ‘generalist’ lifestyle 
not by relying on substrates that are present at all times (e.g., host mucins), but rather by modifying 
its resource utilization strategy to effectively compete with other microbes for diet-derived poly-
saccharides not metabolized by the host.
Community-wide analysis of diet-induced changes in microbial gene expression
To develop a more complete understanding of the dynamic changes that occur in gene expression 
over time and throughout the community following diet perturbations, we performed microbial 
RNA-Seq analyses using feces obtained at select time-points from mice in the LF/HPPèHF/
HSèLF/HPP treatment group of E
2
 (Fig. S3).
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We began with a ‘top-down’ analysis in which every RNA-Seq read count from every gene 
in the model microbiome was binned based on the functional annotation of the gene from which it 
was derived, regardless of its species of origin. In this case, the functional annotation used as the 
binning variable was the predicted enzyme commission (EC) number for a gene’s encoded protein 
product. Expecting that some changes might occur rapidly, while others might require days or 
weeks, we searched for significant differences between the terminal time-points of the first two 
diet phases (i.e., points at which the model human gut microbiota had been allowed 13 days to 
acclimate to each diet). The 157 significant changes we identified were subjected to hierarchical 
clustering by EC number to determine which functional responses occurred with similar kinetics. 
The results revealed that unlike the rapid diet-induced structural reconfigurations in community 
composition, community-level changes in gene expression occurred with highly variable timing 
that differed from function to function. These changes were dominated by EC numbers associated 
with enzymatic reactions relevant to carbohydrate and amino acid metabolism (see Table S7 for 
a summary of all significant changes observed, including aggregate expression values for each 
functional bin (EC number) at each time-point). Significant responses could be divided into one 
of three groups: ‘rapid’ responses denoting EC numbers whose representation in the transcriptome 
increased/decreased dramatically within 1-2 days of a diet switch; ‘gradual’ responses where the 
representation of EC numbers changed notably, but slowly, between the two diet transition points; 
and ‘delayed’ responses where no significant change occurred immediately but did occur by the 
end of a diet phase (Fig. 3, Table S7). EC numbers associated with reactions important in carbohy-
drate metabolism and transport were distributed across all three response types for each of the two 
diets. Nearly all genes encoding proteins with EC numbers related to amino acid metabolism that 
were significantly upregulated on HF/HS chow binned into the ‘rapid’ or ‘gradual’ groups, sug-
gesting this diet put immediate pressure on the community to increase its repertoire of expressed 
amino acid biosynthesis and degradation genes. Genes with assigned EC numbers involved in 
amino acid metabolism that were significantly upregulated on the other, polysaccharide-rich, LF/
HPP diet were spread more evenly across the three groups (Fig. 3).
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Careful inspection of our top-down analysis results and a complementary ‘bottom-up’ anal-
ysis in which normalization was performed at the level of individual species, rather than the com-
munity, allowed us to identify other important responses that would have gone undetected were it 
not for the fact that we were dealing with a defined community where all genes in its component 
members’ genomes (microbiome) were known. For example, an assessment of the representa-
tion of EC 3.2.1.8 (endo-1,4-β-xylanase) within the metatranscriptome before and after the first 
diet switch (LF/HPPèHF/HS) initially suggested that this activity was reduced to a statistically 
non-significant degree as a result of the diet switch (day 13 versus day 27, p=0.25; Fig. S7A). Ag-
gregation by species of all sequencing read counts assignable to mRNAs encoding proteins with 
this EC number revealed that over 99% of the contributions to this functional bin originated from 
B. cellulosilyticus WH2 (Fig. S7B), implying that the community-level response and the response 
of this Bacteroides species were virtually one and the same. A tally of all sequencing reads assign-
able to B. cellulosilyticus WH2 at each time-point disclosed that although this strain maintains 
high proportional representation in the community throughout each diet oscillation period (range: 
10.3-42.5% and 11.6-43.3% for E
1
 and E
2
, respectively), its contribution to the community meta-
transcriptome is substantially decreased during the HF/HS diet phase (Fig. S7C). This dramatic 
reduction in the extent to which B. cellulosilyticus WH2 contributes to the community metatran-
scriptome in HF/HS-fed mice ‘masks’ the highly significant upregulation of EC 3.2.1.8 (endo-1,4-
β-xylanase) that occurs within the B. cellulosilyticus WH2 transcriptome following the first diet 
shift (Fig. S7D). A further breakdown of endo-1,4-β-xylanase upregulation in B. cellulosilyticus 
WH2 when mice are switched to the HF/HS diet reveals that most of this response is driven by two 
genes, BWH2_4068 and BWH2_4072 (Fig. S7E). Our realization that one of the most significant 
diet-induced gene expression changes in the second most abundant strain in the model community 
was undetectable when inspecting functional responses at the community level provides a strong 
argument for expanding the use of model microbiota comprised exclusively of sequenced species, 
whose individual contributions to community activity can be evaluated in a rigorous way that is 
not possible with consortia of unknown or poorly defined gene composition.
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High-resolution profiling of the cecal metaproteome sampled at the time of sacrifice
In principle, protein measurements can provide a more direct readout of expressed community 
functions than an RNA-level analysis, and thus a deeper understanding of community members’ 
interactions with one another and with their habitat [29,30]. For these reasons and others, much 
work has been dedicated to applying shotgun proteomics techniques to microbial ecosystems in 
various environments [31,32]. Though these efforts have provided illustrations of significant meth-
odological advances, they have been limited by the complexity of the metaproteomes studied and 
by the difficulties this complexity creates when attempting to assign peptide identities uniquely 
to proteins of specific taxa. Recognizing that a metaproteomics analysis of our model community 
would not be subject to such uncertainty given its fully-defined microbiome and thus fully-defined 
theoretical proteome, we subjected cecal samples from two mice from each diet treatment group 
in E
1
 (n=4 total) to high-performance liquid chromatography-tandem mass spectrometry (LC-MS/
MS; see Methods). We had three goals: (i) to evaluate how our ability to assign peptide-spectrum 
matches (PSMs) to particular proteins within a theoretical metaproteome is affected by the pres-
ence of close homologs within the same species and within other, closely-related species; (ii) to 
test the limits of our ability to characterize protein expression across different species given the 
substantial dynamic range we documented in microbial species abundance; and (iii) to collect 
semi-quantitative peptide/protein data that might validate and enrich our understanding of func-
tional responses identified at the mRNA level, particularly with respect to the niche (profession) of 
CAZyme-rich B. cellulosilyticus WH2.
Given the evolutionary relatedness of the strains involved, we expected that some fraction 
of observed PSMs from each sample would be of ambiguous origin due to non-unique peptides 
shared between species’ proteomes. To assess which species might be most affected by this phe-
nomenon when characterizing the metaproteome on different diets, we catalogued each strain’s 
theoretical peptidome using an in silico tryptic digest. This simulated digest took into account both 
the potential for missed trypic cleavages and the peptide mass range that could be detected using 
our methods. The results (Fig. S8A, Table S8) demonstrated that for a community of modest com-
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plexity, the proportion of peptides within each strain’s theoretical peptidome that are ‘unique’ (i.e., 
assignable to a single protein within the theoretical community metaproteome) varies substantially 
from species to species, even among those that are closely related. We found the lone represen-
tative of the Actinobacteria in the community, C. aerofaciens, to have the highest proportion of 
unique peptides (94.2%), while B. caccae had the lowest (63.0%). Interestingly, there was not a 
strong correlation between the fraction of a species’ peptides that were unique and the total number 
of unique peptides that species contributed to the theoretical peptidome. For example, C. aero-
faciens (2,367 predicted protein-coding genes) contributed only 81,894 (1.5%) unique peptides, 
the lowest of any community member, despite having a proteome composed of mostly unique 
peptides. B. cellulosilyticus WH2, on the other hand (5,244 predicted protein-coding genes), con-
tributed 241,473 (4.5%) unique peptides, the highest of any community member, despite a high 
fraction of non-unique peptides (18.4%) within its theoretical peptidome. The evolutionary relat-
edness of the Bacteroides components of the model gut microbiota appeared to negatively affect 
our ability to assign their peptides to specific proteins; their six theoretical peptidomes had the six 
lowest uniqueness levels. However, their greater number of proteins and peptides relative to the 
Firmicutes and Actinobacteria within the community more than compensated for this deficiency; 
over 60% of unique peptides within the unique theoretical metaproteome were contributed by the 
Bacteroides.
We also found that the proportion of PSMs uniquely assignable to a single protein within 
the metaproteome varied significantly by function, suggesting that some classes of proteins can 
be traced back to specific microbes more readily than others. For example, when considering all 
theoretical peptides that could be derived from the proteome of a particular bacterial species, those 
from proteins with roles in categories with high expected levels of functional conservation (e.g., 
translation and nucleotide metabolism) were on average deemed unique more often than those 
from proteins with roles in functions we might expect to be less conserved (e.g., glycan biosyn-
thesis and metabolism) (See Table S8 for a summary of how peptide uniqueness varied across dif-
ferent KEGG categories and pathways, and across different species in the experiment). However, 
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even in KEGG categories and pathways with high expected levels of functional conservation, the 
vast majority of peptides were found to be unique when a particular species was not closely related 
to other members of the model community.
Next, we determined the average number of proteins that could be experimentally identi-
fied in our samples for each microbial species within each treatment group in E
1
. The results (Fig. 
S8B, Table S9) illustrate two important conclusions. First, although equal concentrations of total 
protein were evaluated for each sample, slightly less than twice as many total microbial proteins 
were identified in samples from the LF/HPP-fed mice as those from mice fed the HF/HS diet 
(4,659 versus 2,777, respectively). While there are a number of possible explanations, this finding 
and the higher number of mouse proteins detected in samples from this treatment group is consis-
tent with our fecal DNA analysis that had indicated that the HF/HS diet supports lower levels of 
gut microbial biomass compared to the LF/HPP diet (Figs. S4A, B). Second, a breakdown of all 
microbial proteins detected by species of origin (Fig. S8B) revealed that the degree to which we 
could inspect protein expression for a given species was dictated to a large degree by its relative 
abundance and the diet to which it was exposed.
Next, our ability to detect a substantial number of B. cellulosilyticus WH2’s expressed 
transcripts and proteins in samples from mice on either diet allowed us to determine the degree to 
which RNA and protein data for an abundant, active member of the community might correlate, 
and whether or not the type of genes considered might influence the degree of correlation between 
these two datasets. We first performed a spectral count-based correlation analysis on the diet-
induced, log-transformed, average fold-differences in expression for all B. cellulosilyticus WH2 
genes that were detectable at both the RNA and protein level for both diets. The results revealed 
a moderate degree of linear correlation between RNA and protein observations (Fig. S8C, black 
plot; r=0.53). However, subsequent division of these genes into functionally related subsets, which 
were each subjected to their own correlation analysis, revealed striking differences in the degree 
to which RNA level and protein-level expression changes agreed with one another. For example, 
diet-induced changes in mRNA expression for genes involved in translation showed virtually no 
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correlation with changes measured at the protein level (Fig. S8C, red plot; r=0.03). Correlations 
for other categories of B. cellulosilyticus WH2 genes, such as those involved in energy metabo-
lism (Fig. S8C, green plot; r=0.36) and amino acid metabolism (Fig. S8C, orange plot; r=0.48) 
were also poorer than the correlation for all genes collectively. In contrast, the correlation for the 
110 genes with predicted involvement in carbohydrate metabolism was quite strong (Fig. S8C, 
blue plot; r=0.69), and was in fact the best correlation identified for any functional category of 
genes considered. The significant range of correlations observed in different categories of genes 
suggests that the degree to which RNA-based analyses provide an accurate picture of microbial 
adaptation to environmental perturbation may be strongly impacted by the functional nature of 
the genes involved. Additionally, these data further emphasize the need for enhanced dynamic 
range metaproteome measurements and better bioinformatic methods to assign/bin unique and 
non-unique peptides so that deeper and more thorough surveys of the microbial protein landscape 
may be performed and evaluated alongside more robust transcriptional datasets. Below we focus 
on two highly expressed, strongly diet-specific loci relevant to in vivo carbohydrate utilization by 
B. cellulosilyticus WH2.
Identifying two diet-inducible, xylanase-containing PULs whose genetic disruption results in 
diet-specific loss of fitness
Several of the most highly expressed and diet-sensitive B. cellulosilyticus WH2 genes in this study 
fell within two putative PULs. One PUL (BWH2_4044-55) contains 12 ORFs that include a dual 
susC/D cassette, three putative xylanases assigned to CAZy families GH8 and GH10, a putative 
multifunctional acetyl xylan esterase/a-L-fucosidase, and a putative hybrid two-component sys-
tem regulator (Fig. 4A). Gene expression within this PUL was markedly higher in mice consuming 
the plant polysaccharide-rich LF/HPP diet at both the mRNA and protein level. mRNA analysis 
disclosed that BWH2_4047 was the most highly expressed B. cellulosilyticus WH2 susD homolog 
on this diet. Likewise, BWH2_4046/4, the two susC-like genes within this PUL, were the 2nd and 
4th most highly expressed B. cellulosilyticus WH2 susC-like genes in LF/HPP-fed animals, and 
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exhibited reductions in expression levels of 99.5% and 93% in animals consuming the HF/HS diet. 
The same LF/HPP diet bias was observed for other genes within this PUL (Figs. 2A, 4B) but not 
for neighboring genes. The same trends were obvious and amplified when we quantified protein 
expression (Fig. 4C). In mice fed LF/HPP chow, only three B. cellulosilyticus WH2 SusC-like pro-
teins had higher protein levels than BWH2_4044/6, and only two SusD-like proteins had higher 
levels than BWH2_4045/7. Strikingly, we were unable to detect a single peptide from 9 of the 12 
proteins in this PUL in samples obtained from mice fed the HF/HS diet, emphasizing the strong 
diet specificity of this locus.
A second PUL in the B. cellulosilyticus WH2 genome composed of a susC/D-like pair 
(BWH2_4074/5), a putative hybrid two-component system regulator (BWH2_4076), and a xy-
lanase (GH10) with dual carbohydrate binding module domains (CBM22) (BWH2_4072) (Fig. 
4A) demonstrated a strong but opposite diet bias, in this case exhibiting significantly higher ex-
pression in animals consuming the HF/HS ‘Western’-like diet. mRNA-level analysis showed that 
this xylanase was the second most highly-expressed B. cellulosilyticus WH2 CAZyme in animals 
consuming this diet (Fig. 2A). As with the previously described PUL, shotgun metaproteomics 
validated the transcriptional analysis (Figs. 4B, C); except the gene encoding the PUL’s presumed 
transcriptional regulator (BWH2_4076), the diet specificity was substantial with protein-level fold 
changes ranging from 10.0-33.3 across the locus (Table S10).
Recent work by Dodd and colleagues has done much to advance our understanding of 
the regulation and metabolic role of xylan utilization system gene clusters in xylanolytic mem-
bers of the Bacteroidetes, particularly within the genus Prevotella [33]. The ‘core’ gene cluster of 
the prototypical xylan utilization system they described consists of two tandem repeats of susC/
susD homologs (xusA/B/C/D), a downstream hypothetical gene (xusE) and a GH10 endoxylanase 
(xyn10C). The 12-gene PUL identified in our study (BWH2_4044-55) appears to contain the only 
instance of this core gene cluster within the B. cellulosilyticus WH2 genome, suggesting that this 
PUL, induced during consumption of a plant polysaccharide-rich diet, is likely to be the primary 
xylan utilization system within this organism. A recent study characterizing the carbohydrate utili-
128
zation capabilities of B. ovatus ATCC 8483 also identified two PULs involved in xylan utilization 
whose gene configurations differ from the paradigm described by Dodd [18]. The smaller of the 
two xylanase-containing PULs described above appears to be evolutionarily related to a subset of 
the genes found within BACOVA_04385-94, highlighting the fact that Bacteroidetes have likely 
evolved multiple strategies for the utilization of this important hemicellulose.
Having established that expression of BWH2_4044-55 and BWH2_4072-6 is strongly dic-
tated by diet, we next sought to determine if these PULs are required by B. cellulosilyticus WH2 
for fitness in vivo. A follow-up study was performed in which mice were fed either a LF/HPP or 
HF/HS diet after being colonized with a model human gut microbiota similar to the one utilized 
in E
1
 and E
2
 (see Methods). In this community, the wild-type B. cellulosilyticus WH2 strain used 
in our previous experiments was replaced with a transposon mutant library consisting of 26,750 
distinct transposon insertion mutants in over 78% of all predicted ORFs (average 5.3 distinct in-
sertion mutants / ORF). The library was constructed using methods similar to those reported by 
Goodman et al. (see Methods) so that the relative proportion of each insertion mutant in both the 
input (orally gavaged) and output (fecal) populations could be determined using insertion sequenc-
ing (INSeq) [34]. The results of this analysis revealed clear, diet-specific losses of fitness when 
components of these loci were disrupted (Fig. 4D). Additionally, as observed in E
1
 and E
2
, expres-
sion of each PUL was strongly biased by diet, with genes BWH2_4072-5 demonstrating upregu-
lation on the HF/HS diet and BWH2_4044-55 on the LF/HPP diet. The extent to which a gene’s 
disruption impacted the fitness of B. cellulosilyticus WH2 on one diet or the other correlated well 
with whether or not that gene was highly expressed on a given diet. For example, four of the five 
most highly expressed genes in the BWH2_4044-55 locus were the four genes shown to be most 
crucial for fitness on the LF/HPP diet. Of these four genes, three were homologs of either the susC 
or susD gene in B. thetaiotaomicron (the fourth was the putative endo-1,4-b-xylanase thought to 
constitute the last element of the xylan utilization system core). Though the fitness cost of disrupt-
ing genes within BWH2_4044-55 varied from gene to gene, disruption of any one component of 
the BWH2_4072-6 PUL had serious consequences for B. cellulosilyticus WH2 in animals fed the 
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HF/HS diet. This could suggest that while disruption of some components of the BWH2_4044-55 
locus can be rescued by similar or redundant functions elsewhere in the genome, the same is not 
true for BWH2_4072-5. Notably, disruption of the BWH2_4076 gene (which is predicted to en-
code a hybrid two-component regulatory system) had negative consequences on either diet tested, 
suggesting that the regulation of this locus is crucial even when the PUL is not actively expressed. 
While many genes outside of these two PULs were also found to be important for the in vivo fitness 
of B. cellulosilyticus WH2, those within these PULs were among the most essential to diet-specific 
fitness, suggesting these loci are central to the metabolic lifestyle of B. cellulosilyticus WH2 in the 
gut. 
Characterizing the carbohydrate utilization capabilities of B. cellulosilyticus WH2 and B. 
caccae
The results described in the preceding section indicate that B. cellulosilyticus WH2 prioritizes xy-
lan as a nutrient source in the gut and that it tightly regulates the expression of its xylan utilization 
machinery. Moreover, the extraordinary number of putative CAZymes and PULs within the B. 
cellulosilyticus WH2 genome suggests that it is capable of growing on carbohydrates with diverse 
structures and varying degrees of polymerization. To characterize its carbohydrate utilization ca-
pabilities, we defined its growth in minimal medium supplemented with one of 46 different carbo-
hydrates [18]. Three independent growths, each consisting of two technical replications, yielded a 
total of six growth curves for each substrate. Of the 46 substrates tested, B. cellulosilyticus WH2 
grew on 39 (Table S11); they encompassed numerous pectins (6 of 6), hemicelluloses/β-glucans 
(8 of 8), starches/fructans/α-glucans (6 of 6) and simple sugars (14 of 15), as well as host-derived 
glycans (4 of 7) and one cellooligosaccharide (cellobiose). The seven substrates that did not sup-
port growth included three esoteric carbohydrates (carrageenan, porphyran, and alginic acid), the 
simple sugar N-acetylneuraminic acid, two host glyans (keratan sulfate and mucin O-glycans) 
and fungal cell wall-derived α-mannan. B. cellulosilyticus WH2 clearly grew more robustly on 
some carbohydrates compared to others. Excluding simple sugars, fastest growth was achieved 
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on dextran (0.099±0.048), laminarin (0.095±0.014 OD
600
 units/h), pectic galactan (0.088±0.018), 
pullulan (0.088±0.026), and amylopectin (0.085±0.003). Although one study has reported that 
the type strain of B. cellulosilyticus degrades cellulose [35], the B. cellulosilyticus WH2 strain of 
B. cellulosilyticus failed to demonstrate any growth on minimal medium plus cellulose (specifi-
cally, Solka-Floc 200 FCC, International Fiber Corp.) after five days. Maximum cell density was 
achieved with amylopectin (1.17±0.02 OD
600
 units), dextran (1.12±0.20), cellobiose (1.09±0.08), 
laminarin (1.08±0.08), and xyloglucan (0.99±0.04). Total B. cellulosilyticus WH2 growth (i.e., 
maximum cell density achieved) on host-derived glycans was typically very poor, with only two 
substrates achieving total growth above 0.2 OD
600
 units (chondroitin sulfate, 0.50±0.04; glyco-
gen, 0.99±0.02). The disparity between total growth on plant polysaccharides versus host-derived 
glycans, including O-glycans which are prevalent in host mucin, indicates a preference for diet-
derived saccharides, consistent with our in vivo mRNA and protein expression data.
We determined how the growth rate of B. cellulosilyticus WH2 on these substrates com-
pared to the growth rates for other prominent gut Bacteroides spp.. After subjecting B. caccae 
to the same phenotypic characterization as B. cellulosilyticus WH2, we combined our measure-
ments for these two strains with previously published measurements for B. thetaiotaomicron and 
B. ovatus [18]. The results underscored the competitive growth advantage B. cellulosilyticus WH2 
likely enjoys when foraging for polysaccharides in the intestinal lumen. For example, of the eight 
hemicelluloses and β-glucans tested in our carbohydrate panel, B. cellulosilyticus WH2 grew fast-
est on six while B. ovatus grew fastest on two (Table S11). B. caccae and B. thetaiotaomicron, on 
the other hand, failed to grow on any of these substrates. Across all the carbohydrates for which 
data are available for all four species, B. cellulosilyticus WH2 grew fastest on the greatest number 
of polysaccharides (11 of 26) and tied with B. caccae for the greatest number of monosaccharides 
(6 of 15). B. thetaioatomicron and B. caccae did, however, outperform the other two Bacteroides 
tested with respect to utilization of host glycans in vitro, demonstrating superior growth rates on 
four of five substrates tested (Table S11).
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B. cellulosilyticus WH2’s rapid growth to high densities on xylan, arabinoxylan, and xylo-
glucan, as well as xylose, arabinose, and galactose, is noteworthy given our prediction that two of 
its most tightly-regulated, highly-expressed PULs appear to be involved in the utilization of xylan, 
arabinoxylan, or some closely-related polysaccharide. To identify specific mono- and/or polysac-
charides capable of triggering the activation of these two PULs, as well as the 111 other putative 
PULs within the B. cellulosilyticus WH2 genome, we used RNA-Seq to characterize its transcrip-
tional profile at mid-log phase in minimal medium (Table S12) plus one of 16 simple sugars or 
one of 15 complex sugars (Table S13) (see Methods; n= 2-3 cultures/substrate; 5.2-14.0 million 
raw Illumina HiSeq reads generated for each of the 90 transcriptomes). After mapping each read 
to the B. cellulosilyticus WH2 reference gene set, counts were normalized using DESeq to allow 
for direct comparisons across samples and conditions. Hierarchical clustering of the normalized 
dataset resulted in a well-ordered dendrogram in which samples clustered almost perfectly by 
the carbohydrate on which B. cellulosilyticus WH2 was grown (Fig. 5A). The consistency of this 
clustering illustrates how (i) technical replicates within each condition exhibit strong correlation 
with one another, suggesting any differences between cultures in a treatment group (e.g., small dif-
ferences in density or growth phase) had at best minor effects on aggregate gene expression, and 
(ii) growth on different carbohydrates results in distinct, substrate-specific gene expression signals 
capable of driving highly discriminatory differences between treatment groups. The application of 
rigorous bootstrapping to our hierarchical clustering results also revealed several cases of higher-
level clusters in which strong confidence was achieved. These dendrogram nodes (illustrated as 
white circles), indicate sets of growth conditions that yield gene expression patterns more like 
each other than like the patterns observed for other substrates. Two notable examples were xylan/
arabinoxylan (which are structurally related and share the same xylan backbone) and L-fucose/L-
rhamnose (which are known to be metabolized via parallel pathways in E. coli).
Importantly, these findings suggested that when combined with in vivo expression data from 
the model community, it is possible to identify the particular carbohydrates to which B. cellulosi-
lyticus WH2 is exposed and accessing within its gut environment. To explore this concept further, 
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we compared expression of each gene in each condition to its expression on our control treatment, 
minimal medium plus glucose (MM-G). The results revealed a dynamic PUL activation network 
in which some PULs were activated by a single substrate, some by multiple substrates, and some 
that were transcriptionally silent across all conditions tested. Of the 118 putative susC/D pairs in 
B. cellulosilyticus WH2 that we have used as markers of PULs, 30 were dramatically activated 
on one or more of the substrates tested; in these cases, both the susC- and susD-like genes in the 
cassette were upregulated an average of >100-fold relative to MM-G across all technical replicates 
(Fig. 5B). At least one susC/D activation signature was identified for every one of the 17 oligosac-
charides and polysaccharides and for six of the 13 monosaccharides tested (Table S14). The lack 
of carbohydrate-specific PUL activation events for some monosaccharides (fructose, galactose, 
glucuronic acid, sucrose, and xylose) was expected, given that these loci are primarily dedicated to 
polysaccharide acquisition. Further inspection of gene expression outside of PULs disclosed that 
B. cellulosilyticus WH2 prioritizes use of its non-PUL-associated carbohydrate machinery, such 
as putative phosphotransferase system (PTS) components and monosaccharide permeases, when 
grown on these monosaccharides (Table S14).
Several carbohydrates activated the expression of multiple PULs. Growth on water-sol-
uble xylan and wheat arabinoxylan produced significant upregulation of five susC/D-like pairs 
(BWH2_0865/0866, 0867/0868, 4044/4045, 4046/4047, and 4074/4075). No other substrate test-
ed activated as many loci within the genome, again hinting at the importance of xylan and arabi-
noxylan to this strain’s metabolic strategy in vivo. Cecal expression data from E
1
 showed that 15 
of these activated PULs were expressed in vivo on one or both of the diets tested (see circles to 
the right of heatmap in Fig. 5B). In mice fed the polysaccharide-rich LF/HPP chow, B. cellulosi-
lyticus WH2 upregulates three susC/D pairs (BWH2_2717/8, 4044/5, 4046/7) whose expression 
is activated in vitro by arabinan and xylan/arabinoxylan. The three most significantly upregulated 
susC/D pairs (BWH2_1736/7, 2514/5, 4074/5) in mice fed the HF/HS diet rich in sugar, corn 
starch and maltodextrin are activated in vitro by amylopectin, ribose, and xylan/arabinoxylan, 
respectively. All three PULs identified as being upregulated at the RNA level in LF/HPP-fed mice 
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were also found to be upregulated at the protein level (Fig. 5B). Two of the three PULs induced 
at the mRNA level in HF/HS-fed mice were shown to be upregulated at the protein level as well, 
along with four other PULs whose upregulation was only evident in our LC-MS/MS data. The 
presence of a dextran (starch)-activated PUL among the latter four loci is noteworthy, given the 
significant amount of starch present in the HF/HS diet. Such examples of loci whose induction is 
expected but evident only in one data type or the other reinforce the notion that protein data both 
complement and supplement mRNA data when profiling microbes of interest.
Two of the five susC/D pairs activated by xylan/arabinoxylan form the four-gene cassette 
in the previously discussed PUL comprising BWH2_4044-55 that is activated in mice fed the plant 
polysaccharide-rich chow (see Fig. 4A). Another one of these five is the susC/D pair found in 
the PUL comprising BWH2_4072-6 that is activated in mice fed the HF/HS ‘Western’-like chow 
(see Fig. 4A). Thus, we have identified a pair of putative PULs in close proximity to one another 
on the B. cellulosilyticus WH2 genome that encode CAZymes with similar predicted functions, 
are subject to near-identical levels of specific activation by the same two polysaccharides (i.e., 
xylan, arabinoxylan) in vitro, but are discordantly regulated in vivo in a diet-specific manner. The 
highly expressed nature of these PULs in the diet environment where they are active, their shared 
emphasis on xylan/arabinoxylan utilization, and their tight regulation indicate that they are likely 
to be important for the in vivo success of this organism in the two nutrient environments tested. 
However, the reasons for their discordant regulation are unclear. One possibility is that in addition 
to being activated by xylan/arabinoxylan and related polysaccharides, these loci are also subject 
to repression by other substrates present in the lumen of the gut, and this repression is sufficient 
to block activation. Alternatively, the specific activators of each PUL may be molecular moieties 
shared by both xylan and arabinoxylan that do not co-occur in the lumenal environment when mice 
are fed the diets tested in this study.
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Prospectus
Elucidating generalizable ‘rules’ for how microbiota operate under different environmental condi-
tions is a substantial challenge. As our appreciation for the importance of the gut microbiota in 
human health and well-being grows, so too does our need to develop such rules using tractable ex-
perimental models of the gut ecosystem that allow us to move back and forth between in vivo and 
ex vivo analyses, using one to inform the other. Here, we have demonstrated the extent to which 
high-resolution DNA-, mRNA- and protein-level analyses can be applied (and integrated) to study 
a model community of sequenced human gut microbes colonizing gnotobiotic mice. Our efforts 
have focused on characterizing community-level and species-level adaptation to dietary change 
over time and ‘leverage’ results obtained from in vitro expression profiling of individual commu-
nity member responses to a panel of purified carbohydrates to deduce glycan exposures and con-
sumption strategies in vivo. This experimental paradigm could be applied to any number of ques-
tions related to microbe-microbe, environment-microbe and host-microbe interactions, including 
for example the metabolic fate of particular nutrients of interest (metabolic flux experiments), 
microbial succession, and biotransformations of xenobiotics. Studying representative model com-
munities in gnotobiotic mice also allows us to evaluate the technical limitations of current molecu-
lar approaches for characterizing native gut communities. For example, the structure of a defined 
community can be evaluated over time at low cost using short read shotgun DNA sequencing data 
mapped to all microbial genomes within the community (COPRO-Seq). This allows for a much 
greater depth of sequencing coverage (i.e., more sensitivity) and much less ambiguity in the as-
signment of reads to particular taxa than traditional 16S rRNA gene-based sequencing allows. 
Short read cDNA sequences transcribed from total community RNA can also often be assigned to 
the exact microbial gene from which they were derived, and the same is also often true for pep-
tides derived from particular microbial proteins. However, substantial dynamic range in species/
transcript/protein abundance within any microbiota, defined or otherwise, imposes limits on our 
ability to characterize the least abundant elements of these systems.
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The effort to obtain a more complete understanding of the operations and behaviors of mi-
nor components of the microbiota is an area deserving of significant attention, given known exam-
ples of low-abundance taxa that play key roles within their larger communities and in host physi-
ology [5,36]. Developing such an understanding requires methods and assays that are collectively 
capable of assessing the structure and function of a microbiota at multiple levels of resolution. 
The need for high sensitivity and specificity in these approaches will become increasingly relevant 
as we transition towards experiments involving defined communities of even greater complexity, 
including bacterial culture collections prepared from the fecal microbiota of humans [37]. We an-
ticipate that the study of culture collections transplanted to gnotobiotic mice will be instrumental 
in determining the degree to which physiologic or pathologic host phenotypes can be ascribed to 
the microbiota as well as specific constituent taxa.
One of the greatest advantages of studying defined model microbiota is the ability they 
afford to interrogate the biology of key bacterial species of interest in a focused manner. The 
synthetic model human gut microbiota we studied included Bacteroides cellulosilyticus WH2, a 
species that warrants further study as a model gut symbiont given its exceptional carbohydrate 
utilization capabilities, its apparent fitness advantage over many other previously characterized gut 
symbionts, and its genetic tractability. This genetic tractability should facilitate future experiments 
in which transposon mutant libraries are screened in vivo as one component of a larger model com-
munity in order to identify this strain’s most important fitness determinants under a wide variety of 
dietary conditions. Identifying the genetic elements that allow B. cellulosilyticus to persist at the 
relatively high levels observed, regardless of diet, should provide microbiologists and synthetic 
biologists with new ‘standard biological parts’ that will aid them in developing the next generation 
of prebiotics, probiotics, and synbiotics.
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Figure legends
Figure 1. COPRO-Seq analysis of the structure of a 12-member model human microbiota as 
a function of diet and time. (A) The 12 bacterial species comprising the model microbiota in this 
study. (B) Principal coordinates analysis (PCoA) was applied to relative abundance data generated 
by COPRO-Seq from two experiments (E
1
, E
2
), each spanning six weeks. Following colonization 
(day 0), mice were switched between two different diets at two-week intervals as described in Fig. 
S3. COPRO-Seq data from E
1
 and E
2
 were ordinated in the same multi-dimensional space. For 
clarity, only data from E
2
 are shown here (for the E
1
 PCoA plot, see Fig. S5A). Red/blue, feces; 
magenta/cyan, cecal contents. (C) Proportional abundance data from E
1
 illustrating the impact of 
diet on fecal levels of a diet-sensitive strain with higher representation on HF/HS chow (B. cac-
cae), a diet-sensitive strain with higher representation on LF/HPP chow (B. ovatus), a diet-insensi-
tive strain with no obvious diet preference (B. thetaiotaomicron), and a diet-sensitive strain with a 
preference for the LF/HPP diet that also achieves a high level of community representation on the 
HF/HS diet (B. cellulosilyticus WH2). Mean values ± SEM are shown. Plots illustrating changes 
in abundance over time for all species in both experiments are provided in Fig. S4C.
Figure 2. B. cellulosilyticus WH2 CAZyme expression in mice fed different diets.
(A) Overview of the 50 most highly expressed B. cellulosilyticus WH2 CAZymes (i.e., glycoside 
hydrolases (GH), glycosyltransferases (GT), polysaccharide lyases (PL) and carbohydrate ester-
ases (CE)) for samples from each diet treatment group. List position denotes the rank order of gene 
expression for each treatment group, with higher expression levels situated at the top of each list. 
Genes common to both lists are identified by a connecting line, with the slope of the line indicating 
the degree to which a CAZyme’s prioritized expression is increased/decreased from one diet to the 
other. CAZy families in bold, colored letters highlight those list entries found to be significantly 
upregulated relative to the alternative diet (i.e., a CAZyme with a bold green family designation 
was upregulated on the LF/HPP diet; a bold orange family name implies a gene was upregulated 
significantly on HF/HS diet). Statistically significant fold-changes between diets are denoted in 
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the “F.C.” column (non-significant fold-changes are omitted for clarity). (B) Breakdown by CAZy 
family of the top 10% most expressed CAZymes on each diet whose expression was also found to 
be significantly higher on one diet than the other. Note that for each diet, the family with the great-
est number of upregulated genes was also exclusively upregulated on that diet (LF/HPP, GH43; 
HF/HS, GH13). In total, 25 genes representative of 27 families and 12 genes representative of 13 
families are shown for the LF/HPP and HF/HS diets, respectively.
Figure 3. Top-down analysis of fecal microbiome gene expression in mice receiving oscil-
lating diets. The fecal metatranscriptomes of four animals in the LF/HPPèHF/HSèLF/HPP 
treatment group of E
2
 were analyzed using microbial RNA-Seq at seven time-points to evaluate 
the temporal progression of changes in expressed community functions triggered by a change in 
diet. After aligning reads to genes in the defined model human gut microbiome, raw counts were 
collapsed by the functional annotation (EC number) of the gene from which the corresponding 
reads originated. Total counts for each EC number in each sample were normalized, and any EC 
numbers demonstrating a statistically significant difference in their representation in the metatran-
scriptome between the final days of the first two diet phases were identified using a model based 
on the negative binomial distribution [38]. Normalized expression values for 157 significant EC 
numbers (out of 1,021 total tested) were log-transformed, mean-centered, and subjected to hier-
archical clustering, followed by heatmap visualization. ‘Rapid’ responses are those where expres-
sion increased/decreased dramatically within 1-2 days of a diet switch; ‘gradual’ responses are 
those where expression changed notably, but slowly, between the two diet transition points; and 
‘delayed’ responses denote changes that did not achieve statistical significance until the end of a 
diet phase. EC numbers specifying enzymatic reactions relevant to carbohydrate metabolism and/
or transport are denoted by purple markers, while those with relevance to amino acid metabolism 
are indicated using orange markers. A full breakdown of all significant responses over time and the 
outputs of the statistical tests performed are provided in Table S7.
Figure 4. Two xylanase-containing B. cellulosilyticus WH2 PULs demonstrating strong diet-
specific expression patterns in vivo. (A) The PUL spanning genes BWH2_4044-55 includes a 
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four-gene cassette comprising two consecutive susC/D pairs, multiple genes encoding glycoside 
hydrolases (GHs) and carbohydrate esterases (CEs), and a gene encoding a putative hybrid two-
component system (HTCS) presumed to play a role in the regulation of this locus. GH10 enzymes 
are endo-xylanases (most often endo-b-1,4-xylanases), while some GH5 and GH8 enzymes are 
also known to have endo- or exo-xylanase activity. CE6 enzymes are acetyl xylan esterases, as 
are some members of the CE1 family. A second PUL spanning genes BWH2_4072-6 contains a 
susC/D cassette, an endo-xylanase with dual GH10 modules as well as dual carbohydrate (xylan) 
binding modules (CBM22), a hypothetical protein of unknown function, and a putative HTCS. 
(B) Heat map visualization of GeneChip expression data for BWH2_4044-55 and BWH2_4072-6 
showing marked upregulation of these putative PULs when mice are fed either a plant polysaccha-
ride-rich LF/HPP diet or a diet high in fat and simple sugar (HF/HS), respectively. Data are from 
cecal contents harvested from mice at the endpoint of experiment E
1
. (C) Mass spectrometry-based 
quantitation of the abundance of all cecal proteins from the BWH2_4044-55 and BWH2_4072-6 
PULs that were detectable in the same material used for GeneChip quantitation in panel B. Bars 
represent results (mean ± SEM) from two technical runs per sample. For each MS run, the spectral 
counts for each protein were normalized against the total number B. cellulosilyticus WH2 spectra 
acquired. (D) Comparison of in vivo PUL gene expression as measured by RNA-Seq (top) and the 
degree to which disruption of each gene within each PUL by a transposon impacts the fitness of B. 
cellulosilyticus WH2 on each diet, as measured by insertion sequencing (INSeq, bottom). For the 
lower plots, fitness measurements are calculated by dividing a mutant’s representation (normalized 
sequencing counts) within the fecal output community by the mutant’s representation within an in-
put population that was introduced into germ-free animals by oral gavage along with other model 
community members. For cases in which no instances of a particular mutant could be measured 
in the fecal output community (resulting in a fitness calculation denominator of zero), the data are 
plotted as “<0.01” and are drawn without error bars. 
Figure 5. In vitro microbial RNA-Seq profiling of B. cellulosilyticus WH2 during growth on 
different carbohydrates. (A) Hierarchical clustering of the gene expression profiles of 90 cul-
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tures grown in minimal medium supplemented with one of 31 simple or complex sugars (n=2-3 
replicates per condition). Circles at dendrogram branch points identify clusters with strong boot-
strapping support (>95%; 10,000 repetitions). Solid circles denote clusters comprising only rep-
licates from a single treatment group/carbohydrate, while open circles denote higher-level clus-
ters comprising samples from multiple treatment groups. Colored rectangles indicate the type of 
carbohydrate on which the samples within each cluster were grown. (B) Unclustered heat map 
representation of fold-changes in gene expression relative to growth on minimal medium plus 
glucose (MM-Glc) for 60 of the 236 paired susC- and susD-like genes identified within the B. 
cellulosilyticus WH2 genome (for a full list of all paired and unpaired susC and susD homologs, 
see Table S2). Data shown are limited to those genes whose expression on at least one of the 31 
carbohydrates tested demonstrated a >100-fold increase relative to growth on MM-Glc for at least 
one of the replicates within the treatment group. Yellow boxes denote areas of the map where both 
genes in a susC/D pair were upregulated >100-fold for at least two of the replicates in a treatment 
group and where the average upregulation for each gene in the pair was >100-fold across all rep-
licates of the treatment group. Two sets of columns to the right of the heatmap indicate PULs that 
were detectably expressed at the mRNA level (left set of columns) and/or protein level (right set of 
columns) in experiment 1 (E
1
). Red and black circles indicate that both genes in a susC/D pair were 
consistently expressed on a particular diet, as determined by GeneChip analysis of cecal RNA (≥5 
of 7 animals assayed) or LC-MS/MS analysis of cecal protein (2 of 2 animals assayed). In both 
cases, a red circle denotes significantly higher expression on one diet compared to the other.
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Supplementary material
Supplementary materials and methods
B. cellulosilyticus WH2 genome sequencing. A strain of B. cellulosilyticus designated ‘WH2’ 
(see Figs. S1A, B) was isolated from a human fecal sample during an iteration of the Microbial 
Diversity Summer Course overseen by A. Salyers (Univ. of Illinois, Urbana-Champaign) at the 
Marine Biological Laboratory (Woods Hole, MA). The genome of this isolate was sequenced us-
ing a combination of long-read and short-read technologies, yielding 51,819 plasmid and fosmid 
end reads (library insert sizes: 3.9, 4.9, 6.0, 8.0, and 40 kb; ABI 3730 platform), 333,883 unpaired 
454 reads (FLX+ and XL+ chemistry), and 10 million unpaired Illumina reads (HiSeq; 42 nt read 
length). A hybrid assembly was constructed using MIRA v3.4.0 (method: de novo; type: genome; 
quality grade: accurate) with default settings [39,40]. Gene calling was performed using the YA-
COP metatool [41]. Additionally, the four ribosomal RNA (rRNA) operons within the B. cellu-
losilyticus WH2 genome were sequenced individually to ensure high sequence accuracy in these 
difficult to assemble regions. Further details for the B. cellulosilyticus WH2 assembly are provided 
in Table S1.
Bacterial strains. Details regarding the 12 bacterial strains used in this study are provided 
in Table S3. Cells were grown in supplemented TYG (TYG
S
; [34]) at 37°C under anaerobic condi-
tions in a Coy anaerobic chamber (atmosphere; 75% N
2
, 20% H
2
, 5% CO
2
). After reaching station-
ary phase, cells were pelleted by centrifugation and resuspended in TYG
S
 medium supplemented 
with 20% glycerol. Individual aliquots containing 400-800 µL of each cell suspension were stored 
at -80°C in 1.8 mL borosilicate glass vials with aluminum crimp tops. The identity of each spe-
cies was verified prior to its use in experiments by extracting DNA from a frozen aliquot of cells, 
amplifying the 16S rRNA gene by PCR using primers 8F/27F (AGAGTTTGATCCTGGCTCAG; 
[42]) and 1391R (GACGGGCGGTGWGTRCA; [43]), sequencing the entire amplicon with an 
ABI 3730 capillary sequencer (Retrogen, Inc.), and comparing the assembled 16S rRNA gene 
sequence to the known reference sequence.
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Preparation of strains for oral gavage. Details regarding the construction of each inocu-
lum are provided in Table S4. The inocula used to gavage germ-free mice in each experiment were 
prepared either directly from frozen stocks (experiment #1, E
1
) or from a combination of frozen 
stocks and overnight cultures (experiment #2, E
2
). The recoverable cell density for each batch of 
frozen stocks used in inoculum preparation was determined prior to pooling, while the same val-
ues for overnight cultures were calculated after pooling. An aliquot of cells from each overnight 
culture or set of frozen stocks was used to prepare a ten-fold dilution series in phosphate-buffered 
saline (PBS), and each dilution series was plated on brain-heart-infusion (BHI; BD Difco) agar 
supplemented with 10% (v/v) defibrinated horse blood (Colorado Serum Co.). Plates were grown 
for up to 3 d at 37°C under anaerobic conditions in a Coy chamber, colonies were counted, and the 
number of colony-forming units per milliliter (CFUs/mL) was calculated. The volume of each cell 
suspension included in the final inoculum was normalized by its known or estimated viable cell 
concentration in an effort to ensure that no species received an early advantage during establish-
ment of the model human gut microbiota in the germ-free animals. Total CFUs per gavage were 
estimated at 8.0x107 and 4.2x108 for experiments E
1
 and E
2
, respectively.
Mice. Experiments were performed using protocols approved by the animal studies com-
mittee of the Washington University School of Medicine (animal studies protocol #20110232). For 
each experiment, two groups of 10-12 week-old male germ-free C57BL/6J mice were maintained 
in flexible film gnotobiotic isolators under a strict 12 h light cycle, during which time they received 
sterilized food and water ad libitum. Animals were fasted for 4 h prior to gavage with 500 µL of 
a cell suspension inoculum containing the 12 sequenced, human-gut derived bacterial symbionts. 
After gavage, animals were maintained in separate cages throughout the course of the experiment. 
Fresh fecal pellets were periodically collected directly into screw-cap sample tubes that were im-
mediately frozen in liquid nitrogen. At the time of sacrifice, the contents of each animal’s cecum 
were divided into thirds and snap-frozen in liquid nitrogen for later use in DNA, RNA, and total 
protein isolations.
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Diets. Animals were subjected to dietary oscillations comprising three consecutive phases 
of two weeks each (see Fig. S3). Prior to inoculation, germ-free mice were maintained on a stan-
dard autoclaved chow diet low in fat and rich in plant polysaccharides (‘LF/HPP’, B&K rat and 
mouse autoclavable chow #73780000, Zeigler Bros, Inc). Three days prior to inoculation, one 
group of germ-free animals was switched to a ‘Western’-like chow high in fat and simple sugars 
(‘HF/HS’; Harlan Teklad TD96132), while the other continued to receive LF/HPP chow. After 
gavage, each group of animals was maintained on its respective diet for two weeks, after which 
each treatment group was switched to the alternative diet. Two weeks later, the diets were switched 
back to their original starting diet and were retained on this diet up through the time of sacrifice. 
The ingredients in plant polysaccharide-rich LF/HPP chow include: wheat, soybean meal, wheat 
middlings, corn, fish meal, lignin sulfoate, soy oil, dicalcium phosphate, limestone, sodium chlo-
ride, calcium propionate, L-lysine, choline chloride, zinc sulfate, vitamin E, and other vitamin and 
mineral premixes. The ingredients in the ‘Western’-like HF/HS diet include (% by weight): casein 
(23.60%), sucrose (18.262%), corn starch (16.0%), maltodextrin (12.0%), shortening (10.0%), 
beef tallow (10.0%), mineral mix [TD 94046] (4.13%), cellulose (4.0%), vitamin mix [Teklad 
40060] (1.18%), calcium phosphate [dibasic] (0.472%), DL-methionine (0.354%), and ethoxyquin 
(0.002%).
DNA and RNA extraction. DNA and RNA were extracted from fecal pellets and cecal 
contents as previously described [8]. 
COmmunity PROfiling by Sequencing (COPRO-Seq). COPRO-Seq measurements of the 
proportional representation of all species present in each fecal/cecal sample analyzed were per-
formed as previously described [8] using short-read (36 nt) data collected from an Illumina GAIIx 
sequencer. After deplexing of each barcoded pool, reads were trimmed to 25 bp prior to alignment 
to the reference genomes. An abundance threshold cutoff of 0.003% was set, based on the pro-
portion of reads from each experiment that were found to spuriously align to distractor reference 
genomes of bacterial species not included in this study. Normalized counts for each bacterial spe-
cies in each sample were used to calculate a simple intra-sample percentage (“% of community”). 
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In order to make changes in abundance over time more easily comparable between species with 
significantly different relative abundances, these percentages were also normalized by the maxi-
mum abundance (%) observed for a given species across all time-points from a given animal. This 
transformation resulted in a value representing the ratio of a given percentage to the maximum 
percentage achieved (“% of % max”) that was used to evaluate which species were most/least 
responsive to dietary interventions.
Ordination of COPRO-Seq data using QIIME. COPRO-Seq proportional abundance data 
were subjected to ordination using scripts found in QIIME v1.5.0-dev [44]. Data from both E
1
 
and E
2
 were combined to generate a single tab-delimited table conforming to QIIME’s early (pre-
v1.4.0-dev) OTU table format. This pseudo-OTU table was subsequently converted into a biom-
formatted table object that was used as the input for beta_diversity.py to calculate the pairwise 
distances between all samples using a Hellinger metric. Principle coordinates analysis (PCoA) 
calculations were performed using principal_coordinates.py. These coordinates and sample meta-
data were passed to make_3d_plots.py to generate PCoA plots. Plots shown are visualized using 
v2.21 of the KiNG software package [45].
Metatranscriptomics (GeneChip). A custom Affymetrix GeneChip (‘SynComm1’) with 
perfect match/mismatch (PM/MM) probe sets targeting 97.6% of the predicted protein-coding 
genes within the genomes of the 12 bacterial species in this study (plus three additional species 
not included in the model human gut microbiota) was designed and manufactured in collaboration 
with the Affymetrix chip design team. Control probes targeting intergenic regions from each ge-
nome were also tiled onto the array to allow detection of any contaminating gDNA. Hybridizations 
were carried out with 0.9-5.1 µg cDNA using the manufacturer’s recommended protocols. Details 
regarding the design of this GeneChip are deposited under Gene Expression Omnibus (GEO) ac-
cession GPL9803.
Custom mask files were generated for each species on the GeneChip for the purposes of 
performing data normalization one species at a time. Normalization of raw intensity values was 
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carried out in Affymetrix Microarray Suite (MAS) v5.0. MAS output was exported to Excel where 
advanced filtering was used to identify those probe sets called present in at least 5 of 7 cecal 
RNA samples in at least one diet tested. Data from probe sets that did not meet these criteria (i.e., 
genes that were not expressed on either condition) were not included in subsequent analyses. Nor-
malized, filtered data were evaluated using the Cyber-T web server [46] to identify differentially 
expressed genes. Genes were generally considered significantly differentially expressed in cases 
meeting the following three criteria: p < 0.01, PPDE(<p) ≥ 0.99, and |fold-change| ≥2.
Metatranscriptomics (microbial RNA-Seq). Methods for extracting total microbial RNA 
from mouse feces and cecal contents, depleting small RNAs (e.g., tRNA) and ribosomal RNA (5S, 
16S, and 23S rRNA), and for converting depleted RNA to double-stranded cDNA were described 
previously [10]. Illumina libraries were prepared [8] from 26 fecal samples obtained from the 
second diet oscillation experiment (4 animals, 6-7 time-points surveyed per animal), using 500 ng 
of input double-stranded cDNA/sample/library. RNA-Seq reads were aligned to the reference ge-
nomes using the SSAHA2 aligner [47]. Normalization of the resulting raw counts was performed 
using the DESeq package in R [38]. Raw counts derived from the community metatranscriptome 
were normalized either at the community level (i.e., counts from all genes were included in the 
same table during normalization) for purposes of looking at community-level representation of 
functions (ECs) of interest, or at the species level (i.e., counts from each species were independent-
ly normalized) for purposes of looking at gene expression changes within individual species. Data 
adjustment (logarithmic transformation) and hierarchical clustering were performed using Cluster 
3.0 [48] and GENE-E. Heatmap visualizations of expression data were prepared using JavaTree-
view [49] and Microsoft Excel. The B. cellulosilyticus WH2 in vitro gene expression dendrogram 
presented was prepared using GENE-E. Bootstrap probabilities at each edge of the dendrogram 
were calculated using the ‘pvclust’ package in R (10,000 replications). Clusters with bootstrap p-
values >0.95 were considered strongly supported and statistically significant.
Metaproteomics (sample preparation). Cecal contents were collected from four mice and 
solubilized in 1 mL SDS lysis buffer (4% w/v SDS, 100mM Tris·HCl (pH 8.0), 10mM dithioth-
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reitol (DTT)), lysed mechanically by sonication, incubated at 95°C for 5 min, and centrifuged at 
21,000 x g. Crude protein extracts were precipitated using 100% trichloroacetic acid (TCA), pel-
leted by centrifugation, and washed with ice-cold acetone to remove lipids and excess SDS. Pro-
tein precipitates were resolubilized in 500 µL of 8M urea and 100mM Tris·HCl (pH 8.0), reduced 
by incubation in DTT (final concentration of 10mM) for 1 h at room temperature, and sonicated 
in an ice water bath (Branson (model SSE-1) sonicator; 20% amp; 2 min total (cycles of 5 sec on, 
10 sec off)). An aliquot of each protein extract was quantified using a bicinchoninic acid (BCA)-
based protein assay kit (Pierce). Protein samples (1 mg) were subsequently diluted with 100mM 
Tris·HCl and 10mM CaCl
2
 (pH 8.0) to a final urea concentration below 4M. Proteolytic digestions 
were initiated with sequencing grade trypsin (1/100, w/w; Promega) and incubated overnight at 
room temperature. A second aliquot of trypsin was added (1/100) after the reactions were diluted 
with 100mM Tris·HCl (pH 8.0) to a final urea concentration below 2M. After incubation for 4 h 
at room temperature, samples were reduced by incubation in 10 mM DTT for 1 h at room tem-
perature. Finally, the peptides were acidified (protonated) in 200mM NaCl and 0.1% formic acid, 
filtered, and concentrated with a 10 kDa molecular weight cutoff spin column (Sartorius).
Metaproteomics (LC-MS/MS data collection). The peptide mixture from each mouse was 
analyzed in technical duplicate via two-dimensional liquid chromatography (LC)-MS/MS on a 
hybrid LTQ Orbitrap Velos mass spectrometer (Thermo Fisher Scientific). Peptides (~100 µL per 
sample) were separated using a split phase 2D (strong-cation exchange (SCX) and C
18
 reverse 
phase (RP))-LC column over a 12-step gradient for each run. All MS analyses were performed in 
positive ion mode. Mass spectral data were acquired using Xcalibur (v2.0.7) in data-dependent 
acquisition mode for each chromatographic separation (22 h run). One precursor MS scan was 
acquired in the Orbitrap at 30K resolution followed by ten data-dependent MS/MS scans (m/z 400-
1700) at 35% normalized collision energy with dynamic exclusion enabled at a repeat count of 1. 
MS/MS spectra were searched with SEQUEST (v.27; [50]) using the following settings: enzyme 
type = trypsin; precursor ion mass tolerance = 3.0 Da; fragment mass tolerance = 0.5 Da; fully 
tryptic peptides and those resulting from up to 4 missed cleavages only. All datasets were filtered 
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with DTASelect (v1.9; [51]) using the following parameters: Xcorrs of 1.8, 2.5, and 3.5 for singly, 
doubly, and triply charged precursor ions; DeltCN ≥ 0.08; ≥ 2 fully tryptic peptides per protein.
A custom-built FASTA target-decoy database [52,53] was generated and searched with 
SEQUEST at a peptide-level false positive rate (FPR) estimated at ≤ 0.5%. The database contained 
theoretical proteomes predicted from the genomes of the 12 bacterial species characterized in this 
study (see Tables S3, S8), some diet components (e.g., rice and yeast) and common contaminants 
(e.g., keratins). Three additional theoretical bacterial proteomes predicted from the genomes of 
Eubacterium rectale, Faecalibacterium prausnitzii M21/2 and Ruminococcus torques were in-
cluded as distractors (negative controls) that were not expected to be present in any of the samples 
analyzed. An in silico tryptically digested protein sequence database was also used to generate a 
theoretical peptidome of unique peptides within a mass range of 600-4,890 Da and ≤ 1 miscleav-
ages.
Metaproteomics (analysis of proteomic datasets). Spectral counts for each protein were 
normalized by either the total number of spectra collected for all species in a sample (normaliza-
tion by community, ‘NBC’), or by the total number of spectra collected for all proteins from a 
given species (normalization by species, ‘NBS’). p values for each protein were calculated using 
the Mann–Whitney U test. To correct for multiple comparisons, q values were calculated using an 
optimized false discovery rate (FDR) approach with the ‘qvalue’ package in BioConductor. Re-
gardless of the normalization strategy employed, p and q values were only calculated for proteins 
with at least 3 valid runs, where a valid run was one with more than 5 spectral counts. In NBC data, 
p and q values were calculated for all proteins within the model metaproteome. In NBS data, p and 
q values were calculated for each species-specific set of proteins. Differences in spectral counts 
between treatment groups (diets) were calculated using group medians. A protein was designated 
as ‘UP’-regulated if both its p and q values were less than 0.05 and the spectral count difference 
between treatment groups was greater than 5. The same criteria were applied in the opposite direc-
tion for proteins labeled as ‘DOWN’. For proteins labeled ‘NULL’, there was insufficient evidence 
to report any significant difference between the two treatment groups. Finally, a protein was con-
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sidered detected, or ‘present’, in a sample if at least four (raw) spectral counts were assigned to 
that protein when aggregating the results from the two runs (technical replications) performed on 
the sample.
Phenotypic screen of the growth of Bacteroides spp. on various carbohydrates. The abil-
ity of Bacteroides cellulosilyticus WH2 and Bacteroides caccae (ATCC 43185) to grow on a panel 
of 47 simple and complex carbohydrates was evaluated using a phenotypic array whose compo-
sition has been previously described [18]. Growth measurements were collected in duplicate (2 
wells per substrate) over the course of three days at 37°C under anaerobic conditions. A total of 
three independent experiments were performed for each species tested (i.e., n=6 growth profiles/
per substrate/species). Total growth (A
tot
) was calculated from each growth curve as the differ-
ence between the maximum and minimum optical densities (OD
600
) observed (i.e., A
max
 - A
min
). 
Growth rates were calculated as total growth divided by time (A
tot
 / (t
max
-t
min
)), where t
max
 and t
min
 
correspond to the time-points at which Amax and Amin, respectively, were collected. Consolidated 
statistics from all six replicates for each of the 47 conditions tested for each species are provided 
in Table S11.
Profiling of B. cellulosilyticus WH2 gene expression during growth in defined minimal 
medium containing various carbohydrates (microbial RNA-Seq). To characterize the impact of 
select mono- and polysaccharides on the in vitro gene expression of B. cellulosilyticus WH2, cells 
were cultured in minimal medium (‘MM’) supplemented with one of 31 distinct carbohydrates 
(for the formulation of MM and a list of the carbohydrates used as growth substrates, see Tables 
S12, S13). After recovery from a frozen stock on BHI blood agar, a single colony was picked and 
inoculated into 5 mL of MM containing 5 mg/mL glucose. Anaerobic conditions were generated 
within each individual culture tube using a previously described method [54] with the following 
modifications: (i) the cotton plug was lit and extinguished before being pushed below the lip of 
the culture tube; and, (ii) 200 µL of saturated sodium bicarbonate was combined with 200 µL 35% 
(w/v) pyrogallate solution on top of the cotton plug before a bare rubber stopper was used to seal 
the tube. Cultures were grown overnight at 37°C. Twenty microliters of this ‘starter’ culture was 
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subsequently inoculated into a series of ‘acclimatization’ cultures, each containing 5 mL of MM 
plus one of the 31 carbohydrates to be tested (5 mg/mL final concentration), and anaerobic cultur-
ing was carried out as above. This second round of culturing served two purposes: (i) it ensured 
cells were acclimated to growth on their new carbohydrate substrate prior to the inoculation of 
the final cultures that were harvested for RNA; and (ii) it provided an opportunity to obtain OD
600
 
measurements indicating, for each carbohydrate, the range of optical densities corresponding to 
B. cellulosilyticus WH2’s logarithmic phase of growth. Finally, 50 µL of each ‘acclimatization’ 
culture was inoculated into triplicate 10 mL volumes of medium of the same composition, and 
the 93 ‘harvest’ cultures were grown anaerobically at 37°C. At mid-log phase, 5 mL of cells were 
immediately preserved in Qiagen RNAprotect Bacteria Reagent according to the manufacturer’s 
instructions. Cells were then pelleted, RNAprotect reagent was poured off, and the bacteria were 
stored at -80°C.
After thawing, while still cold, each bacterial cell pellet was combined with 500 µL Buffer B 
(200mM NaCl, 20mM EDTA), 210 µL of 20% SDS, and 500 µL of acid phenol:chloroform:isoamyl 
alcohol (125:24:1, pH 4.5). The pellet was resuspended by manual manipulation with a pipette tip 
and transferred to a 2 mL screwcap tube containing acid-washed glass beads (Sigma, 212-300 µm 
diameter). Tubes were iced, bead-beaten for 2 min at room temperature (BioSpec Mini-Beadbeat-
er-8; set to ‘homogenize’), placed on ice, and bead-beaten for an additional 2 min, after which time 
the RNA extraction protocol proceeded as for fecal/cecal samples.
Identification of diet-specific fitness determinants within the B. cellulosilyticus WH2 
genome using INsertion Sequencing (INSeq). Whole genome transposon mutagenesis of B. cel-
lulosilyticus WH2 was performed using protocols originally developed for B. thetaiotaomicron 
[Goodman 2009, 2011], with some modification. Initial attempts to transform B. cellulosilyticus 
WH2 with the pSAM_Bt construct reported by Goodman et al. yielded very low numbers of an-
tibiotic resistant clones, which we attributed to poor recognition of one or more promoters in the 
mutagenesis plasmid. Replacement of the promoter driving expression of the transposon’s eryth-
romycin resistance gene (ermG) with the promoter for the gene encoding EF-Tu in B. cellulosi-
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lyticus WH2 (BWH2_3183) dramatically improved the number of resistant clones recovered after 
transformation. The resulting library consisted of 26,750 distinct transposon insertion mutants in 
78.8% of all predicted ORFs (mean = 5.3 distinct insertion mutants / ORF).
At 11-weeks-of-age, male germ-free C57BL/6J mice (individually caged) were fed either 
a diet low in fat and rich in plant polysaccharides (LF/HPP) or high in fat and simple sugars (HF/
HS). After a week on their experimental diet, the animals received a single gavage containing the 
B. cellulosilyticus WH2 transposon library and 14 other species of bacteria (i.e., the model com-
munity consisted of the 12 species listed in Fig. 1A, plus B. thetaiotaomicron 7330, Eubacterium 
rectale ATCC 33656, and Clostridium symbiosum ATCC 14940). After 16 d, fecal pellets were 
collected, and total fecal community DNA was extracted.
Five hundred nanograms of each fecal DNA extraction was diluted in 15 µL of TE buffer 
and digested with MmeI (4 U, New England Biolabs) in a 20 µL reaction supplemented with 10 
pmoles of 12 bp DNA containing an MmeI restriction site (to improve the efficiency of restriction 
enzyme digestion) [Goodman, 2009]. The reaction was incubated for 1 h at 37oC and then termi-
nated (80oC for 20 min). MmeI-digested DNA was subsequently purified using 125 µL of AMPure 
beads (after washing the beads once with 100 µL of sizing solution (1.2 M NaCl and 8.4% PEG 
8000)). The digested DNA was added to the beads and the solution incubated at room temperature 
for 5 min. Beads were pelleted with a Magnetic Particle Collector (MPC), washed twice (each time 
using a mixture composed of 20 µL TE (pH 7.0) and 100 µL sizing solution, with bead recovery 
via MPC after each wash), followed by two ethanol washes (180µL 70% ethanol/wash) and air-
drying for 10 min. Samples were resuspended in 18 µL TE (pH 7.0) and the DNA was removed 
after pelleting beads with the MPC. Ligation of adapters was performed in a 20 µL reaction that 
contained 16 µL of purified DNA, 1 µL of T4 Ligase (2000 U/µL; NEB), 2 µL 10X ligase buf-
fer and10 pmoles of barcoded adapter (incubation for 1 h at 16oC). Ligations were subsequently 
diluted with TE (pH 7.0) buffer to a final volume of 50 µL, mixed with 60 µL of AMPure beads, 
and incubated at room temperature for 5 min. Beads with bound DNA were pelleted using the 
MPC and washed twice with 70% ethanol as above. After allowing the ethanol to evaporate for 10 
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min, 35 µL of nuclease-free water was added and the mixture was incubated at room temperature 
for 2 min before collecting the beads with the MPC. Enrichment PCR was performed in a final 
volume of 50 µL using 32µL of the cleaned up sample DNA, 10 µL 10X Pfx amplification buffer 
(Invitrogen), 2 µL 10mM dNTPs, 0.5 µL 50mM MgSO
4
, 2 µL of 5µM amplification primers (For-
ward primer: 5’CAAGCAGAAGACGGCATACG3’, Reverse primer: 5’AATGATACGGCGAC-
CACCGAACACTCTTTCCCTACACGA3’), and 1.5 µL Pfx polymerase (2.5 U/µL; Invitrogen) 
22 cycles of denaturation at 94oC for 15 sec, annealing at 65oC for 1 min and extension at 68oC for 
30 sec. The 134 bp PCR product from each reaction was purified [4% metaphore gel; MiniElute 
Gel extraction kit (Qiagen)] in a final volume of 20 µL, and was quantified (Qubit, dsDNA HS As-
say Kit; Invitrogen). Reaction products were then combined in equimolar amounts into a pool that 
was subsequently adjusted to 10nM and sequenced (Illumina Hi-Seq2000 instrument).
Supplementary results
Evaluating the carbohydrate utilization capabilities and preferences of B. caccae, a HF/HS 
diet-adapted species. Comparing CAZyme expression between three diet-insensitive Bacteroides 
spp. (B. thetaiotaomicron, B. vulgatus, and B. cellulosilyticus WH2) and HF/HS-favoring B. cac-
cae revealed that these two groups have dissimilar profiles. While diet-insensitive strains express 
many CAZymes on both diets, and roughly equal percentages of their encoded CAZymes in a 
diet-specific manner, B. caccae’s CAZyme utilization is heavily skewed (Fig. S6B). While 19% of 
B. caccae CAZymes were expressed in mice regardless of the diet consumed, an additional 28% 
of this species’ predicted CAZymes were expressed in animals consuming the HF/HS diet. In con-
trast, B. caccae expressed only 1% of its predicted CAZymes in a LF/HPP diet-specific manner.
Phenotypic characterization of B. caccae on the same carbohydrate growth array we used 
to characterize B. cellulosilyticus WH2’s substrate utilization capabilities revealed significant de-
ficiencies in B. caccae’s ability to utilize many simple and complex sugars (Table S11). Of par-
ticular note were its complete lack of any starch utilization system (as evidenced by its inability 
to grow on amylopectin derived from both potato and maize, as well as dextran and pullulan) and 
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its inability to utilize any type of hemicellulose or β-glucan tested. These deficiencies strongly 
contrast the strong growth we observed for B. cellulosilyticus WH2 when it was grown on several 
such compounds. A complete comparison of the growth capabilities of B. cellulosilyticus WH2 and 
B. caccae reveals the striking fact that with the exception of one monosaccharide (N-acetylneur-
aminic acid), B. cellulosilyticus WH2 growth outperforms that of B. caccae on every carbohydrate 
tested.
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Supplementary figure legends
Figure S1. Phylogenetic relatedness of B. cellulosilyticus WH2 to other Bacteroides species. 
(A) Near full-length 16S rRNA gene sequences from the B. cellulosilyticus WH2 isolate, its three 
closest relatives (B. xylanisolvens, B. intestinalis, and B. cellulosilyticus), and Parabacteroides 
distasonis (the latter was included as an outgroup) were aligned against the SILVA SEED using the 
SINA aligner [55]. The 5’ and 3’ ends of the resulting multiple sequence alignment were trimmed 
to remove ragged edges, and the final alignment was used to construct an approximately-maxi-
mum-likelihood phylogenetic tree using FastTree v2.1.4 [56]. Sequences in the trimmed alignment 
used to generate the tree shown correspond to bases 22-1498 of the Escherichia coli 16S rRNA 
gene [57]. Parenthetical identifiers indicate the locus tag (for B. cellulosilyticus WH2, whose ge-
nome contains four copies of the 16S rRNA gene) or accession number (for all other strains) of 
each sequence included in the phylogenetic analysis. (B) Identity matrix summarizing the pairwise 
similarities (as % nucleotide sequence identity) for all 16S rRNA gene sequences used to construct 
the tree shown in panel A.
Figure S2. Representation of all putative glycoside hydrolase (GH) families identified in the 
B. cellulosilyticus WH2 genome compared to their representation in other sequenced Bacte-
roidetes species. Enumeration of the GH repertoire of Bacteroides cellulosilyticus WH2 relative 
to (A) the six other Bacteroidetes species included in the model community described in Fig. 1A, 
and (B) the 86 Bacteroidetes currently annotated in the CAZy database. GH numbers in red signify 
CAZy families whose representation is greater in B. cellulosilyticus WH2 than any of the other 
Bacteroidetes to which it is being compared. An asterisk following a GH family number indicates 
genes encoding proteins from that family were found exclusively in the B. cellulosilyticus WH2 
genome. In (B), GH family numbers are ordered from left to right and from top to bottom by their 
average representation within the 87 Bacteroidetes genomes included in the analysis.
Figure S3. Design and sampling schedule for experiments E
1
 and E
2
.
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Figure S4. COPRO-Seq analysis of the proportional representation of component taxa in 
the 12-member model human gut microbiota as a function of time after colonization of gno-
tobiotic mice and the diet they were consuming. (A) Average DNA yields from fecal and cecal 
samples collected from each treatment group in experiment E
1
. (B) DNA yields from samples col-
lected in experiment E
2
. (C) COPRO-Seq quantitation of the 12 bacterial species comprising the 
synthetic community used to colonize germ-free mice in experiments E
1
 and E
2
. Vertical dashed 
lines at days 14 and 28 denote time-points at which diets were switched. Panels A-C share a com-
mon key, provided in the upper right. Circles and triangles denote samples from experiments E
1
 
and E
2
, respectively. Cecal sample data points (obtained at sacrifice on day 42 of the experiment) 
are plotted as for fecal sample data, but with inverted colors (i.e., colored outline, solid black fill). 
For all panels (A-C), data shown are mean ± SEM.
Figure S5. Further COPRO-Seq analysis of the relative abundance of components of the 
12-member model human microbiota as a function of diet and time. (A) Plot of the ordination 
results for experiment 1 (E
1
) from the principle coordinates analysis (PCoA) described in Fig. 1B. 
COPRO-Seq data from E
1
 and E
2
 were ordinated in the same multi-dimensional space. For clar-
ity, only data from E
1
 are shown (for the E
2
 PCoA plot, see Fig. 1B). Color code: red/blue, feces; 
magenta/cyan, cecal contents. (B) Heatmap representation of the relative abundance data from 
E
1
 normalized to each species’ maximum across all time-points within a given animal (“% of % 
max”). Each heatmap cell denotes the mean for one treatment group (n=7 animals), and each treat-
ment group is shown as its own heatmap.
Figure S6. GeneChip profiling of the cecal metatranscriptome in mice fed different diets. (A) 
Venn diagram illustrating the number of bacterial genes whose expression was scored as ‘present’ 
(i.e., detectable in ≥ 5 of 7 animals), only in mice that were consuming the plant polysaccharide-
rich LF/HPP diet, only in mice that were consuming a ‘Western’-like HF/HS diet, or in both 
groups. (B) Overview of the diet-specificity of CAZyme gene expression in the 12-member model 
microbiota and in four prominent community members that maintained a proportional representa-
tion in the cecal microbiota that was >5% on each diet.
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Figure S7. Dissecting the model human gut microbiota’s in vivo expression of EC 3.2.1.8 (endo-
1,4-β-xylanase). (A) Gene expression in E
2
 fecal samples was evaluated by microbial RNA-Seq. 
After data from all 12 species in the model microbiome were binned by EC number annotation and 
normalized (i.e., data were ‘community-normalized’ at the level of ECs), no significant difference 
in the representation of EC 3.2.1.8 in the metatranscriptome was observed when comparing day 
13 (LF/HPP diet) and day 27 (HF/HS diet) data. (B) Transcribed B. cellulosilyticus WH2 genes 
account for >99% of community-normalized RNA-Seq counts assignable to EC 3.2.1.8. Thus, B. 
cellulosilyticus WH2 virtually dictates the degree to which expressed endo-1,4-β-xylanase genes 
are represented within the community metatranscriptome. (C) B. cellulosilyticus WH2 contributes 
a greater number of normalized RNA-Seq counts to the community metatranscriptome in HF/
HS-fed mice, despite being relatively more abundant in LF/HPP-fed animals. (D) When B. cel-
lulosilyticus WH2 gene expression data are normalized independently of data from other commu-
nity members (i.e., when data are ‘species-normalized’), statistically significant increases in the 
representation of EC 3.2.1.8 within the B. cellulosilyticus WH2 transcriptome become apparent 
in HF/HS-fed mice. (E) Breakdown of the total species-normalized counts in (D) by the B. cel-
lulosilyticus WH2 gene from which they were derived. Mean values ± SEM are shown. Means for 
all panels were calculated from data from four animals at each time-point, except day 26 (n=2).
Figure S8. Shotgun metaproteomic analysis of cecal samples from gnotobiotic mice colonized 
with the model 12-member human gut microbiota. (A) Each species’ theoretical proteome was 
subjected to in silico trypsinization (see Methods). Of the resulting peptides, those specific to a 
single protein within our database of all predicted proteins encoded by the genomes of the 12 bac-
terial community members, the mouse, and 3 bacterial ‘distractors’ (Eubacterium rectale, Faecali-
bacterium prausnitzii, and R. torques) were classified as ‘unique’, while all others were considered 
‘non-unique’. The ‘unique’ fraction of a species’ predicted peptides indicates how many can be 
unambiguously traced back to a single protein of origin if detected by LC-MS/MS. (B) Compari-
son of the average relative cecal abundance of each bacterial community member (dark gray bars) 
with the percentage of proteins within its theoretical proteome that were detected by LC-MS/MS 
160
(red bars), and the percentage of all genes within its genome whose expression was detected using 
our custom GeneChip (light gray bars). Data shown are mean values ± SEM. (C) Scatter plots il-
lustrating Pearson’s correlation between log-transformed averages of diet-specific expression fold-
differences as determined by GeneChip assay (RNA, x-axis) and LC-MS/MS (protein, y-axis) in 
E
1
. Data points within the black scatter plot represent the 448 B. cellulosilyticus WH2 genes for 
which reliable quantitative data could be obtained for animals in both diet treatment groups for 
both the GeneChip and LC-MS/MS assays (i.e., any gene for which a signal could not be detected 
on at least one diet treatment in at least one assay were excluded). Scatter plots in color represent 
the results of correlation analyses performed on subsets of genes within the black plot whose 
KEGG annotations fall within particular functional categories, including “Translation” (r=0.03, 
59 genes), “Energy metabolism” (r=0.36, 58 genes), “Amino acid metabolism” (r=0.48, 67 genes) 
and “Carbohydrate metabolism” (r=0.69, 110 genes). For both (B) and (C), n=2 mice per treatment 
group (4 mice total).
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Figure S5.
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Figure S8.
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Chapter 4
Future directions
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Introduction
The experimental system and molecular tools developed over the course of this dissertation pro-
vide a means of addressing any number of questions about how the human gut microbiota as-
sembles, operates, and responds to environmental changes over time. Our studies of the effects 
of introducing probiotic strains into an established microbiota (discussed in Chapter 2) provide a 
framework for identifying and characterizing future probiotic strains, probiotic consortia, prebiot-
ics, and synbiotics (combinations of pre- and probiotics). We expect that data from studies using 
model communities to dissect the mechanisms by which probiotic strains influence host physiol-
ogy will significantly impact the ways we treat individuals suffering from malnutrition, metabolic 
syndrome, inflammatory disorders, and other pathophysiological states that have been linked to 
the gut microbiota/microbiome [1-3]. Our studies of the influence of diet change over time on 
the microbiota (discussed in Chapter 3) provided many valuable insights about how communities 
are reconfigured in terms of both their structure and function in response to an altered nutrient 
landscape, as well as how prominent taxa (e.g., B. cellulosilyticus WH2) adjust their substrate 
utilization strategies. Follow-up future studies can adopt a similar strategy to identify the specific 
components of diets that drive desirable or undesirable reconfigurations in microbiota of different 
human populations. At least three additional areas of research and development building on the 
findings reported in Chapters 2 and 3 could and should be pursued, as described below.
Creating more representative models of the human microbiota
Culturing the ‘unculturable’
Although research performed in our laboratory has recently demonstrated that a significant number 
of the microbes residing in a human gut microbiota represent lineages that can be cultured using 
traditional methods [4], the fact remains that the human gut also harbors many species that are 
recalcitrant to growth in the laboratory [5]. One example is the bacterial phylum TM7. Repre-
sentatives from this as-yet ‘unculturable’ group were first identified by sequencing the 16S rRNA 
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gene in environmental samples from a German peat bog [6]. Since then, they have been found in 
many other habitats, including the human intestine [7]. Unculturable gut bacteria also come from 
phyla (divisions) with many cultured representatives. For example, some families from two of the 
best-studied intestinal phyla, the Firmicutes (e.g., Lachnospiraceae) and the Bacteroidetes (e.g., 
Porphyromonadaceae, Prevotellaceae, Rickenellaceae) are comprised of many species we cannot 
yet study in isolation. The defined communities of human gut bacteria characterized in this dis-
sertation have been comprised exclusively of sequenced, culturable organisms. If monocultures of 
a microbe cannot be prepared or if a microbe’s genome cannot be sequenced, it is not eligible for 
inclusion in model community studies of the type described here. Because we know or infer from 
culture-independent metagenomic studies that currently unculturable organisms can play impor-
tant roles in the human gut [8], finding ways to expand our inventory of culturable gut microbes 
will be critical as we aim to develop even more functionally and structurally representative models 
of human gut communities.
Some ‘unculturable’ organisms may not be amenable to being grown in isolation because 
their metabolism requires inputs (e.g., nutrients, signaling cues) from other microbial partners, and/
or researchers may not be sufficiently replicating essential aspects of their natural gut environment 
[9]. Model communities such as those employed here offer one avenue for characterizing the na-
ture of such mutualistic relationships through in vivo coculture experiments. In theory, a researcher 
could use gnotobiotic mice colonized with defined and representative model communities as a type 
of culturing vessel or in vivo ‘test tube’ into which difficult or impossible-to-culture organisms 
could be introduced. Such organisms could come from samples where species diversity has been 
artificially depressed to enrich the target species population, for example through the administra-
tion of antibiotics. These low-complexity consortia could then be introduced into gnotobiotic mice 
harboring model communities with the aim of establishing the unculturable organism in a more 
defined setting. Studies of environments with low levels of species complexity, such as acid mine 
drainage sites, have shown that the genomes of the organisms comprising simple communities can 
be reconstructed from metagenomic data [10]. We anticipate that if an unculturable organism (and 
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a small number of other accompanying species) could be established in a gnotobiotic mouse colo-
nized beforehand with species whose genomes are sequenced, it should be possible to reconstruct 
the genomes of the newly introduced organisms. Further, establishment of the target species in a 
model ecosystem would allow us to study its metabolic lifestyle with the same metatranscriptomic 
(RNA-Seq) and high-resolution metaproteomic methods used in this dissertation to characterize 
microbe-microbe and diet-microbe interactions, offering important insights not provided by the 
inspection of its genome sequence alone [11].
Personal culture collections
The studies carried out over the course of this dissertation have made use of carefully constructed 
models meant to be representative of a healthy human gut microbiota in terms of its phylogenetic 
structure, gene content, and functional capacity. As we strive to assemble even more representative 
models of the microbiota, we must account for that the fact that the way in which assemblages of 
organisms operate may be dictated by their composition, their co-evolution within an individual, 
family or population representing a given lifestyle (cultural tradition), as well as the physiological 
status of an individual host. Thus, a ‘one size fits all’ model community may not always be ap-
propriate or most effective for addressing particular biological questions. For this reason, we an-
ticipate a move in the future towards greater study of ‘personal culture collections’ [4] comprised 
of clonally arrayed, culturable microbes isolated from single individuals. These personal culture 
collections would each be constructed using a sample (e.g., feces) from an individual possessing 
particular age, physiological state, cultural tradition, or disease state. Armed with our current and 
future (see above) understanding of the culturing requirements of gut microbes, we would isolate 
the majority of taxa from a human subject’s microbiota and archive them as a subject-specific 
model microbiota. Transplantation of these culture collections into germ-free mice would then be 
performed to determine if consortia faithfully recapitulate (transmit) microbiota-mediated human 
donor phenotypes in gnotobiotic animals. Should our attempts at transferring human phenotypes to 
germ-free hosts using culture collections prove effective, further characterization of the microbes 
driving particular phenotypes could be conducted. Such follow-up studies could include the se-
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quencing of isolate genomes to gain insight about their metabolic potential and nutrient require-
ments, introduction of subsets of the community, mutagenesis of individual isolates prior to their 
inclusion in a model community, and/or replacement of a given member with by closely-related 
species to determine how general or specific important traits might be within a specific lineage. 
Developing new and improved tools and techniques for characterizing model communities
Construction of more representative models of the human gut microbiota should also be accom-
panied by development of new and improved methods for characterizing these communities; this 
would allow us to interrogate their structure and operations in more detailed (comprehensive) as 
well as more holistic ways. Some of the methods that were developed or improved over the course 
of this dissertation can be scaled to characterize highly diverse model communities fairly easily. 
For example, COPRO-Seq can accommodate communities of nearly any complexity, provided 
they are comprised exclusively of sequenced species whose genomes can be differentiated from 
one another. Microbial RNA-Seq is also scalable and can be used to characterize complex commu-
nities if financial resources are available to sequence the metatranscriptome deeply. Although the 
structure and function of model communities can be probed readily with current techniques, there 
are also many biological parameters of the gut ecosystem that we are not yet capable of measuring 
with sufficient accuracy or throughput. This includes, for example, the spatial relationship between 
microbes and the gut’s cellular and luminal contents (the latter includes its mucus layer as well as 
partially digested food particles). Future efforts to develop methods for measuring some of these 
parameters are described below.
Absolute quantitation of microbial biomass and taxon abundance
In earlier chapters, we demonstrated that COPRO-Seq provides precise and accurate measure-
ments of the proportional representation of each species within a model community. When inter-
preting changes in a species’ proportional abundance over time, it is important to consider that 
such changes can be driven by at least two factors: (i) an increase/decrease in the absolute abun-
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dance of that species within the community, and (ii) an increase/decrease in the absolute abun-
dance of other species within the community. Currently, COPRO-Seq is not capable of providing 
the researcher with precise measurements of absolute abundance unless additional data (e.g., mea-
surements of total microbial cell concentrations, total community biomass) are provided. In cases 
where the proportional abundance of an organism is impacted to a significant degree by a pertur-
bation, the direction of the perturbation’s effect on a particular species can be inferred with strong 
confidence. However, subtle changes can be much more difficult to interpret. We have therefore 
begun investigating approaches that can complement COPRO-Seq by providing measures of total 
cell concentrations or total community biomass over time, so that the absolute abundance of each 
species in a community can be calculated. In the simplest method, total community DNA is used 
as a proxy for community biomass. Experimental data suggest, however, that measurements of fe-
cal DNA concentrations are noisy from sample-to-sample, and we cannot rule out the possibility 
that the composition of the diet fed to a gnotobiotic host might affect DNA extraction yields. A 
second method involves using fluorescence activated cell sorting (FACS) to ‘count’ the number 
of bacterial cells in a gut sample (e.g. feces). This approach uses DNA-specific dyes and the light 
scattering properties of bacterial cells to differentiate microbes in a sample from all other particles. 
By counting labeled cells and comparing their concentration to that of a spiked-in bead standard 
of known size, a reliable estimate of the total bacterial cell count in a sample can be obtained. It is 
also possible that the addition of other reagents might allow for the discrimination of live and dead 
cells. Although the latter approach for quantifying the absolute abundance of the species within a 
model community is still under investigation, we anticipate that it will ultimately serve as an im-
portant element of the molecular tool kit used by those studying model gut communities.
An expanded role for INSeq in model community studies
In Chapter 3, INsertion Sequencing (INSeq; [12,13]) was used to confirm that certain highly-ex-
pressed loci within the genome of Bacteroides cellulosilyticus WH2 act as important diet-specific 
fitness determinants in vivo. This approach, which was developed as part of the study described 
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in Appendix A, provides the researcher with a powerful tool for identifying fitness determinants 
in any microbial species that can be transformed with a sequencing-adapted mariner transposon 
delivery vector. Recently, members of our laboratory developed a version of this delivery vector 
that incorporates specific barcodes that, when sequenced along with captured chromosomal DNA 
located adjacent to an inserted transposon, can be used to distinguish different mutagenized popu-
lations of cells. This improvement on the original pSAM vector allows us to mutagenize and pool 
multiple species of gut bacteria when constructing model communities so that rather than iden-
tifying the genetic determinants of fitness in one species at a time, many different species can be 
evaluated simultaneously. Future studies leveraging this technical innovation should be performed 
to identify genes that are broadly important for microbial success/persistence within the gut. Such 
studies, identifying ‘general’ fitness determinants shared among members of a particular microbial 
lineage, could serve as a foundation for experiments that seek to identify other shared suites of 
genes needed for fitness in particular contexts (e.g., specific host physiological/pathological states 
or diets). Given their dominance in the human gut, role in human health [14] and the breakdown of 
macronutrients [15], and their genetic tractability, we see members of the Bacteroidetes as prime 
candidates for such studies going forward.
New imaging techniques for evaluating gut biogeography
Although metagenomic surveys have taught us much about the overall composition of the distal 
human gut microbiota, we still know surprisingly little about the microhabitats occupied by in-
dividual lineages and how the spatial distribution of a particular species is impacted by variables 
such as diet and invasion of the ecosystem by new taxa. Fluorescence in situ hybridization (FISH) 
has been used for years as a method for quantifying [16] and visualizing [17,18] microbes in a vari-
ety of ecosystems; the method is based on short, fluorescently-labeled oligonucleotide probes that 
hybridize to small subunit ribosomal RNAs (e.g.,16S rRNA). One of the drawbacks of traditional 
FISH-based methods is the inability of fluorescence microscopes to differentiate more than a hand-
ful of fluorophores simultaneously. This limitation prevents those studying microbial communities 
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from using more than two or three labeled oligonucleotide probes at once. Therefore, these stud-
ies typically involve low-resolution visualization of bacteria using ‘universal’ probes which label 
most or all bacteria, or probes designed to label taxonomically-related species (e.g., those of the 
same genus or class). In collaboration with researchers at the Marine Biological Laboratory, we 
have begun to apply a new variation of FISH to the study of defined model human gut communi-
ties in gnotobiotic mice. This method, known as combinatorial labeling and spectral imaging fluo-
rescence in situ hybridization (CLASI-FISH; [19,20]) allows the researcher to visualize at least 15 
and as many as hundreds of different species simultaneously. Our initial experiments have shown 
that the method is tractable in samples collected from mice, and that spatial relationships between 
all taxa in a model community can be quantified simultaneously. As these methods are developed 
further and applied to defined communities of increasing complexity, we expect to delineate new, 
previously unappreciated syntropic relationships between taxonomic groups and develop a greater 
understanding of how microbes compete and cooperate to achieve stable community configura-
tions within the gut.
Further study of specific taxa and ecological guilds
Focused studies characterizing widely distributed gut taxa are important for understanding how 
particular lineages influence the operations of larger gut communities, and help us understand the 
role of keystone species within these systems. For instance, decades of research on Bacteroides 
thetaiotaomicron, whose genome was first sequenced in 2003 [21], have helped us better under-
stand how gut microbes utilize polysaccharides [22,23], interact with the mucosal immune system 
[24], and adapt metabolically during postnatal host development [25]. In another example, exten-
sive microbiological studies of Faecalibacterium prausnitzii and the Roseburia have revealed the 
important role these species play in the production of butyrate, an important source of energy for 
colonocytes [26]. Studies focused on different ecological guilds of intestinal microbes (i.e., those 
that exploit the same resources, often in related ways) have also taught us a about their roles in gut 
food webs. Examples of such guilds are the methanogenic archaea [27] and acetogenic bacteria 
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[28]. As our appreciation grows for the diversity of functional niches occupied by intestinal bacte-
ria, so too will our need to better characterize the roles and capabilities of individual members of 
the gut microbiota. 
Based on the experimental results described in Chapter 3, we would advocate strongly for 
further characterization of B. cellulosilyticus WH2, both in vitro and as a component of defined 
model human gut communities. Our draft sequence of this microbe’s genome reveals it to be the 
largest of any Bacteroides species to date. More importantly, it is also the most replete in carbohy-
drate active enzymes (CAZymes) and polysaccharide utilization loci (PULs) of any member of the 
Bacteroidetes sequenced so far. Though the link between its substantial carbohydrate utilization 
armamentarium and its strong fitness on disparate diets is still somewhat speculative, our data do 
suggest that this species utilizes multiple carbohydrates in vivo, perhaps indicative of a diversified 
nutrient utilization strategy. Such a strategy is likely to provide a fitness advantage to a bacterium 
colonizing the gut of a host whose diet is far from monotonous. 
While the studies outlined in this dissertation have greatly expanded our understanding of 
this bacterium, further efforts to ‘crack the code’ of its carbohydrate utilization strategy are needed. 
Our efforts thus far have successfully identified one or more substrates that trigger the expression 
of at least 30 susC/D gene pairs (the core elements of PULs) in its genome and have revealed that 
its metabolic strategy focuses largely on the catabolism of diet-derived xylans. However, the sub-
strates capable of triggering the expression of over two-thirds of this organism’s 113 PULs remain 
unidentified. Furthermore, we know little about the regulatory mechanisms and exact molecular 
moieties that control the expression of individual PULs. Delineating these regulatory networks 
should help us understand how gut microbes ‘decide’ what carbon sources to compete for and 
utilize, and which receive low priority from a metabolic perspective. INSeq-based analyses have 
shown that the ability to utilize xylan is critically important to B. cellulosilyticus WH2 in vivo. 
However, the degree to which disrupting key components of PULs required for the utilization of 
other substrates and the impact of disrupting the normal regulation of these loci are areas deserving 
of further attention.
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Finally, though further characterization of carbohydrate utilization mechanisms in this 
prominent Bacteroides will be instructive, even greater insight might be gained by characterizing 
multiple other Bacteroides spp. using the same strategies employed here. Identifying the genes 
required for the utilization of particular glycans in a number of lineages should allow us to be-
gin describing different PUL ‘families’ (i.e., clusters of genes with non-identical configurations/
compositions that confer similar substrate utilization capabilities). Theoretically, the presence of 
genetic elements known to be associated with a particular PUL family could even be used as a 
metagenomic biomarker to indicate whether or not a given individual’s microbiota harbors the 
capacity to utilize particular dietary substrates. Such information could be incredibly useful as 
researchers begin to develop microbiome-directed therapeutics tailored to ‘supplement’ deficient 
activities using probiotic strategies, or ‘boost’ the representation of important lineages using pre-
biotic compounds. Finally, as more knowledge is acquired about the carbohydrate utilization capa-
bilities of different species, we anticipate the development of quantitative models that allow us to 
predict which bacteria will prosper (or perish) under particular dietary regimens and to prescribe 
diets that improve the nutritional status of humans representing different cultural traditions, at vari-
ous stages of their lifecycle.
Concluding statements 
As our appreciation grows for the many ways in which our gut microbes impact human health, 
we must be judicious and thoughtful in the ways we address the many outstanding questions that 
remain. Certainly, gut microbiota studies in human subjects will continue to yield new insights 
about the nature of our relationship with our intestinal symbionts. However, a greater focus on the 
careful characterization of representative models of this complex system under controlled condi-
tions is also warranted, and necessary, if we are to develop generalizable principles and ‘rules’ for 
how this important ‘microbial organ’ operates.
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SUMMARY
The human gut microbiota is a metabolic organ
whose cellular composition is determined by a
dynamic process of selection and competition. To
identify microbial genes required for establishment
of human symbionts in the gut, we developed an
approach (insertion sequencing, or INSeq) based
on a mutagenic transposon that allows capture of
adjacent chromosomal DNA to define its genomic
location. We used massively parallel sequencing to
monitor the relative abundance of tens of thousands
of transposon mutants of a saccharolytic human
gut bacterium, Bacteroides thetaiotaomicron, as
they established themselves in wild-type and
immunodeficient gnotobiotic mice, in the presence
or absence of other human gut commensals. In vivo
selection transforms this population, revealing func-
tions necessary for survival in the gut: we show how
this selection is influenced by community composi-
tion and competition for nutrients (vitamin B12).
INSeq provides a broadly applicable platform to
explore microbial adaptation to the gut and other
ecosystems.
INTRODUCTION
Our indigenous microbial communities play critical roles in
shaping myriad features of our biology. The distal gut hosts the
majority of our microbes; these include representatives of all
three domains of life, plus their viruses. The density of organisms
occupying this habitat is astonishing, exceeding 1012 cells/mL.
Most phylogenetic types (phylotypes) observed in the guts of
humans and other mammals belong to just two bacterial divi-
sions (phyla)—the Firmicutes and the Bacteroidetes (Ley et al.,
2008). Microbial community (microbiota) exchange experiments
indicate that gut community members are dynamically selected:
for example, transplantation of a Proteobacteria-dominated
zebrafish gut microbiota into germ-free mice transforms this
community so that it comes to resemble a mouse gut microbiota,
while transplantation of a mouse microbiota into germ-free
zebrafish has the opposite effect, yielding a community that
has the phylum-level characteristics of the native zebrafish
microbiota (Rawls et al., 2006).
Within the Firmicutes and Bacteroidetes, hundreds to thou-
sands of phylotypes partition available niches (professions) to
create a community able to maintain itself in this continuously
perfused ecosystem despite shifts in host diet, regular ingestion
of foreign bacteria, intense resource competition, high bacterio-
phage levels, and immune surveillance. Comparisons of the
sequenced genomes of cultured representatives of major gut
phylogenetic lineages provide a means for identifying genomic
features potentially important for colonization and competition
in the gut. However, the recent surge in microbial genome
sequencing projects has far outpaced development of broadly
applicable tools for directly testing the role of genes in deter-
mining fitness in this habitat. The paucity of tools is unfortunate,
as fundamental questions connecting genome content to func-
tion remain unexplored. For example, how are the determinants
of fitness related to nutrient availability, and how closely do the
genes required for fitness in vivo mirror those required for maxi-
mizing growth rate in vitro? Does community structure influence
this map of genetic requirements, or is competition largely
‘‘within species’’? Do the major recognized components of the
host immune system play a dominant role in determining which
genes are critical for symbiont fitness in vivo? To address these
questions, we integrated a simple and broadly applicable
genetic tool with second-generation DNA sequencers and
gnotobiotic mouse models to identify fitness determinants in
the genome of a human gut mutualist.
Mariner transposon mutagenesis is an attractive forward
genetic strategy for connecting phenotype to gene because
stable random insertions can be generated in a recipient genome
without specific host factors: the ability of these transposons to
serve as mutagenic agents is well established in members of all
three domains of life (Lampe et al., 1996; Mazurkiewicz et al.,
2006). After alignment of the inverted repeat (IR) sequences
that delimit mariner family transposons, we noted that a single
G-T transversion at a nonconserved position would create
a recognition sequence for the type IIs restriction enzyme
MmeI. When directed to this location, MmeI would cleave 16 bp
outside of the transposon, capturing a genomic fragment that
identifies the insertion site. Moreover, if the genome sequence
of the recipient organism were known, the short genomic
DNA sequences captured by this MmeI digestion would be suffi-
cient to uniquely map transposon location. We reasoned that
in a mixed population of transposon mutants produced in a
given recipient bacterial species, the relative abundance of
each MmeI-liberated genomic fragment, identified after limited
PCR amplification and massively parallel sequencing, would in
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principle mirror the abundance of each mutant in the population.
Putting this population under potentially selective conditions
(e.g., colonization of the intestines of gnotobiotic mice) could
then be used to highlight mutants that change in relative abun-
dance, and thereby identify genes and pathways critical for
fitness under these conditions (Figure 1A).
Using this insertion-sequencing (INSeq) approach, we sub-
jected a mutagenized population of the prominent human gut
symbiont, Bacteroides thetaiotaomicron, to varying selective
pressures: in vitro growth in continuous flow chemostats, mono-
association of wild-type and knockout germ-free mice lacking
major branches of their innate or acquired immune systems,
and as one component of several defined in vivo communities
of human gut-derived microbes. The results provide evidence
that human gut symbionts, like their pathogenic counterparts,
possess dedicated mechanisms critical for interaction with their
host and each other. The relative importance of these mecha-
nisms is not static but instead is shaped by other members of
the microbiota. As a strategy for functional characterization of
newly sequenced genomes in general, and of the human gut
microbiome in particular, INSeq extends existing techniques in
several important aspects.
RESULTS
We constructed pSAM, a sequencing-adapted mariner trans-
poson delivery vector with three major features: an antibiotic
resistance cassette flanked by MmeI-modified mariner IRs,
a multiple cloning site immediately upstream of the himar1C9
mariner transposase (Lampe et al., 1999), and machinery for
replication in the donor strain and transfer by conjugation (see
Figures S1A–S1C available online). B. thetaiotaomicron was
chosen as the recipient species to test this approach for several
reasons (Figure S2A). First, it is highly adapted to life in the distal
human gut (Zocco et al., 2007). A prominent member of the
gut microbiota, this mutualist is richly endowed with a broad
arsenal of genes encoding glycoside hydrolases and polysac-
charide lyases not represented in the human genome (Xu et al.,
2003). These genes are incorporated together with genes
encoding nutrient sensors and carbohydrate transporters into
88 polysaccharide utilization loci (PULs) representing 18% of
the organism’s genome (Martens et al., 2008). Thus equipped,
B. thetaiotaomicron functions as a flexible forager of otherwise
indigestible dietary glycans, as well as host glycans when
dietary polysaccharides are not available (Martens et al., 2008).
Second, >200 GeneChip data sets of B. thetaiotaomicron’s
transcriptome have been collected during growth in vitro under
a variety of conditions, after monocolonization of germ-free
mice fed different diets, as well as after cocolonization with
another human gut bacterial or archaeal species (NCBI GEO
archive). Third, functional genomic studies conducted in gnoto-
biotic mice have shown that monoassociation withB. thetaiotao-
micron can recapitulate a number of host responses evoked
by a complete mouse gut microbiota. Fourth, a limited number
of in vivo competition experiments conducted in gnotobiotic
mice colonized with isogenic wild-type and mutantB. thetaiotao-
micron have identified a few fitness determinants that could
serve as reference controls for the present study (Peterson
et al., 2007).
Construction and Characterization of a Transposon
Mutant Population by INSeq
We found that transfer of the MmeI-modified mariner transposon
into the genome of B. thetaiotaomicron occurs with high effi-
ciency (Figure S2). To identify the site of transposon insertion
and the relative abundance of each mutant in an otherwise
isogenic population, we developed a straightforward procedure
to extract the two 16 bp genomic sequences adjacent to each
Figure 1. Mapping and Quantifying Tens of
Thousands of Transposon Insertion Strains
by High-Throughput INSeq
(A) A negative selection scheme for identification
of genes required for colonization in vivo. Mutants
in genes important for competitive growth (red) are
expected to decrease in relative abundance in the
output population.
(B) Preparation of an INSeq library. Genomic DNA
is extracted from the mutagenized bacterial
population, digested with MmeI, and separated
by polyacrylamide gel electrophoresis (PAGE).
Transposon-sized fragments are appended with
double-stranded oligonucleotide adapters by liga-
tion. Limited cycles of PCR create the final library
molecules for sequencing.
(C) Map of insertion sites in the B. thetaiotaomi-
cron genome. An arrow marks the origin of
replication.
(D) Reproducibility of library preparation and
sequencing protocols. Technical replicates were
prepared and sequenced from a single transposon
mutant population. Each point represents the
abundance of insertions in a single gene; the
coefficient of determination, R2, on log-trans-
formed abundance values is 0.92.
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transposon, append sequencing adapters to these fragments,
and separate the desired molecules from genomic background
(Figure 1B and Supplemental Experimental Procedures).
Sequencing these tags using an Illumina Genome Analyzer II
produced 8 million raw reads from a single flow cell lane:
90% of these reads contained the transposon (Figure S2D).
We designed a software package, MapSAM, to filter out low-
quality sequences, quantify and pair reads generated from either
side of an insertion, and assign these paired reads to a specific
location in the target genome (Figure 1C). Examination of
technical replicates indicated that the library preparation,
sequencing, and mapping strategies were highly reproducible
(Figure 1D and Figure S3). The proportion of reads that were
unambiguously mapped (98%) matched predictions from an
in silico model of random transposon insertion (Figure S4A);
no insertion sequence bias beyond the known ‘‘TA’’ dinucleotide
requirement (Bryan et al., 1990) was apparent (Figures S4B
and S4C).
We first characterized a mutant population containing
35,000 B. thetaiotaomicron transposon insertion strains. Inser-
tions were well distributed across the genome at an average
density of 5.5 insertions/kb (Figure 1C). After filtering out inser-
tions in the distal (30) 10% of any coding region (because such
insertions could possibly still permit gene function), we found
that 3435 of the 4779 predicted open reading frames in the
genome (72%) had been directly disrupted in the mutant
population. Inclusion of genes disrupted by upstream (polar)
mutations in a predicted operon increased this number to 78%;
rarefaction analysis suggested that this population is approach-
ing saturation (Figure S4D).
To identify B. thetaiotaomicron genes unable to tolerate trans-
poson insertion, we generated and mapped a second, indepen-
dent mutant population. We combined both data sets and
applied a Bayesian model to account for the number of informa-
tive insertion sites in each gene (Lamichhane et al., 2003). The
results yielded a conservative list of 325 candidate essential
genes for growth under anaerobic conditions when plated onto
rich (tryptone-yeast extract-glucose; TYG) medium (Table S1).
These genes were significantly enriched (Benjamini-Hochberg
corrected p < 0.05) for Clusters of Orthologous Groups (COG)
categories representing cell division (category D), lipid trans-
port/metabolism (I), translation/ribosomal structure/biogenesis
(J), and cell-wall/membrane biogenesis (M). This is consistent
with genome-wide mutagenesis studies of Escherichia coli and
Pseudomonas aeruginosa (Baba et al., 2006; Jacobs et al.,
2003). For nonessential genes, insertion frequency showed
some correlation (R2 of log-transformed values = 0.33) with
GeneChip-defined expression levels during mid-log phase
growth of the parental wild-type strain in batch fermentors
containing TYG medium (Figure S4E). The reason for this rela-
tionship is not known, although studies of mariner transposition
in vitro suggest that the enzyme has a preference for bent or
bendable DNA (Lampe et al., 1998).
Combinatorial Mapping of Individual Insertion Strains
from an Archived Mutant Collection
A mutant population of this complexity contains insertions in
most of the coding potential of the genome and can facilitate
forward genetic approaches for identifying genotypes con-
nected with a phenotype of interest. These mixed populations,
however, are less amenable to reverse genetics: specific geno-
types are not individually retrievable. Arrayed transposon mutant
collections, in which strains of known genotype are archived
individually, provide an important avenue for retrieval and further
study of specific strains of interest. To date, such collections
have been created by using a strain-by-strain procedure that
typically consists of cell lysis, removal of cellular debris, multiple
rounds of semirandom or single-primer PCR, DNA cleanup, and
individual Sanger sequencing of each amplicon. As an alterna-
tive, we developed a combinatorial technique for simultaneously
mapping thousands of individually archived transposon mutant
strains in parallel (Figure 2A, Figure S5, and Supplemental Exper-
imental Procedures).
This approach consists of three basic steps: (1) culturing and
archived storage of randomly picked mutant colonies in indi-
vidual wells of 96-well (or higher density) plates, (2) placement
of each of these strains into pools in unique patterns, and (3)
sequencing of these pools by INSeq in order to associate
each transposon insertion location with a strain in the original
arrayed multiwell plates. Because n pools can contain 2n unique
presence/absence patterns, a small number of pools can
uniquely identify a large number of strains. To this end, a bench-
top liquid-handling robot was used to distribute archived
transposon mutant strains across a subset of pools in a pattern
selected to minimize the likelihood of mistaking one strain for
another or incorrectly mapping clonal strains (Figure 2B and
Supplemental Experimental Procedures). Libraries were then
prepared from each pool using the same method described in
Figure 1B, except that a pool-specific, barcoded adaptor
(Table S2) was used in the ligation step. These libraries were
combined into a single sample that can be sequenced with an
Illumina Genome Analyzer II using just one lane of the instru-
ment’s eight-lane flow cell. Reads were first mapped to the
reference B. thetaiotaomicron genome to determine insertion
sites; to assign an insertion site to a specific archived strain,
the pool-specific barcodes associated with a given insertion
location on the chromosome were then matched with the
patterns assigned to the strains in the original archived set of
plates.
Using this strategy, we were able to identify the insertion coor-
dinates for over 7000 individually archived B. thetaiotaomicron
transposon mutant strains in parallel (Table S3). To verify the
accuracy of these assignments, we first used ELISA to test
strains predicted to have lost reactivity to two monoclonal anti-
bodies of known specificity (Peterson et al., 2007). We also
amplified transposon-genome junctions of test strains by semi-
random PCR and sequenced the amplicons. In total, 179 of
183 strains tested (98%) produced the anticipated results
(Figure 2C), confirming that combinatorial barcoding and INSeq
can be used to efficiently and economically generate archived,
sequence-defined, mutant collections.
Identification of Genes Required for Fitness In Vitro
To identify genes that contribute to exponential growth in
nutrient-rich conditions in vitro, we maintained a 35,000-strain
mutant population in this growth phase (OD600 0.1–0.4), under
anaerobic conditions, in chemostats that were continuously
supplied with fresh TYG medium. Output populations were
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sampled from four independent chemostats; two after 15 hr
of continuous exponential growth and two after 45 hr of
growth. DNA was prepared from each of these populations,
and transposon-adjacent genomic fragments were identified
by INSeq. After removing insertions in the 30 10% of each
gene, a z test was applied to identify genes that show a signif-
icantly altered representation from the overall distribution of
output:input abundance ratios after q value correction for
multiple hypothesis testing (q < 0.05; see the Supplemental
Experimental Procedures). To test this approach for identifying
fitness determinants, we also examined insertions in intergenic
‘‘neutral loci’’ (Figure S6A). None of these 80 control regions
passed the statistical cutoff for underrepresentation (three
increased in abundance). In contrast, 477 genes (14% of
the genes represented in the input population) showed a
statistically significant change in abundance after in vitro selec-
tion (265 underrepresented/212 overrepresented; Figure S6B
and Table S4). Consistent with selection for maximal growth
rate in rich medium, the list of factors important for fitness
under these conditions was significantly enriched in genes
annotated as being in COG category C (energy production
and conversion).
As a proof of principle, we asked whether an observed
enrichment in a broad functional group (COG category), repre-
sented among genes required for fitness, could be altered by
manipulating environmental conditions. To do so, we harvested
exponentially growing cells from mutant populations grown in
minimal defined medium in the presence or absence of exoge-
nous amino acids and quantified the abundance of transposon
mutants by INSeq (n = 4 replicate populations, each assayed
independently). Gratifyingly, the set of genes required for fitness
specifically in the amino acid-depleted condition was most
highly enriched (p < 0.0005) in COG category E (amino acid
transport/metabolism) (Figure S7 and Table S5).
Genes Required for Establishment
of B. thetaiotaomicron within the Distal Gut
of Monoassociated Gnotobiotic Mice
To survey the B. thetaiotaomicron genome for genes critical for
fitness in a mammalian gut ecosystem, we colonized germ-free
mice with a single gavage of approximately 108 colony-forming
units (CFUs) of the 35,000-strain mutant population (n = 15
animals representing three independent experiments, each
involving a cohort of five 8- to 12-week old C57BL/6J males;
experiments were performed 3 months apart). The five animals
in each cohort were caged individually in a shared gnotobiotic
isolator and fed a standard, autoclaved, polysaccharide-rich,
low-fat chow diet ad libitum. The relative abundance of each
mutant strain in the cecal bacterial population was defined at
the time of sacrifice 14 days after gavage; this interval between
gavage and sacrifice encompassed several cycles of turnover
of the mucus layer and the underlying gut epithelium, and is
sufficient to allow mobilization of innate and adaptive immune
responses (Peterson et al., 2007).
All recipients of the gavage harbored equivalent levels of
B. thetaiotaomicron at the time of sacrifice (1011–1012 CFU/
mL cecal contents as quantified by plating and by qPCR). More-
over, the relative representation of mutants was consistent
Figure 2. Mapping an Archived Strain
Collection by Combinatorial Pooling and
High-Throughput Sequencing
(A) Individual strains are archived in a 96-well
format and then placed into a subset of 24 pools
according to a unique 24-bit binary string as-
signed to each strain. Libraries are prepared
from each of these pools using the workflow
shown in Figure 1B, except that one of 24 pool-
specific barcoded dsDNA adaptors is employed
in the ligation step. Libraries are then combined
and sequenced in a single run. Reads mapping
to a specific insertion location are compiled and
the associated pool-specific barcodes are identi-
fied to recreate the 24-bit string and, with it, the
physical location of the corresponding strain in
the archived collection. For details, see the
Supplemental Experimental Procedures.
(B) Sample pool distribution patterns for archived
strains. A given strain (row) is placed in pools
(columns) designated with white boxes and
omitted from pools marked with black boxes.
The patterns generated are each distinct in at
least six positions and do not overlap to produce
another pattern in the set. For details, see the
Supplemental Experimental Procedures.
(C) Confirmation of strain-insertion assignments.
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between the ceca of individual mice (Tables S9–S11) and for
most genes reflected their abundance in the input population
(Figure 3A). However, compared to the input population, mutants
in 370 genes showed significantly (q < 0.05) altered representa-
tion (90 overrepresented/280 underrepresented) in all three
cohorts of mice (Table S6; note that the largest category of genes
identified in this screen encode hypothetical or conserved hypo-
thetical proteins). Only one of the 80 ‘‘neutral intergenic’’ controls
described above was significantly underrepresented in these
populations (two were overrepresented).
While the smaller group of 90 genes that produce a competitive
advantage in the cecum when mutated (highlighted in Table S6
in blue and green) are not significantly enriched in any broad
predicted functional (COG) categories, only half can be
explained by corresponding behavior in chemostats containing
rich medium. The underrepresented genes show a similar trend:
half (146) of the 280 genes critical for in vivo fitness can be
predicted from growth defects in rich medium; the remainder
(134/280), which are highlighted in Table S6 in yellow, do not
show a defect after prolonged exponential growth in vitro. These
include loci with diverse predicted functions, including assem-
bly of polysaccharide- and protein-based surface structures
(BT1339-55, BT1953-7), synthesis and utilization of vitamin
B12-dependent cofactors (BT2090-1, BT2760), and an rnf-like
oxidoreductase complex (BT0616-22) (e.g., Figure S8).
To confirm that the requirement for these genes in vivo
could not be explained by general growth defects, we analyzed
individual mutant strains retrieved from the archived strain
collection. This collection contained sequence-defined, single-
insertion transposon mutants in 70% of the genes designated
as critical for survival in the distal gut in vivo (80% if predicted
polar effects are included) (Table S3). After validating the site of
selected transposon insertions by semirandom PCR and Sanger
sequencing, we determined the exponential doubling time of
representative strains individually (Figure 3B). Strains carrying
transposon insertions in genes uniquely required in vivo had an
in vitro growth rate similar to wild-type B. thetaiotaomicron,
further suggesting that the critical function of these genes
in vivo cannot be simply explained by a necessity for sustaining
exponential growth in rich medium. In contrast, mutants that
exhibited a competitive defect in the 35,000-strain population
both in vitro and in vivo had a slower doubling time when cultured
individually, suggesting that these genes play a basic role in
bacterial cell physiology.
An earlier report from our group used a targeted mutagenesis
strategy to disable expression of genes encoding capsular poly-
saccharide (CPS) 4 in this organism; this strain was rapidly dis-
placed by wild-type B. thetaiotaomicron after initial inoculation
as a 1:1 mixture into germ-free mice (Peterson et al., 2007).
The 35,000-strain transposon mutant population recapitulated
this observation (Figure 3C and Figure S9). The transposon
mutant population included over 1100 independent insertions
across 143 genes that span all eight CPS loci encoded in the
B. thetaiotaomicron genome. None of the other CPS loci
Figure 3. Identification of Genetic Determi-
nants of Fitness In Vivo
(A) The transposon mutant population is largely
stable in vivo. The relative abundance of mutations
in each gene (points) was compared between
input and output (median from wild-type monoas-
sociated mice, n = 15) populations. Genes that
show a statistically significant change (q < 0.05)
in representation in all three cohorts of mice are
shown in red, others in gray. The relative abun-
dances of 80 gene-sized neutral loci are shown
in black (no significant change) and green (three
neutral loci that pass the significance criteria).
(B) Individual strains retrieved from the archived
collection demonstrate that genes critical for
fitness in vivo are dispensable in vitro. Each
strain was cultured individually in TYG medium,
and doubling time was calculated from OD600
measurements; error bars represent one standard
deviation based on triplicate experiments. Mut-
ants predicted by INSeq to have in vitro growth
defects are marked with arrows. N/D, no growth
detected. rnf, Na+-transporting NADH:ubiquinone
oxidoreductase (BT0616-22); S layer, putative S
layer locus (BT1953-7); nqr, Na+-translocating
NADH-quinone reductase (BT1155-60);hly, hemo-
lysin A (BT3459).
(C) Insertions in the CPS4 locus (BT1338-58) show
a consistent in vivo fitness defect. Individual inser-
tion locations (open arrowheads) in a representa-
tive gene (BT1346; green arrow) are shown at
top. Read counts for input (black) and output
(orange) samples at each insertion location are indicated (output counts represent the median from the ceca of wild-type monoassociated mice, n = 15). Median
output:input ratios for each gene (black/green arrows) across the CPS4 locus are shown below. Asterisks indicate the average FDR-corrected p value (q) across
three experimental cohorts (n = 5 mice/cohort): *q < 0.05; **q < 0.01.
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were required for fitness in vivo, indicating that CPS4 plays
a unique role for B. thetaiotaomicron in the gut environment of
monoassociated gnotobiotic mice fed a standard plant polysac-
charide-rich chow diet. Moreover, our observation that trans-
poson inactivation of genes in any single PUL did not confer
a competitive disadvantage in vivo is consistent with B. thetaio-
taomicron’s capacity for adaptive foraging of a broad range of
glycans present in this diet (a total of 5137 distinct transposon
mutants, involving 810 genes in all 88 PULs).
The Impact of Host Genotype and Community Structure
on Selection In Vivo
We next asked whether a broad view of the mutant population as
a whole could help address some basic questions in mammalian
gut microbial ecology described in the Introduction: are the
genetic determinants of fitness influenced by the bacterial
community (microbiota) context; do inter-specific competition
and intra-specific competition play distinct roles in shaping the
selective pressures on a genome; is this selection primarily main-
tained by elements of the host immune system?
To explore these questions, we manipulated two features
of the host habitat: (1) the immune system, by introducing the
B. thetaiotaomicron mutant population into germ-free mice with
genetically engineered defects in innate or adaptive immunity
(Myd88/ and Rag1/, respectively); or (2) microbial composi-
tion, by including this mutant population as one component of
three different types of defined communities, one consisting of
six other sequenced human gut-associated Bacteroidetes,
another composed of eight sequenced human gut-associated
Firmicutes and Actinobacteria, and a third consisting of all 14
Figure 4. Identification of Environmental
and Microbial Factors that Determine the
Fitness Landscape for B. thetaiotaomicron
(A) The relative abundance of each mutant in
the B. thetaiotaomicron population was evaluated
in multiple host genotypes (wild-type C57Bl/6;
Rag1/; Myd88/) and microbial contexts.
(B) qPCR assays of cecal microbial community
composition in gnotobiotic mice at the time of
sacrifice. The 35,000-strain B. thetaiotamicron
population is indicated with arrows.
of these representatives of the human
distal gut microbiota (n = 4–5 animals per
treatmentgroupperexperiment;Figure4A
and Table S7). Animals were sacrificed 14
days after gavage and their cecal contents
harvested. qPCR assays of cecal DNA,
using species-specific primers, revealed
that gavage with a given multispecies
input community yielded consistent
cecal ‘‘output’’ community compositional
profiles (Figure 4B and Table S8).
Each of these treatments shifted the
B. thetaiotaomicron population from its
input distribution (Tables S9–S12). To
search for functional trends in these shifts,
we assigned the genes underrepresented
in output populations to functional (COG) categories. The in vivo
fitness determinants were significantly enriched in different pre-
dicted functions compared to essential genes, or to the genes
required for maximal exponential growth in rich medium in vitro
(Figure 5). For example, the predicted essential genes are most
prominently enriched in COG categories J (translation, ribosome
structure/biogenesis) and D (cell-cycle control and cell division),
neither of which is enriched among the in vivo fitness determi-
nants. Instead, the genes required in vivo are biased toward
energy production/conversion (category C) and amino acid and
nucleotide transport/metabolism (COG categories E and F,
respectively). This represents an expansion beyond the single
category (C) enriched after selection for maximal growth rate
in vitro and is consistent across all in vivo treatment groups.
Closer examination of enriched COGs and carbohydrate-
active enzyme (CAZy) families highlights the role of polysaccha-
ride synthesis for competitive fitness in this environment;
overrepresented functions include UDP-glucose-4-epimerases
and glycosyltransferases (specifically, GT2 and GT4 families
[Cantarel et al., 2009]) (Table S13). Together, these observations
suggest that at the level of statistical enrichment of broad func-
tional groups, the in vivo fitness requirements were distinct from
those derived in vitro but that these enrichments were consistent
across in vivo treatment conditions. Many of the annotated
fitness determinants (e.g.,CPS4 and the rnf-like oxidoreductase)
followed this pattern: dispensable in vitro but critical across all
in vivo conditions tested.
This functional category enrichment analysis depends
critically on genome annotation (50% of genes were not
assignable to COG categories), while not accounting for
Cell Host & Microbe
INSeq-Based Functional Analysis of Microbial Genomes
284 Cell Host & Microbe 6, 279–289, September 17, 2009 ª2009 Elsevier Inc.
differences in selection magnitude between treatments. To
circumvent these limitations, we used unsupervised hierarchical
clustering to evaluate the relationships between all in vitro and
in vivo output populations (48 samples in total). In this analysis,
samples are clustered based on the relative abundance of
mutants in each gene independent of annotation. A dendrogram
of the clustering results separates the in vitro populations
from those shaped by in vivo selection (Figure 6A). The popula-
tions recovered from monoassociated wild-type, Rag1/, and
Myd88/ mice formed shared branches on this tree of mutant
population structures, suggesting that B. thetaiotaomicron may
have multiple, redundant pathways for countering immune pres-
sures, at least under the conditions of these experiments. In
contrast, the transposon mutant populations recovered from
mice that also harbored other Bacteroidetes species were fully
separable from the population structures selected in B. thetaio-
taomicron monoassociations or those resulting from the pres-
ence of a Firmicutes+Actinobacteria consortium. These patterns
were recovered in >99% of bootstrapped dendrograms and also
by unsupervised hierarchical clustering of samples based only
on the genes that showed a significantly altered output:input
ratio by z test (data not shown).
To further evaluate the robustness of the clustering algorithm,
we conducted a principal coordinates analysis on these 48
transposon mutant populations (Figure 6B and Figure S10).
Similar to the hierarchical clustering dendrograms, the first prin-
cipal coordinate separates in vitro from in vivo mutant popula-
tions. The second coordinate separates these populations by
microbial context: Bacteroidetes-containing communities shape
a B. thetaiotaomicron mutant population that is distinct from that
produced in monoassociations, or in the Firmicutes+Actinobac-
teria consortia, further indicating that although the same broad
functional categories are enriched among B. thetaiotaomicron
fitness determinants under a range of in vivo conditions, these
mutant populations are additionally shaped by changes in micro-
bial community composition.
We applied a random forest classifier (Breiman, 2001) to iden-
tify genes that were responsible for the observed separation of
mutant populations in monoassociated mice from those mutant
populations present in Bacteroidetes cocolonized mice. This
machine-learning algorithm serves to estimate the importance
of predictor variables (i.e., genes) for differentiating between
classes (i.e., the monoassociation versus Bacteroidetes
cocolonized groups, which were distinguished by unsupervised
clustering and principal coordinates analysis). This approach
identified a total of 220 genes as important for differentiating
these groups (Table S14). Mutants in 144 of these predictor
genes had lower output:input ratios in the monoassociations:
in other words, these genes were more important when other
Bacteroidetes were not present. Mutants in 76 genes had lower
output:input ratios in mice cocolonized with other Bacteroidetes.
These 76 genes, which provide a signature of functions under
increased selection for B. thetaiotaomicron in the presence of
other Bacteroidetes, are enriched for components of amino
acid biosynthetic pathways, suggesting that although these
functions are required in all in vivo conditions, other Bacteroi-
detes may outcompete B. thetaiotaomicron for exogenous
amino acids.
The Functional Requirement for a Vitamin
B12-Regulated Locus Is Modulated by Community
Composition
We identified 165 independent transposon insertions, mapping
to five adjacent genes (BT1957-53), that conferred a drastic
fitness disadvantage during monoassociation of germ-free
mice yet had no impact on exponential growth in vitro. Moreover,
their effect on fitness was influenced by community context: the
Bacteroidetes-only community exacerbated the competitive
defect, while the Firmicutes+Actinobacteria consortium fully
nullified the requirement for these genes. Introducing all 14 of
these species resulted in an intermediate phenotype (Figures
7A and 7B).
Examination of B. thetaiotaomicron transcriptional profiles
(NCBI GEO archive) disclosed that expression of genes in this
locus (spanning BT1957–BT1949) is strongly upregulated
in vivo compared to growth in vitro under a variety of conditions.
Moreover, in two closely matched experiments conducted in
defined minimal medium that differed in five components,
expression was modulated >10-fold (Table S15). This observa-
tion was validated by qRT-PCR assays of BT1954 and BT1956
(data not shown). Systematic addition of each variable
Figure 5. COG Category-Based Classification of Genes Critical for
Fitness In Vitro and In Vivo
Percent representation was calculated as (number of genes in a COG cate-
gory/number of genes underrepresented in output population). Significant
enrichments in specific COG categories, assessed by comparing these
percentages to a null expectation based on the size of the list of selected
genes and the representation of a given category in the genome, are marked
with asterisks (Benjamini-Hochberg corrected, p < 0.05).
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component revealed that locus transcription is induced in
response to reduced levels of vitamin B12 (Figure 7C). Moreover,
the ABC transporter encoded by BT1952-50 shares homology
with the BtuFCD B12 acquisition system of S. typhimurium LT2
(23%, 35%, and 25% identity, respectively).
Vitamin B12 is critically involved in normal mammalian physi-
ology yet is synthesized exclusively by microbes (Krautler,
2005). Because the complete genome sequence of each member
of the defined microbial communities used in our experiments was
known, we were able to use BLAST to identify homologs to known
B12 synthesis, transport, or utilization genes in the synthetic
human gut microbiomes (Tables S16 and S17). As described for
the related species Porphorymonas gingivalis (Roper et al.,
2000), members of the Bacteroidetes community (including
B. thetaiotaomicron) were missing some or all of the genes neces-
sary for synthesis of B12 or its direct precursors but encoded pre-
dicted transporters and likely have an obligate B12 requirement for
growth. In contrast, the Firmicute/Actinobacteria group contained
several members that harbored complete B12 biosynthetic path-
ways. To test these predictions, we attempted to culture each
species on defined medium in the presence and absence of
vitamin B12. R. obeum, a Firmicute that encodes a complete B12
biosynthetic pathway and is predicted to require the vitamin for
methionine synthesis, grew robustly without B12 in the medium,
while the Bacteroidetes were auxotrophic (Table S16). These
observations suggest that the capacity for vitamin B12 biosyn-
thesis is determined by community structure (Figure 7D) and
that B. thetaiotaomicron responds to changes in community
membership via the gene products encoded by BT1957-49.
Consistent with this observation, the fitness defect of BT1957-3
mutants correlated well with variation inR. obeum levels between
mice in vivo (R2 of log-transformed values = 0.77; Figure 7E).
Figure 6. Clustering of B. thetaiotaomicron
Mutant Population Structures after Manipu-
lation of Host Environment or Microbial
Context
(A) Unsupervised hierarchical clustering of
B. thetaiotaomicron mutant population structures
in vitro and in vivo. Branches are colored by treat-
ment. Pie charts indicate the microbial context of
the mutant population in samples from different
branches of the tree. Bootstrap support is indi-
cated by a square at each node: >50% (white),
>90% (yellow), >99% (black/unmarked).
(B) Principal coordinates analysis based on the
representation of transposon-disrupted genes.
DISCUSSION
By simultaneously profiling the relative
abundance of tens of thousands of
B. thetaiotaomicron mutants across
multiple conditions, we identified hun-
dreds of genes that are critical for the
fitness of this prominent human gut
symbiont in vivo. A large number of these
genes are not determinants of exponen-
tial growth in nutrient-replete medium
in vitro.
This approach (INSeq) for functional genome-wide analysis of
organisms for which a genome sequence (and possibly little else)
is known is generally applicable and extends existing techniques
in several important ways. First, a single transposon replaces
the sets of individually barcoded variants needed for signature-
tagged mutagenesis (Hensel et al., 1995). Second, high-
throughput sequencing provides a general alternative to the
species-specific DNA microarrays required for hybridization-
based mutant profiling (Mazurkiewicz et al., 2006). Third, this
sequencing-based strategy identifies the precise genomic loca-
tion and provides a ‘‘digital’’ count-based abundance readout of
individual insertions in both coding and noncoding regions. In
this way, independent insertions with shared behavior serve to
validate gene-level fitness effects. Finally, because mariner
family transposon activity has been demonstrated in Bacteria,
Archaea, and Eukarya, this method is generalizable. Further,
the barcoded pooling strategy used to create a sequence-
defined archived strain collection allows for retrieval of individual
strains of interest for follow-up studies of the impact of individual
gene disruptions on various microbial functions and adaptations.
In this way, a forward genetic tool (a mutagenized cell population
that can be screened for phenotypes en masse) can also serve
as a platform for reverse genetics (a collection of isogenic,
sequence-defined mutations in most of the coding potential of
the target genome).
Surprisingly, mice lacking major branches of the immune
system did not exhibit noticeably restructured B. thetaiotaomi-
cron mutant populations compared to wild-type animals. It is
possible that examination of microbial populations in closer
contact with the host mucosa, or populations from host animals
exposed to intentional immune stimulation, would aid the identi-
fication of genes differentially required for fitness in response to
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host immune surveillance. INSeq already can be applied to rela-
tively small amounts of starting material: further decreases
should help address the largely unexplored question of the rela-
tionship between the activities of the innate and/or adaptive
immune systems and the biogeography of the microbiota.
Our study underscores how selection is shaped by microbial
context. Because the INSeq strategy specifically targets
transposon-adjacent chromosomal fragments, it is possible to
monitor changes in the structure of a mutagenized population
(in either wild-type or genetically manipulated gnotobiotic
mice) even if this population constitutes a small fraction of
a larger microbial community. For example, using unsupervised
hierarchical clustering and principal coordinates analysis to eval-
uate the relationships between B. thetaiotaomicron mutant
population structures in defined microbial communities in vivo,
we observed that the presence of other Bacteroides was an
important determinant of the selective pressures acting on the
B. thetaiotaomicron genome. Additionally, we identified a mech-
anism by which B. thetaiotaomicron senses and responds to
changes in gut microbial community structure: this species
employs the products of BT1957-49 in response to variations
in vitamin B12 levels that result from changes in community
composition. These genes are dispensable in rich medium
in vitro and become increasingly critical for fitness in vivo as
the levels of B12 prototrophic species (such as R. obeum) are
reduced. The mechanism by which R. obeum relieves this selec-
tive pressure, the role of the surface (S layer) proteins encoded
by this locus, and the consequences of microbial B12 competi-
tion on host physiology await further study.
In principle, INSeq can be extended to an analysis of commu-
nities of defined species composition introduced into gnotobi-
otic mice together with, before, or after introduction of one or
more transposon-mutagenized species. Subsequent INSeq-
based time series studies of these deliberately constructed
microbial populations offer the opportunity to address a wide
range of unanswered questions about properties of our gut
microbiota, ranging from the characteristics, determinants, and
ecologic principles underlying its initial assembly, to the genomic
correlates of niche partitioning among its members, to the
genetic and metabolic factors that determine the persistence
Figure 7. Community Context Modulates
the Fitness Requirement for a Vitamin B12-
Regulated Locus in B. thetaiotaomicron
(A) Genetic organization and predicted annotation
of the BT1957-49 locus.
(B) The relative abundance of transposon insertion
mutants in input and output mutant populations is
dependent on community context. Asterisks indi-
cate FDR-corrected p value (q) for each cohort:
*q < 0.05; **q < 0.01. Note that few insertions/
reads were identified in the input community for
BT1952-49 (Table S9); therefore, these genes are
not included in the analysis shown in this panel.
(C) BT1956 gene expression is regulated by
vitamin B12. Error bars represent one standard
deviation based on triplicate qRT-PCR experi-
ments. Similar results were observed for BT1954
(data not shown). Interestingly, BT1956 insertion
mutants do not exhibit growth defects in medium
containing either 37 or 0.37 nM B12, suggesting
that multiple loci are involved in acquisition of
this vitamin in vitro (data not shown). Consistent
with this observation, other loci annotated as
being potentially involved in B12 uptake were
coordinately upregulated with BT1957-49 in
genome-wide transcriptional profiling experi-
ments.
(D) Pie charts showing that the defined microbial
communities characterized in this study vary in
their capacity for vitamin B12 biosynthesis. Color
codes are as follows: dark blue, species with a pre-
dicted complete biosynthetic pathway (see Tables
S16 and S17 for annotations) that are able to grow in defined medium lacking B12 (‘‘demonstrated prototrophs’’); light blue, organisms with a predicted complete
biosynthetic pathway able to grow on rich medium but not on defined medium with or without B12 (‘‘predicted prototrophs’’); dark green, species without
a complete pathway whose growth in defined medium requires B12 (‘‘demonstrated auxotrophs’’); light green, species without a complete biosynthetic pathway
unable to grow on defined medium with or without B12 (‘‘predicted auxotrophs’’); black, species that do not grow on defined medium with or without B12 but that
possess a B12-independent methionine synthase (the presence of such an enzyme implies the absence of a B12 requirement). The relative proportions of proto-
trophs and auxotrophs shown represent the average in each community in vivo as determined by species-specific qPCR of cecal contents.
(E) The B. thetaiotaomicron fitness requirement for BT1957-3 correlates with levels of the B12-prototrophic species Ruminococcus obeum in the microbial
community. Each point represents an individual mouse containing a defined multispecies microbiota in addition to the B. thetaiotaomicron transposon mutant
population. Color code is as follows: blue, Firmicutes+Actinobacteria community; pink, Bacteroidetes+Firmicutes+Actinobacteria. The relative abundance of
R. obeum (determined by qPCR analysis of cecal contents at the time of sacrifice) is plotted against the average output:input ratio of B. thetaiotaomicron trans-
poson mutants in genes BT1957-3 in each individual.
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and impact of various probiotic and enteropathogen species
(and degree to which the functions required for persistence of
gut mutualists overlap with those of pathogens [Hendrixson
and DiRita, 2004; Lalioui et al., 2005; Liu et al., 2008; Shea
et al., 2000]).
In summary, INSeq can be applied to a variety of phylotypes to
identify factors that shape their adaptations to myriad environ-
ments, and further, to readily retrieve mutants in the genes
encoding such factors. As such, INSeq, and the rapidly evolving
capacity for massively parallel DNA sequencing that supports its
application, should be a useful platform for microbial genetics,
genomics, and ecology.
EXPERIMENTAL PROCEDURES
Bacterial Culture Conditions
Escherichia coliS-17 lpir strains (Cowles et al., 2000) were grown at 37C in LB
medium supplemented with carbenicillin 50 mg mL1 where indicated in the
Supplemental Experimental Procedures. B. thetaiotaomicron VPI-5482
(ATCC 29148) was grown anaerobically at 37C in liquid TYG medium (Holde-
man et al., 1977) or on brain-heart-infusion (BHI; Becton Dickinson) agar
supplemented with 10% horse blood (Colorado Serum Co.). Antibiotics (genta-
micin 200mg mL1 and/or erythromycin 25mg mL1) were added as indicated in
the Supplemental Experimental Procedures. Other human gut-derived species
were cultured in supplemented TYG (TYGs: see the Supplemental Experimental
Procedures).
Genetic Techniques
DNA purification, PCR, and restriction cloning were performed by using
standard methods. Primer sequences are provided in Table S19. pSAM
construction and mutagenesis protocols are described in the Supplemental
Experimental Procedures.
Preparation and Sequencing of Transposon Population Libraries
A detailed protocol is provided in the Supplemental Experimental Procedures.
Genomic DNA was purified, digested with MmeI, and separated by PAGE.
Transposon-sized fragments were extracted from the gel and ligated to
a double-stranded DNA adaptor bearing a 30-NN overhang. PAGE-purified
adaptor-ligated library molecules were PCR amplified for 18 cycles using
a transposon-specific and an adaptor-specific primer. The 125 bp product
was purified by PAGE and sequenced using an Illumina Genome Analyzer as
described in the user’s manual. Sequence images were converted into raw
reads using Illumina software with default settings. Filtered, normalized, and
mapped sequencing results from all samples are provided in Tables S9–S12
and S18.
Gnotobiotic Husbandry
All experiments using mice were performed using protocols approved by the
animal studies committee of Washington University. Germ-free mice were
maintained in gnotobiotic isolators and fed a standard autoclaved chow
diet (B&K Universal, East Yorkshire, UK) ad libitum. Animals were sacrificed
14 days after gavage and cecal contents frozen immediately at 80C.
ACCESSION NUMBERS
All of the sequencing results from this study are available from the Gene
Expression Omnibus (GEO) database (http://www.ncbi.nlm.nih.gov/geo/) at
accession number GSE17712.
SUPPLEMENTAL DATA
Supplemental Data include 10 figures, Supplemental Experimental Proce-
dures, Supplemental Protocol, Supplemental MapSAM Software, Supple-
mental References, and 19 tables and spreadsheets and can be found with
this article online at http://www.cell.com/cell-host-microbe/supplemental/
S1931-3128(09)00281-9.
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any XMRV isolates with the same or nearly the
same sequences identified elsewhere originated
from this event (23).
References and Notes
1. R. Schlaberg, D. J. Choe, K. R. Brown, H. M. Thaker,
I. R. Singh, Proc. Natl. Acad. Sci. U.S.A. 106, 16351 (2009).
2. A. Urisman et al., PLoS Pathog. 2, e25 (2006).
3. V. C. Lombardi et al., Science 326, 585 (2009).
4. A. C. Van der Kuyl, M. Cornelissen, B. Berkhout,
Front. Microbiol. 1, 147 (2011).
5. R. A. Weiss, BMC Biol. 8, 124 (2010).
6. S. Hué et al., Retrovirology 7, 111 (2010).
7. H. C. Groom, M. W. Yap, R. P. Galão, S. J. Neil,
K. N. Bishop, Proc. Natl. Acad. Sci. U.S.A. 107, 5166
(2010).
8. T. Paprotka et al., J. Virol. 84, 5719 (2010).
9. K. Stieler, N. Fischer, PLoS ONE 5, e11738 (2010).
10. H. P. Bogerd, F. Zhang, P. D. Bieniasz, B. R. Cullen,
Virology 410, 234 (2011).
11. C. Chaipan et al., J. Virol. 85, 4888 (2011).
12. R. M. Sramkoski et al., In Vitro Cell. Dev. Biol. Anim. 35,
403 (1999).
13. E. C. Knouf et al., J. Virol. 83, 7353 (2009).
14. M. Nagabhushan et al., Cancer Res. 56, 3042
(1996).
15. T. G. Pretlow et al., J. Natl. Cancer Inst. 85, 394
(1993).
16. C. W. Gregory, R. T. Johnson Jr., J. L. Mohler, F. S. French,
E. M. Wilson, Cancer Res. 61, 2892 (2001).
17. Materials and methods are available as supporting
material on Science Online.
18. B. Oakes et al., Retrovirology 7, 109 (2010).
19. M. J. Robinson et al., Retrovirology 7, 108 (2010).
20. V. Courgnaud, J.-L. Battini, M. Sitbon, A. L. Mason,
Proc. Natl. Acad. Sci. U.S.A. 107, 15666 (2010).
21. A. van Bokhoven et al., Prostate 57, 205 (2003).
22. V. K. Pathak, H. M. Temin, Proc. Natl. Acad. Sci. U.S.A.
87, 6019 (1990).
23. Further discussion in support of the unique origin of
XMRV and its role as the source of XMRV in PC and
CFS patients is available as supporting material in
Science Online.
24. J. Zhuang, S. Mukherjee, Y. Ron, J. P. Dougherty, J. Virol.
80, 6706 (2006).
25. R. S. Arnold et al., Urology 75, 755 (2010).
26. X. Qiu et al., Retrovirology 7, 68 (2010).
27. S. C. Lo et al., Proc. Natl. Acad. Sci. U.S.A. 107, 15874
(2010).
Acknowledgments: We thank W. Shao for analysis of MLV
diversity, and E. Freed and S. Hughes for helpful
discussions. This research was supported in part by the
Intramural Research Program of the Center for Cancer
Research, National Cancer Institute, NIH. The content
of this publication does not necessarily reflect the views
or policies of the Department of Health and Human
Services nor does mention of trade names, commercial
products, or organizations imply endorsement by the
U.S. government. This work was also supported in part
by a Bench-to-Bedside Award to V.K.P., research grant
R37 CA 089441 to J.M.C., and R01CA150197 to H.J.K.
J.M.C. was a Research Professor of the American
Cancer Society with support from the F.M. Kirby
Foundation.
Supporting Online Material
www.sciencemag.org/cgi/content/full/science.1205292/DC1
Materials and Methods
Figs. S1 to S8
Table S1
References
1 February 2011; accepted 5 May 2011
Published online 31 May 2011;
10.1126/science.1205292
Predicting a Human Gut Microbiota’s
Response to Diet in Gnotobiotic Mice
Jeremiah J. Faith, Nathan P. McNulty, Federico E. Rey, Jeffrey I. Gordon*
The interrelationships between our diets and the structure and operations of our gut microbial
communities are poorly understood. A model community of 10 sequenced human gut bacteria
was introduced into gnotobiotic mice, and changes in species abundance and microbial gene
expression were measured in response to randomized perturbations of four defined ingredients
in the host diet. From the responses, we developed a statistical model that predicted over 60%
of the variation in species abundance evoked by diet perturbations, and we were able to identify
which factors in the diet best explained changes seen for each community member. The approach
is generally applicable, as shown by a follow-up study involving diets containing various
mixtures of pureed human baby foods.
Owing to its many roles in human health(1–3), there is great interest in decipher-ing the principles that govern the opera-
tions of an individual’s gut microbiota. Current
estimates indicate that each of us harbors several
hundred bacterial species in our intestine (4, 5),
and different diets lead to large and rapid changes
in the composition of themicrobiota (6, 7). Given
the dynamic interrelationship between diet, the
configuration of the microbiota, and the parti-
tioning of nutrients in food to the host, inferring
the rules that govern the microbiota’s responses
to dietary ingredients represents a challenge (8).
Gnotobiotic mice colonized with simple, de-
fined collections of sequenced representatives of
the various phylotypes present in the human gut
microbiota provide a simplified in vivo model
system in which metabolic niches, host-microbe,
and microbe-microbe interactions can be ex-
amined by using a variety of techniques (9–12).
These studies have focused on small commu-
nities exposed to a few perturbations. We used
gnotobiotic mice harboring a 10-member com-
munity of sequenced human gut bacteria to mod-
el the response of a microbiota to changes in host
diet. We aimed to predict the absolute abundance
of each species in this microbiota on the basis of
knowledge of the composition of the host diet.
Furthermore, we wanted to gain insights into the
niche preferences of members of the microbiota
and to discover how much of the response of the
community was a reflection of their phenotypic
plasticity.
The 10 bacterial species were introduced into
germ-free mice to create a model community
with representatives of the four most prominent
bacterial phyla in the healthy human gut micro-
biota (fig. S1A) (13). Their genomes encodemajor
metabolic functions that have been identified in
anaerobic foodwebs, including the ability to break
down complex dietary polysaccharides not acces-
sible to the host (Bacteroides thetaiotaomicron,
Bacteroides ovatus, and Bacteroides caccae);
consume oligosaccharides and simple sugars
(Eubacteriumrectale,Marvinbryantia formatexigens,
Collinsella aerofaciens, and Escherichia coli);
and ferment amino acids (Clostridium symbiosum
and E. coli). We also included two species capa-
ble of removing the end products of fermentation:
a H2-consuming, sulfate-reducing bacterium
(Desulfovibrio piger) and aH2-consuming acetogen
(Blautia hydrogenotrophica).
To perturb this community, we used a series
of refined diets in which each ingredient rep-
resented the sole source of a given macronutri-
ent (casein = protein, corn oil = fat, cornstarch =
polysaccharide, and sucrose = simple sugar) and
in which the concentrations of these four ingre-
dients were systematically varied (fig. S1, B
and C, and table S1). Each individually caged
male C57Bl/6J mouse was fed a randomly se-
lected diet, with diet switches occurring every
2 weeks (n = 13 animals; fig. S1D shows the
variation of diet presentation between animals).
Shotgun sequencing of total fecal DNA allowed
us to determine the absolute abundance of each
community member, based on assignment of
reads to the various species’ genomes, in samples
obtained from each mouse on days 1, 2, 4, 7, and
14 of a given diet period (13).
To predict the abundance of each species in the
model human gut microbiome given only knowl-
edge of the concentration of each of the four per-
turbed diet ingredients, we used a linear model
yi ¼ b0 þ bcaseinXcasein þ bstarchXstarch þ
bsucroseXsucrose þ boilXoil ð1Þ
where yi is the absolute abundance of species i;
Xcasein, Xstarch, Xsucrose, and Xoil are the amounts
(in grams per kilogram of mouse diet) of casein,
Center for Genome Sciences and Systems Biology, Washington
University School of Medicine, St. Louis, MO 63108, USA.
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cornstarch, sucrose, and corn oil, respectively, in
a given host diet; b0 is the estimated parameter
for the intercept; and bcasein, bstarch, bsucrose, and
boil are the estimated parameters for each of the
perturbed diet components. Because each mouse
underwent a sequence of three diet permutations
presented in different order, and each of the diet
periods covered all of the 11 possible diets (fig.
S1D), we were able to use two of these three diet
intervals to fit the model for Eq. 1 (13 mice × 2
diets per mouse = 26 samples per bacterial spe-
cies); we then measured our ability to predict
the abundance of each bacterial species for the
13 samples in the remaining (third) diet (13).
Averaging this cross-validation from all three
subsets, the model explained over 61% of the
variance in the abundance of the communitymem-
bers (abundance-weighted mean R2 = 0.61; see
table S2 for species-specific R2).
Although the cross-validation provided evi-
dence that the response of this microbiota was
predictable from knowledge of these diet ingre-
dients, a more conclusive validation of the mod-
el would be its ability to make predictions for
new diets. Therefore, we designed six addition-
al diets with new combinations of the four re-
fined ingredients. Using a design similar to the
first experiment, eight different 10-week-old
gnotobiotic male C57Bl/6J mice harboring the
10-member community were each given a ran-
domized sequence of diets selected from the
six new diets (shaded diets L to Q in fig. S1B)
or one of the previous diets (fig. S1E). Fitting
the model parameters with the data from the
first experiment, we were able to explain 61%
of the variance in the abundance of the commu-
nity members on the new diets, showing virtually
equivalent results to the cross-validation proce-
dure (table S2).
These results indicate that the linear model
explains the majority of the variation in abun-
dance of each organism by using only a knowl-
edge of the species in the community and the
concentrations of casein, cornstarch, sucrose,
and corn oil in the diet, without having to ex-
plicitly consider the effects of microbe-microbe
or microbe-host interactions or diet order. We
also tested several other models, including
adding interactions between the variables, qua-
dratic terms, and interactions with quadratic
terms (13). After correcting for the number of
parameters in the model by using Akaike infor-
mation criterion, the linear model was still the
best-performing.
To further dissect the community response to
these diet perturbations, we needed to infer which
set of diet ingredients is associated with the
abundance of each community member. Feature
selection algorithms assume that the response
Fig. 1. Total communi-
ty abundance (biomass)
and the abundance of
each community member
can best be explained by
changes in casein. (A)
The total DNA yield per
fecal pellet increased as
the amount of casein in
the host diet increased
(shown are mean T SEM
for each tested concentra-
tion of casein). (B) Changes
in species abundance as
a function of changes in
the concentration of casein in the host diet were also apparent for all
10 species; seven species (such as B. caccae) were positively correlated
with casein concentration, whereas the remaining three species (such as
E. rectale) were negatively correlated with casein concentration. Data points
from the first and second set of mice given the refined diets (fig. S1, D and E)
are shown in purple and green, respectively, and the mean and standard error
for all diets at a given concentration of casein are shown in red and tan,
respectively.
Fig. 2. Mean community member abundance for each diet. The height of each bar indicates the total
DNA yield/biomass for a given diet. Casein concentrations (grams per kilogram) for each diet are
displayed in gray above each bar. See fig. S1 and table S1 for a description of diets A to Q.
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variable (in this case, the abundance of each or-
ganism) is potentially affected by only a fraction
of the variables in the model and use statistical
methods to choose the subset of variables that
most informatively predict the abundance of each
species. Using stepwise regression as a feature
selection procedure with the equation above, all
species in our 10-member community had the
diet variable Xcasein significantly associated with
their abundance (table S3).
E. coli and C. symbiosum were the only bacte-
ria with more than one variable significantly
associated with their abundance (casein and
sucrose for E. coli, and casein and starch for
C. symbiosum). Further exploring this finding,
we found casein highly correlated with the yield
of total DNA per fecal pellet across all diets
(Figs. 1A and 2). A component of casein, pre-
sumably amino acids and/or nitrogen, limits
the biomass of the community: This resource
limitation was observed even for combinations
of three additional refined protein and two
additional fat sources (soy, lactalbumin, egg-
white solids, olive oil, and lard; n = 9 different
diets given to another group of 9 C57Bl/6J
male mice) (fig. S2 and table S4). However,
the observed changes in species abundance are
not a simple consequence of a constant relative
abundance of each community member that is
scaled upwards as casein is increased: Three
community members (E. rectale, D. piger, and
M. formatexigens) decreased in absolute abun-
dance by –25 to 50% from the low- to high-casein
diets, even though total community biomass
tripled (Fig. 1B, fig. S3, and table S5). Similar
changes in species abundance and total com-
munity DNA levels were observed when casein
concentrations were altered in gnotobiotic mice
harboring a nine- or eight-member subset of the
original community (minus B. hydrogenotrophica
or minus D. piger and B. hydrogenotrophica)
(table S6).
Microbial RNA-seq was used on fecal RNA
samples—prepared frommice on each diet (mean=
2.1 T 0.7 replicates per diet) (table S7) (13)—to
determine whether perturbations in diet ingre-
dients correlatedwith underlying changes inmRNA
expression by community members. Each of the
36 RNA-seq data sets was composed of 36-
nucleotide-long reads (3.20 T 1.35 × 106 mRNA
reads per sample). Transcript abundances were
normalized for each of the 10 species to reads per
kilobase per million (RPKM) (14). After correct-
ing for multiple hypotheses, we found no statisti-
cally significant changes in gene expression within
a given bacterial species as a function of any of
the diet perturbations (13). Although community
members do not appear to significantly alter their
gene expression, they do respond by increasing
or decreasing their absolute abundances (Fig. 2),
adjusting the total available transcript pool in the
microbiota for processing dietary components.
For example, as casein levels are increased across
the diets B. caccae increases its contribution to
the gene pool/community transcriptome; so, the
number of transcripts per unit of casein remains
roughly constant.
Because RNA-seq provides accurate esti-
mates of absolute transcript levels (15), we used
transcript abundance information as a proxy to
predict the major metabolic niches occupied
by each community member. For species posi-
tively correlated with casein, we found high
expression of mRNAs predicted to be involved
in pathways using amino acids as substrates
for nitrogen, as energy and/or as carbon sources.
In contrast, the three species that negatively cor-
related with dietary casein concentration showed
no clear evidence of high levels of expression
of genes involved in catabolism of amino acids
(13). The changes in abundance of the negative-
ly correlated species (such as E. rectale) can be
explained by competition with another member
of the community that increases with casein (fig.
S4) (13, 16).
The power of the refined diets we used lies
in the capacity to precisely control individual
diet variables and to aid data interpretation from
more complex diets. To test whether the mod-
eling framework we used generalizes to diets
containing food more typically consumed in
human diets, we created 48 meals consisting
of random combinations and concentrations
of four ingredients selected from a set of eight
pureed human baby foods (apples, peaches, peas,
sweet potatoes, beef, chicken, oats, and rice)
(table S8). The meals were administered for
periods of 7 days to the same eight gnotobiotic
mice that we used for the follow-up refined diet
experiments described above and in fig. S1E
(13). Each mouse received a sequence of six
baby-food diets. The order of presentation of
the baby-food diets was varied between ani-
mals (table S8) (13). We measured the abso-
lute abundance of each bacterial community
member on days 1, 5, 6, and 7 for each diet.
Using the linear modeling approach described
above (13), we were able to explain over half
of the variation in species abundance using only
knowledge of the concentrations of the pureed
foods present in each meal (R2 = 0.62). We
used stepwise regression to identify the type of
pureed food (or foods) present in a given mixed
meal that was most significantly associated with
changes in each bacterial species (Fig. 3 and
table S9).
Defining the interrelationship between diet
and the structure and operations of the human gut
microbiome is key to advancing our understand-
ing of the nutritional value of food, for creating
new guidelines for feeding humans at various
stages of their life span, for improving global
human health, and for developing new ways to
manipulate the properties of the microbiota so
as to prevent or treat various diseases. The ex-
periments and model described above highlight
the extent to which host diet can explain the
configuration of the microbiota, both for refined
diets in which all of the perturbed diet compo-
nents are digestible by the host and for human
diets whose ingredients are only partially known.
These models can now be tested by using larger
defined gut microbial communities representing
those of humans living in different cultural set-
tings, and with more complex diets, including
various combinations of food ingredients that
they consume.
Fig. 3. Example of community member responses
to complex human foods. Changes in species
abundance as a function of diet ingredients were
apparent for all 10 species (table S9). (A) B. ovatus
increased in absolute abundance with increased con-
centration of oats in the diet, whereas (B and C) most
of the 10 bacterial species (including E. rectale and
C. aerofaciens) responded to multiple ingredients. The mean and standard error for all diets are plotted
(no error bars are shown when replicate points are not available). The colored z axis mesh grid on the
three-dimensional plots is a triangle-based linear interpolation of the data, with color changes corre-
sponding to the values in the color bar on the right.
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Oxytocin Selectively Gates Fear
Responses Through Distinct Outputs
from the Central Amygdala
Daniele Viviani,1 Alexandre Charlet,1 Erwin van den Burg,1* Camille Robinet,1* Nicolas Hurni,1
Marios Abatis,1 Fulvio Magara,1 Ron Stoop1,2†
Central amygdala (CeA) projections to hypothalamic and brain stem nuclei regulate the
behavioral and physiological expression of fear, but it is unknown whether these different
aspects of the fear response can be separately regulated by the CeA. We combined fluorescent
retrograde tracing of CeA projections to nuclei that modulate fear-related freezing or
cardiovascular responses with in vitro electrophysiological recordings and with in vivo
monitoring of related behavioral and physiological parameters. CeA projections emerged from
separate neuronal populations with different electrophysiological characteristics and different
response properties to oxytocin. In vivo, oxytocin decreased freezing responses in fear-conditioned
rats without affecting the cardiovascular response. Thus, neuropeptidergic signaling can
modulate the CeA outputs through separate neuronal circuits and thereby individually steer
the various aspects of the fear response.
Fear can be severely immobilizing but canalso be a major driving force for some ofhumans’ most heroic acts. In both cases, the internal emotional experience may be similar,although it may lead to substantially differentbehavioral outcomes (1–3). Studies on human
emotions often use autonomic nervous system
parameters to assess arousal, because of the role
of our internal organs in the emotional state
(4, 5). Projections from the central nucleus of the
amygdala (CeA) to the hypothalamus and dif-
ferent brain stem nuclei coordinate behavioral
and physiological fear expression (6). It has been
postulated that different fear responses, charac-
terized by more active or passive behavioral cop-
ing strategies, can be triggered by a neuronal
switch within the CeA (7). The question thus
arises whether fear responses only vary in inten-
sity, or whether different qualities of fear re-
sponses exist, reflected in different associations
between behavioral and physiological compo-
nents. We investigated whether a neurophysio-
logical basis for such a distinct regulation could
be found in the CeA.
1Centre for Psychiatric Neuroscience, Department of Psy-
chiatry, Lausanne University Hospital Center, University of
Lausanne, CH-1015 Lausanne, Switzerland. 2Department of Phys-
iology,University of Lausanne, CH-1015 Lausanne, Switzerland.
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Fig. 1. Distinct neuronal pop-
ulations of the CeM project to
PAG and DVC. (A and B) Coro-
nal views of injection sites (A) in
PAG of fluorescent green and
(B) in DVC of red microspheres
(left), corresponding CeM label-
ing (right). Scale bars: left, 1mm;
right, 500 mm. lPAG, lateral PAG;
vlPAG, ventrolateral PAG; sp5,
spinal trigeminal tract. (C) Sep-
arately labeled CeM neurons af-
ter coinjections of green and red
microspheres in respective PAG
and DVC (left) versus colabeled
neurons after injections of both
microspheres in DVC (right, scale
bar, 50 mm). (D) Quantification
of colabeled (coloc) CeM neurons (see also table S2). (E)
Electrophysiological characteristics of CeM→PAGs, “PAG” and
CeM→DVCs “DVC.” (*P < 0.05; **P < 0.01, n = 22 to 43 neurons) Error bars indicate SEM.
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